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Preface
Society is increasingly aware that food can help prevent the development of certain 
diseases. This, together with the increase in life expectancy, is changing the trend 
of food consumption. For this reason, it is important to know which bioactive 
 compounds possess a functional activity; that is, which ones produce a beneficial 
effect in the organism and can improve human health, as well as which ones can be 
used to develop nutraceuticals.
This book comprehensively reviews and compiles information on molecules with 
effect in health and that can be used to develop nutraceuticals. Organized into five 
chapters, the book covers knowledge of different active compounds in the prevention 
and treatment of prevalent diseases.
The scientists involved in the writing of this book were selected and invited because 
of their recognized expertise and important contributions in their respective fields. 
Their work made the publication of this book possible.
This book will be of help to scientists, doctors, pharmacists, chemists and other 
experts in a variety of disciplines, both academic and industrial.
I would like to thank my daughters Paula and Lucia, and my husband Alex for their 
patience and love. I extend my apologies for many hours spent on the editing of this 
book, which kept me away from them.
Dr. María Chávarri Hueda
Health and Food Area,
Health Division,
Tecnalia Research and Innovation,
Miñano (Alava), Spain
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Nutraceuticals as an Alternative to 
Maintain a Healthy Lifestyle
María Chávarri
1. Introduction
The nutraceutical concept began from a survey conducted in the United 
Kingdom, Germany, and France, which concluded that consumers gave more 
importance to diet than to hereditary factors or to exercise to achieve good health. 
The term nutraceutical was defined by the nutritionist and pharmacist Stephen 
DeFelice, president of the Foundation of Innovation Medicine, in 1989. According 
to him, “a nutraceutical is defined as a food, or part of a food, that provides medi-
cal or health benefits, including prevention and/or treatment of a disease” [1, 2]. 
Specifically, nutraceuticals are formed from active compounds obtained from 
plant foods (such as phytocomplexes) or from foods of animal origin, which are 
concentrated and provided in the appropriate pharmaceutical form, and also have 
a pharmacological effect and nutritional value [3]. These can be used effectively 
to prevent and even cure some diseases when their safety is demonstrated, have a 
greater bioavailability, and have clinically proven health effects [4]. In the case of 
Health Canada, it defines the term nutraceutical as “a product prepared from food, 
but sold in the form of pills, powder or other medicinal forms, which are generally 
not associated with food” [5].
Before the appearance of nutraceutical concept, the consumption of fruits and 
vegetables was related in a preventive and protective way with a lower risk of suf-
fering from chronic and degenerative diseases [6]. These discoveries were and are 
correlated with the diversity of plants and their richness in bioactive compounds, 
natural substances capable of modulating one or more metabolic processes, thus 
promoting health conditions [7, 8]. These substances, called phytochemicals, have 
allowed the discovery and the development of numerous medications especially for 
the treatment of diseases such as cancer, infectious diseases, cholesterolemia, and 
immunological disorders among others [9].
In the literature, other terms such as phytochemicals, herbs, spices, botanical 
medicines, dietary supplements, and secondary metabolites can be found, which 
can be mistaken for nutraceuticals [10]. In the case of dietary supplements, these 
are known as “concentrated sources of nutrients or other substances with a physi-
ological or nutritional effect to complement the diet” [11]. Nutraceuticals can 
be found in various forms (isolated compounds, dietary supplements, or whole 
foods). Therefore, all nutraceuticals are not dietary supplements, and all dietary 
supplements are not nutraceuticals [10]. The difference between nutraceuticals and 
functional food is that the former are bioactive ingredients of natural origin and 
obtained from different food matrices, while the latter is considered any fresh or 
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to having a nutritional function [12]. Therefore, a food is functional when it has 
nutraceutical ingredients.
One of the examples of nutraceuticals is seaweed. The consumption of seaweed 
as traditional food and complementary medicine was recorded 10,000 years ago 
[13]. Traditionally consumed in many Asian countries such as Japan, China, the 
Philippines, Indonesia, Malaysia, South Korea, and North Korea for centuries, the 
culinary use of seaweed began in Japan and China. In the case of western countries, 
its main application has been as a gelling agent and colloid for the food, pharma-
ceutical, and cosmetic industry. However, recently, in western countries, such as 
the USA and Europe, among others, the frequent use of seaweed as part of food has 
begun, especially for its beneficial and functional properties [14]. Currently, the 
great recognition of the beneficial properties of algae has allowed this ingredient to 
be introduced as part of food and beverages, making it an important product for the 
food industry, additives for functional foods, feed supplements, etc. [15].
Algae are a good source of nutrients such as proteins, vitamins, minerals, 
and dietary fiber; in this regard, the kelp dietary fiber is particularly rich in 
soluble fraction. If algae are compared with terrestrial vegetables, there are 
more beneficial components for health, such as ω-3 fatty acids and bioactive 
molecules. Algae synthesize various secondary metabolites that have antioxidant, 
anti-inflammatory, anticancer, and antidiabetic activity. Therefore, algae can be 
considered a natural source of great interest since they contain compounds with 
numerous biological activities and can be used for the development of nutraceu-
ticals. However, currently many industrial products based on seaweed have not 
been developed. This is due to the prolonged studies of nutritional intervention in 
humans required to demonstrate that algae are an excellent ingredient for com-
mercial nutraceuticals [13].
Nutraceuticals can be classified in various ways; however, normally, the chemi-
cal nature, the availability of food, and the mechanism of action of the bioactive 
compound are taken into account [4]. Figure 1 shows a diagram with the categories 
and subcategories. Compounds that are acquired from nature directly and are used 
without change in their form are considered traditional nutraceuticals. These nutra-
ceuticals are divided into (a) phytochemicals, (b) probiotic bacteria, (c) enzymes, 
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Specifically, the nutraceutical market is a growing and relatively new section of the 
food industry. This growth has been due to several causes. On the one hand, consumers 
are increasingly concerned about their health and how it is achieved through food, and 
there is more and more evidence that relates to diet and health. In addition, more and 
more consumers want not to have to go to the doctor or not to consume medications; 
specifically, this fact is marked in the generation of Baby-Boomer. Considering the 
point of view of the consumers, nutraceuticals have several benefits [5]:
• The consumption of nutraceuticals will increase the health value of the 
individual’s diet.
• An increase in the healthy value of the diet will help increase the lifespan of 
individuals.
• Nutraceuticals will help avoid particular medical deficiencies.
• They have beneficial psychological effects.
• Traditional medicines are more likely than nutraceuticals to generate harmful 
effects, so nutraceuticals are considered more natural.
• Nutraceuticals can be a very advantageous alternative for people with specific 
deficiencies or special needs.
Due above all to the increase in people’s life expectancy, it is proposed to maintain a 
good health and well-being rather than having to treat diseases. Therefore, at present, 
the importance of preventing disease development is becoming clearer, being even 
more important than the treatment of diseases. The current progress in the treatment of 
diseases has been tremendous both in medicine and in drugs. At the same time, public 
health spending increases at the same rate as the progress of so-called diseases related to 
bad eating habits, including bad habits in people’s lifestyle. In this sense, in recent years 
the term proactive medicine has appeared; focuses on the prevention of the develop-
ment of diseases, reducing the cost of long-term chronic disease treatments, allowing 
an increase in well-being, improving the quality of life and state of people’s health. 
Nutraceuticals are an alternative to help prevent the development of such diseases.
Author details
María Chávarri
Health and Food Area, Health Division, Tecnalia Research and Innovation, Miñano, 
Álava, Spain
*Address all correspondence to: maria.chavarri@tecnalia.com
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by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Nutraceuticals are defined as a food or food ingredients that prevent and treat
diseases. They contain dietary supplements like proteins, vitamins and minerals,
compound derived from natural sources. They have functions about delaying,
preventing and treating chronic inflammatory diseases due to the presence of the
phytochemicals. They have anti-inflammatory effects by inhibiting of the activation
of NF-κB, blocking the overexpression of tumor necrosis factor and interleukin-1,
downregulation of the overexpression of cell adhesion molecules and inhibiting
phospholipase A2, COX-2, lipoxygenease, iNOS, myeloperoxidase and inhibiting
reactive oxygen species (ROS) generating enzyme activity and increasing ability to
scavenge ROS. They have antioxidative role that can reduce the level of ROS and
free radicals. They have effects on the process of lipid oxidation that inhibit or slow
the formation of free alky radicals and cut off the free radical chain reactions.
Keywords: nutraceuticals, inflammation, oxidative stress, protective functions,
disease
1. Introduction
In recent years, the consumption of natural products or functional foods are
increased and enlarged segment of food industry. At the same time, Nutraceuticals
are increased using as an alternative for pharmaceutical industry especially variety
of diseases and cancers in humans and animals.
Firstly, nutraceutical is a term used by Stefane De Felice Nutraceuticals is
defined as a food, bioactive products or food ingredients that prevent and treat
diseases [1–4]. They are not drugs but they have pharmacologically active substance
[2]. They contain dietary supplements like proteins, vitamins and minerals, com-
pounds derived from natural sources. They provide health and medical benefits that
delay, prevent and treat chronic inflammatory diseases due to the presence of the
phytochemicals [1–4].
They have anti-inflammatory effects by inhibiting of the activation of NF-κB,
blocking the overexpression of tumor necrosis factor and interleukin-1,
downregulation of the overexpression of cell adhesion molecules and inhibiting
phospholipase A2, COX-2, 5-LOX, iNOS, myeloperoxidase and inhibiting ROS
generating enzyme activity and increasing ability to scavenge ROS. They have
antioxidative role that can reduce the level of ROS and free radicals. They have
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effects on the process of lipid oxidation that inhibit or slow the formation of free
alky radicals and cut off the free radical chain reactions. They have intracellular
signaling pathway modular effects [2–4].
The foods including antioxidative nutraceuticals are fruits (grape, citrus, blue-
berries, strawberries, blackberries and crowberries), vegetables (tomato, beans,
broccoli, beet, mushroom, corn, white cabbage, kale, cauliflower, spinach, garlic,
onion, cacao beans and soybean), spices (rosemary, oregano and thyme), herbs
(sage) and beverages (tea, wine) [4–6].
People’s interest about nutraceuticals is increasing day by day due to various
diseases. According to the global market data, China will be first nutraceutical
market as lifestyle. The nutraceutical sector is affected by the stringent regulations
and approval process of European Union. Due to the country, there are different
names of laws on nutraceuticals. Nutraceuticals are using different definitions and
terms including dietary supplement in USA, Natural Health Product in Canada,
complementary medicines in Australia, food supplements in European Union and
foods for special dietary in India [7].
With the increasing technology in the food, health and pharmaceutical sectors,
the orientation to functional foods is increasing and the competition is accelerating.
The sales of global market for nutraceuticals are expected to be US$250 billion by
2018 [8].
When nutraceuticals are evaluated by consumers, the consumption of food has
undergone changes in the past three decades. The easing of access to media and
internet, increasing in scientific studies and obesity related diseases are increased to
sale nutraceutical products by consumers. Between 2018 and 2025 years, the growth
rate of this sector is assumed to exceed 9.7%. The countries including Brazil, China,
India, South Korea, Poland and Mexico are increasing to use functional foods. The
global market of nutraceuticals is assumed to be $578.23 billion by 2025 at CAGR of
8.8% [9].
Inflammation is a protective response against the initial cause of cell injury.
Inflammation is classified as acute and chronic. Acute inflammation is first response
mechanism against infections, trauma, physical and chemical agents, which are
induced wound healing. If this mechanism occurs persistent, it takes chronic phase
[3, 10]. The process of inflammation contain vascular and cellular changes includ-
ing of swollen, redness, local heating and loss of function. The permeability of
capillaries is increased, exudate including the fluid and other elements leak into the
body cavities. The inflammatory cells, leucocytes and other phagocytic cells migrate
through the affected region. The lytic enzymes release from lysosomes of cells.
During the inflammation, chemical mediators are synthesized proinflammatory
cytokines (histamine, 5-hydroxytryptamine, bradykinin, leukotrienes and prosta-
glandins), selectins, integrins and immunoglobulins are stimulated for releasing [1].
Arachidonic acid metabolites including prostaglandins and leukotrienes are stimu-
lated by the increasing expression of phospholipase A2. ROS are released from the
inflammatory cells including neutrophils and macrophages. NADPH oxidase, xan-
thine oxidase and myeloperoxidase are seen increasing due to the ROS. The inflam-
matory cytokines, cell adhesion molecules and enzymes are regulated by the
activation of the transcription factor NF-κB [3, 11].
ROS generate intracellularly as natural by endogenous and exogenous sources.
Endogenous ROS including superoxide, hydrogen peroxide and nitric oxide (NO)
have functions in cell signaling and homeostasis [12]. ROS has functions in regula-
tion of cell survival. At the moderate levels of ROS signaling support cell prolifera-
tion and survival. At the upper levels of ROS cause cell death [12, 13]. There is a
relationship between ROS production and oxidative stress that play a role on redox
signaling from the organelle to the cytosol to nucleus [12, 14].
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ROS are present in different cancer types and age related diseases as
neurodegeneration, inflammation, diabetes, vision and sensory loss [12]. ROS and
reactive nitrogen species damage significant biological molecules which are lipids,
DNA, essential cellular proteins. Oxidative stress is imbalance between the forma-
tion of free radicals and antioxidant defense mechanism [15, 16].
Enzymatic and nonenzymatic antioxidant systems which are superoxide
dismutase, catalase, glutathione peroxidase, lipid soluble vitamin E, carotenes and
water soluble vitamin C arrange between ROS and antioxidants [4, 17, 18].
Oxidative stress starts the oxidation of polyunsaturated fatty acids (PUFA),
proteins, DNA and sterols. The oxidative stress reduce in the body with consump-
tion of fruits and vegetables including high amounts of anti-oxidative nutraceuticals
and for this reason, incidence of cancer and cardiovascular diseases decrease [4, 6].
According to the recent studies, there is a relationship between ROS and athero-
sclerosis, vasospasm, cancers, trauma, stroke, asthma, hyperoxia, arthritis, heart
attack, age pigments, dermatitis, cataractogenesis, retinal damage, hepatitis, liver
injury and periodontitis [4, 19, 20].
2. Nutraceuticals
2.1 Vitamin E
Vitamin E (alpha-, beta-, gamma- and delta-tocopherol, alpha-, beta-, gamma-
and delta-tocotrienol) is quite effective antioxidant and beneficial aspects for rheu-
matoid arthritis [4, 21, 22]. Also, vitamin E has anti-inflammatory effects in animal
recent studies [4, 23]. Tocopherols and tocotrienols have nonpolar structures and
consist in the lipid phase. Tocopherols are member of biological membranes and.
Tocopherols have antioxidants property that defend polyunsaturated fatty acids
into the membrane and LDL [4, 24]. The anti-inflammatory and anti-oxidant
effects of Vitamin E and its derivatives are summarized in Table 1.





controlled human study, 400 mg for 3
months), (The transgenic KRN/NOD
mice, 0.268 mg for 6 weeks)
Effects on rheumatoid arthritis against
the inflammation and oxidative stress
Lee et al. [4],
Aryaeian et al. [21],
Bandt et al. [22]
(Review literature study), (30 and
500 ppm for 30 days in old mice)
Inhibition of cyclooxygenase activity in
macrophages
Lee et al. [4],
Beharka et al. [23]
(Review literature study in elderly
cardiovascular patients)
Decreases risk of cardiovascular disease,
anti-cancer activity and decreases
incidence of Alzheimer’s disease
Meydani [24]
(Review literature study) Changes the level cholesterol and blocks
oxidation of LDL.
Lee et al. [4]
(Review literature study) Alterations of cell membrane integrity,
cell division and cell signaling pathways.
Stimulates indirectly prostaglandin and
cytokines, directly stimulates T cell
function. Reduces incidence of infectious
diseases including respiratory infections
and asthma
Lewis et al. [25]
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2.2 Carotenoids
They are classified as xanthophylls and carotenes. The carotenes have hydrocar-
bon and xanthophylls have oxygen [2, 4]. Carotenoids including alpha- carotene,
lycopene, lutein, zeaxanthin, beta-carotene and beta-cryptoxanthin have antioxi-
dant effects [1, 4]. The anti-inflammatory and anti-oxidant effects of carotenoids
are summarized in Table 2.
Vitamin E and derivatives Anti-oxidant and anti-inflammatory
effects
References
(Different doses, review literature
study)
Prevents and treats a multitude of age
related diseases. Ameliorates of lipid
profile and modulates suppression of the
senescence- associated secretory
phenotype
Malavolta et al. [26]
(The randomized clinical trials, ranging
doses 33-800 IU)
Effects lonely cardiovascular diseases by
reducing myocardial infarction
Loffredo et al. [27]
(The clinical review literature study) Preventive and therapeutic functions in
cardiovascular diseases.
Jain et al. [28]
(The consumption of different doses,
review of literature study in human)
Prevents various types of cancer, heart
disease and chronic ailments
Shahidi [29]
(The ranging doses between 500 IU/kg
for 4 weeks in rats, 600 mg/kg in rats,
45 and 60 mg/kg in rats)
Anti-oxidant roles by decreasing the
distribution of free radicals and
modulating plasmatic lipoproteins in




The effects of Vitamin E and its derivatives, relevant to anti-inflammatory and anti-oxidant activity.
Carotenoids Anti-oxidant and anti-
inflammatory effects
References
(The literature review study) Functions on cell growth, embryonic
development, vision property and
immune system. Modulates activity of
intracellular communication by
interaction with nuclear receptors like




(The literature review study),
(The prospective study of older
women between 55-69 ages)
Protective roles against rheumatoid
arthritis, atherosclerosis, cataracts,
age-related muscular degeneration and
multiple sclerosis
Al-Okbi [1], Lee
et al. [4], Cerhan
et al. [32]
(The ranging numbers and amounts of
cases and exposure, the
epidemiological review study),
(The prospective cohort study
between 1986 and 1992, in cases of 812
prostate cancer ), (The review study
related with the consumption of foods
including different amounts of
carotenoids)
Decreases the expansion of cervical,
colon, prostate, rectal, stomach and





(The literature review study) Blocks the formation of oxidized
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Carotenoids Anti-oxidant and anti-
inflammatory effects
References
(25 and 50 mg/kg of body sweight in
mice for 3 days)
Antimutagenic effect Polivkova et al. [37]
(Daily oral dose 10 mg/kg body weight
and intraperitoneally 25 mg/kg body
weight in female Wistar rats)
Neuroprotective activity Sandhir et al. [38]
(Lycopene complex including 6%
lycopene, 1.5% tocopherols, 1%
phytoene and phytofluene, 0.2% beta-
carotene for 10 days in rats at 6 mg/kg
body weight)
Nephroprotective activity Sahin et al. [39]
(The prospective randomized study in
159 primigravidas at the gestational
time with the consumption of 2 mg
oral lycopene daily for 77 women,
placebo daily for 82 women)
Prevents preclampsia Banerjee et al. [40]
(375 men and 576 women with hip
fracture and nonvertebral fracture in
elderly ages at different amounts of
consumption of carotenoid and
lycopene)
Decreases risk of hip fracture Sahni et al. [41]
(The literature review study) Anti-obesity functions by modulating
insulin resistance and reducing blood
glucose levels by regulation of
cytokine expression from white
adipose tissue
Gammone [42]
(In vitro research of 25 male Holstein
calves in ages of 6–10 weeks and 3
Angus Heifers in ages of 8–30 weeks
with doses of etinoic acid (1 μM) or
β-carotene (8.3 μg/mL)
Promotes leukocyte apoptosis in
bronchoalveolar lavage fluid and
improves efferocytosis in macrophages
Duquette et al. [43]
(The review article study including
animal and human in vitro researches)
Modulates intracellular signaling
cascades, gene expression, and protein
translation and blocks the
translocation of nuclear factor κB to
the nucleus. Inhibits Interleukin-8,
prostaglandin E2 and oxidative strees
damage by activating phase II and
glutathione-S-transferases.
Kaulmann [44]





(The intake of AIN-93G or AIN-93G +
10% Tangerine or red tomato powder
for 35 weeks in mice)




(The different amount of carotenoid
content in commercial tomato hybrid
Zebrino)
Cytoprotective functions by mitigating
ROS production and protects against





clinical trial study in 51 patients with
beta- carotene fortified symbiotic food
including 0.05 g beta carotene)
Decreases levels of insulin,
triglycerides, VLDL-cholesterol, total/
HDL cholesterol ratio, plasma nitric
oxide and glutathione
Asemi et al. [48]
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2.3 Phenolic compounds, polyphenols
The polyphenols are phenolic compounds that are defined as a benzene ring
bearing one or more hydroxyl groups attached to the ring. They are including
plants, vegetables, fruit, vines, tea, coffee and microalgae [2]. The phenolic com-
pounds are classified as simple phenols, benzoquinoes, phenoic acids,
acetophenones, phenylacetic acids, hydroxycinnamic acids, phenylpropens, cou-
marins, chromones, anthraquinones and flavonoids [4]. According to the recent
articles, polyphenols have antioxidant [2, 4], anti-inflammatory [2, 55], anticancer
[2, 56], antibacterial [2, 57], antiatherogenic [2, 58], antiangiogenic [2, 59],
antimutagenic and free radical scavenging properties [4].
Flavonoids, which are water-soluble [3], are popular group of polyphenols and
classified as flavones, flavonols, catechin or flavanols, anthocyanins and
isoflavones. Flavonoids consist as free aglycones or with sugars connected the
chemical structures to generate glycosides. Flavonoids have anti-inflammatory
functions by inhibiting the enzymes responsible for production of phospholipase
A2, cyclooxygenase and lipoxygenase [2, 3, 63]. The beneficial effects to health of
phenolic compounds are listed below in Table 3.
2.3.1 Flavones
They are including apigenin, chrysin, baicalein, scutellarein and wogonin [2]. The
anti-inflammatory and anti-oxidant effects of flavones are summarized in Table 4.
Carotenoids Anti-oxidant and anti-
inflammatory effects
References
(The doses of 20 and 40 mg/kg
xanthophylls in hens and chicks)
Decreases inflammatory mediators
and apoptosis in chick tissues
including liver, duodenum and
jejenum
Gao et al. [49]
(The review article study) Modulates macrophage polarization
and stops the progression of non-
alcoholic fatty liver disease and
provides liver homeostasis
Ni et al. [50]
(The review article study) Neuroprotective functions against the
Alzherimer’s disease that prevents
progression this disease and modulates
of Aβ peptide production and





(59 young participants with the
supplementation of 13 and 27 mg/day
macular carotenoids)
Reduces stress, cortisol and symptoms
of emotional and physical health.
Stringham et al. [52]
(The carotenoid derivatives and
crystalline lycopene from tomato
extract)
Prevents cancer and protects bone
health by inhibiting of the nuclear
factor kappa B activity.
Linnewiel-Hermoni
et al. [53]
(The different amounts of intake
carotenoid in this review article study)
Reduces variety types of cancer
including oral cavity and laryngeal
regions.
Leoncini et al. [54]
Table 2.
The effects of Carotenoids, relevant to anti-inflammatory and anti-oxidant activity.
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Polyphenols Anti-oxidant and anti-inflammatory
effects
References
(The review article study) Anti-inflammatory effects Lushchak et al.
[2], Biesalski
[55]
(The review article study) Anti-cancer functions Lushchak et al.
[2], Fresco et al.
[56]
(The review article study)
(the commercial apple skin
powder including 995.3 mg
chlorogenic acid/100 g and 14.4 mg
Trolox/g)
Anti-bacterial functions Lushchak et al.
[2], Du et al.
[57]
(The interval of different age, dietary
source of polyphenols and contents in
this review article study)
Anti-atherogenic functions Lushchak et al.
[2], Rimbach
et al. [58]
(The review article study) Anti-angiogenic functions. Contributes
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phenolic contents and amounts in foods)
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(The review article study), (The 17
hypercholesterolemic male patients with
the consumption of 40-90 g/day
macadamia nuts for 4 weeks)
Decreases influence of inflammation,
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2.3 Phenolic compounds, polyphenols
The polyphenols are phenolic compounds that are defined as a benzene ring
bearing one or more hydroxyl groups attached to the ring. They are including
plants, vegetables, fruit, vines, tea, coffee and microalgae [2]. The phenolic com-
pounds are classified as simple phenols, benzoquinoes, phenoic acids,
acetophenones, phenylacetic acids, hydroxycinnamic acids, phenylpropens, cou-
marins, chromones, anthraquinones and flavonoids [4]. According to the recent
articles, polyphenols have antioxidant [2, 4], anti-inflammatory [2, 55], anticancer
[2, 56], antibacterial [2, 57], antiatherogenic [2, 58], antiangiogenic [2, 59],
antimutagenic and free radical scavenging properties [4].
Flavonoids, which are water-soluble [3], are popular group of polyphenols and
classified as flavones, flavonols, catechin or flavanols, anthocyanins and
isoflavones. Flavonoids consist as free aglycones or with sugars connected the
chemical structures to generate glycosides. Flavonoids have anti-inflammatory
functions by inhibiting the enzymes responsible for production of phospholipase
A2, cyclooxygenase and lipoxygenase [2, 3, 63]. The beneficial effects to health of
phenolic compounds are listed below in Table 3.
2.3.1 Flavones
They are including apigenin, chrysin, baicalein, scutellarein and wogonin [2]. The
anti-inflammatory and anti-oxidant effects of flavones are summarized in Table 4.
Carotenoids Anti-oxidant and anti-
inflammatory effects
References
(The doses of 20 and 40 mg/kg
xanthophylls in hens and chicks)
Decreases inflammatory mediators
and apoptosis in chick tissues
including liver, duodenum and
jejenum
Gao et al. [49]
(The review article study) Modulates macrophage polarization
and stops the progression of non-
alcoholic fatty liver disease and
provides liver homeostasis
Ni et al. [50]
(The review article study) Neuroprotective functions against the
Alzherimer’s disease that prevents
progression this disease and modulates
of Aβ peptide production and





(59 young participants with the
supplementation of 13 and 27 mg/day
macular carotenoids)
Reduces stress, cortisol and symptoms
of emotional and physical health.
Stringham et al. [52]
(The carotenoid derivatives and
crystalline lycopene from tomato
extract)
Prevents cancer and protects bone
health by inhibiting of the nuclear
factor kappa B activity.
Linnewiel-Hermoni
et al. [53]
(The different amounts of intake
carotenoid in this review article study)
Reduces variety types of cancer
including oral cavity and laryngeal
regions.
Leoncini et al. [54]
Table 2.
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2.3.2 Flavonols
They are protective functions from UV radiation [2]. They are including
kaempferol, quercetin, myricetin, galangin and morin [2]. They have beneficial
effects on different conditions and diseases related oxidative stress and inflamma-
tion. These effects are summarized in Table 5.
Flavones Anti-oxidant and anti-inflammatory
effects
References
(The review article study), (250 μM
quercetin (specific activity, 52.9 mCi/
mM) for 10 min by injecting of Xenopus
laevis oocytes)
Beneficial effects including as GLUT
inhibitors in diabetes
Lee et al. [4],
Kwon et al. [67]
(The review article study) Cyclooxygenase inhibitory ability in
cancer
Lee et al. [4],
Kinghorn et al.
[68]
(The treatment with 2.5–20 μM apigenin
in cell culture including human prostate
cancer PC-3 and 22Rv1)
Anti-tumoral activity that inhibits of the
p-IKKα, NF-ĸB/p65, cell proliferation,
invasion of prostat cancer cells
Shukla et al.
[69]
(The study including phosphorylating
five flavones and showing pancreatic
cholesterol esterase inhibitory functions
by IC50)
Acts as pancreatic cholesterol esterase
inhibitor
Lee et al. [4],
Peng et al. [70]
(The review article study) Reduces neurodegeneration Lee et al. [4],
Gasiorowski
et al. [71]
(The review article study), (Apigenin
which is isolated from Cordia dichotoma
bark, is received 5 mg/kg, p.o. in Male
Swiss mice)
Treats colitis and reduces inflammatory
enzymes
Lee et al. [4],
Ganjare et al.
[72]
(The review article studies) Decreases the expression of tumor





(The review article study) Anti-arthritic functions Laev et al. [74]






(The review article study about anti-
oxidant, anti-cancer, anti-tumoral
activity, anti-inflammatory and hepato-
protective functions of dietary
flavonoids)
Inhibits thromboxane synthesis in animal
model and decreases iNOS and COX-2
expression
Xiao et al. [76]
(50 mg/kg of body weight doses of
apigenin was injected intraperitoneally in
Male C57BL/6J mice)
Immunomodulatory effects that reduces




(1, 10, 25, 50, 75 and 100 μM
concentrations of flavonoids were added
Murine C2C12 cell culture medium)
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2.3.3 Flavanones
They have important effects that regulate on the inflammatory process and
oxidative stress. These beneficial effects are summarized in Table 6.
2.3.4 Catechin or flavanols
They are found in variety of fruits (apples, apricots, blackberries and grapes),
red wine, black tea and cocoa [2]. For example; the long-term consumption of tea
Flavonols Anti-oxidant and anti-inflammatory
effects
References
(At flavonoid concentrations of
10–70 μmol/L were applied in HL-60, U937
and Jurkat cells)
Inhibits intracellular accumulation of
ascorbic acid
Park et al. [79]
(The ranging content amounts of oolong
tea leaves including 54 polyphenols were
evaluated on the pancreatic lipase activity
in vitro)




(At the concentrations of 0, 50, 100 and
250 μM of quercetin for 24–72 hours were
added cell culture medium including
mouse embryo 3T3-L1 cells)
Anti-oxidant activity on cell apoptosis Hsu et al. [81]
(The oral treatment doses at 2.8 g/kg in
male Wistar rats, aged 8–10 weeks)
Anti-oxidant and renoprotective effects in
streptozotocin-diabetic rats
Liu et al. [82]
(The extracts of Ficus carica Linn.
(Moraceae) leaves and fruits and Morus
alba Linn. root barks (Moraceae) were
given 50 and 150 mg/kg in adult female
Swiss albino rats)
Hepatoptotective effects on tetrachloride-




(At the dose of 5 μM kaempferol was added
cell culture medium including rat
osteoblast-like UMR106 cells)
Regulates bone sialoprotein gene
transcription and new bone formation
Yang et al.
[84]
(At the doses of 50 and 100 mg/kg
kaempferol were given orally in animal
model study)
Regulates cyclooxygenase, inhibits
production of nitric oxide
Mahat et al.
[85]
(The review article study), (The double-
blind study was given orally 4 x 500 mg
quercetin in non-smoking, un-treated
sarcoidosis individuals)
Decreases of oxidative stress and
inflammation in sarcoidosis, colonic




(The mice were fed Western diet including
0.05% quercetin for 18 weeks)
Modulates on accumulation and activation
of immune cells and increases expression
of mitochondrial gene in adipose tissue.
Kobori et al.
[87]
(At the doses of 10 and 50 mg/kg quercetin
were given intraperitoneally to the male
Sprague Dawley rats)
Neuroprotective and anti-oxidant effects
in subarachnoid hemorrhage, inhibits
brain damage and edema.
Dong et al.
[88]
(At the doses of 0 and 210 μM quercetin or
taraxasterol were added cell culture
medium including human umbilical vein
endothelial cells)
Anti-atherosclerotic and cardioprotective
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2.3.3 Flavanones
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inhibits low grade inflammation [73]. The chronic consumption of dark chocolate
reduces serum C-reactive protein concentrations in blood circulation [63, 73]. The
other effects on inflammatory and oxidative stress are summarized in Table 7.
Flavanones Anti-oxidant and anti-inflammatory
effects
References
(The review article study) Inhibitory effects on carcinogenesis Kinghorn
et al. [68]
(At the concentrations of 5 and 25 μM of
chalcones and flavanones were given in the
vitro study)








(The review article study) Anti-inflammatory effects Kontogiorgis
et al. [92]
(The review article study) Anti-angiogenic effects Mojzis et al.
[93]
(At the treatment daily doses of 100 mg/kg
naringenin were applied to the female BALB/
c mice)




(At the dose of 50 mg/kg naringenin was
applied to the adult male albino rats)




(At the concentration of 0.25 mmol of
naringin derivatives was applied by agar
dilution technique and direct contact
assaying)




(At the doses of 50 mg/kg of quercetin and
naringenin were applied to mice
intraperitoneally)




(At the doses of 30–200 μmol/L were treated
into the cell culture including macrophage
cell line RAW 274.6 and BV2 microglia)
Inhibit synthesis of nitric oxide and





The effects of flavanones, relevant to anti-inflammatory and anti-oxidant activity.
Catechin Anti-oxidant and anti-inflammatory
effects
References
(The review article including clinical and
experimantal studies)
Cardioprotective effects by inhibiting the




(The review article study) (at the mixture
of cathechin, caffeic acid and resveratrol
doses of 40 and 160 mg/kg body weight/








(The dentifrice including 1.0% green tea
catechin was applied to the male Wistar
rats)




(After the massive hepatectomy, green
tea extract catechins were applied to the
male Wistar rats)
Anti-oxidative and anti-inflammatory
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3. Conclusion
Nutraceuticals are alternative or functional foods or ingredients that prevent or
treatment of inflammatory and oxidative stress induced diseases. Nutraceuticals
are cheaper and easier availability than prescription drugs. For this reason, con-
sumer’s demand has increased in recent years.
The effecting on pathogenesis and activity of diseases are also essential scientific
subject for animal and human health. When the effects of nutraceuticals on oxida-
tive stress and inflammatory related disease are discovered, usages of nutraceuti-
cals in Pharmacology and scientific studies are seen huge growth. The relation
between beneficial effects of nutraceuticals and diseases are required to research
long-term multidisciplinary studies.
People are searching minimally processed food and want to benefit nutritional
values and live healthy. For this reason nutraceutical market is growing day by day.
The aging, fast rising population, changing lifestyle and lifestyle induced dis-
eases, healthcare research, increasing cases of cancer, economic and public prob-
lems are directed people to benefit better choices.
As a conclusion, nutraceuticals are important for nutrition of human and animal.
The consumption of nutraceuticals is necessary to reduce effects of the oxidative
stress and inflammation related diseases.
Conflict of interest
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Catechin Anti-oxidant and anti-inflammatory
effects
References





(At the double-blind randomized study
was applied daily 200 mg flavanols for
28 male smokers)
Anti-inflammatory effects by decreasing
expression of inflammatory genes in
leukocytes and increases vascular health
Weseler et al.
[104]
(At the randomized, placebo-controlled,
double blind, crossover study was applied
capsules including 1 g total catechin for
19 healthy men)
Cardioprotective effects by decreasing





(The consumption of high flavanols
chocolate for 4 weeks was applied to the
overweight men between 45 and 70 ages)
Effects on endothelium related
vasodilation. Increases leukocyte
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Cardiovascular disease (CVD) is a leading cause of worldwide deaths. A num-
ber of risk factors for cardiovascular disease as well as type 2 diabetes and stroke 
present as the metabolic syndrome. Metabolic risk factors include hypertension, 
abdominal obesity, dyslipidaemia and increased blood glucose levels and may also 
include risk factors such as vascular dysfunction, insulin resistance, low high den-
sity lipoprotein (HDL) cholesterol levels and inflammation. Rooibos (Aspalathus 
linearis) and honeybush (Cyclopia spp.) are indigenous South African plants whose 
reported health benefits include anti-tumour, anti-inflammatory, anti-obesity, anti-
oxidant, cardioprotective and anti-diabetic properties. The last two decades have 
seen worldwide interest and success for these plants, not only as health beverages 
but also as preservatives, flavourants and skincare products. This review will focus 
on the current literature supporting the function of these plants as nutraceuticals 
capable of potentially reducing the risk of cardiovascular disease.
Keywords: honeybush, rooibos, cardiovascular disease, diabetes, polyphenols
1. Introduction
Cardiovascular disease is the leading cause of deaths worldwide, killing 
17.9 million people in 2016 [1]. While the number of cardiovascular disease related 
morbidity and mortality in the developed world has decreased or remained steady, 
the developing world has seen an increase. Limited resources, poverty, poor access 
to affordable healthcare, poor implementation of health policies, as well as poor 
education may be some of the reasons for the increase in cardiovascular diseases 
in low to middle income countries [2]. A number of risk factors for cardiovascu-
lar disease as well as type 2 diabetes and stroke present as metabolic syndrome. 
Metabolic risk factors include hypertension, abdominal obesity, dyslipidaemia, 
increased blood glucose levels, and may also include risk factors such as vascular 
dysfunction, insulin resistance, low levels of high density lipoprotein cholesterol 
(HDL-C) and inflammation. Natural products could play a significant role in drug 
discovery and development with examples including morphine, isolated from the 
opium poppy (Papaver somniferum) and artemisinin, from Artemisia afra [3–5]. 
Nutraceuticals are foods or supplements with health benefits [6]. To this end, a 
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include risk factors such as vascular dysfunction, insulin resistance, low high den-
sity lipoprotein (HDL) cholesterol levels and inflammation. Rooibos (Aspalathus 
linearis) and honeybush (Cyclopia spp.) are indigenous South African plants whose 
reported health benefits include anti-tumour, anti-inflammatory, anti-obesity, anti-
oxidant, cardioprotective and anti-diabetic properties. The last two decades have 
seen worldwide interest and success for these plants, not only as health beverages 
but also as preservatives, flavourants and skincare products. This review will focus 
on the current literature supporting the function of these plants as nutraceuticals 
capable of potentially reducing the risk of cardiovascular disease.
Keywords: honeybush, rooibos, cardiovascular disease, diabetes, polyphenols
1. Introduction
Cardiovascular disease is the leading cause of deaths worldwide, killing
17.9 million people in 2016 [1]. While the number of cardiovascular disease related 
morbidity and mortality in the developed world has decreased or remained steady, 
the developing world has seen an increase. Limited resources, poverty, poor access 
to affordable healthcare, poor implementation of health policies, as well as poor 
education may be some of the reasons for the increase in cardiovascular diseases 
in low to middle income countries [2]. A number of risk factors for cardiovascu-
lar disease as well as type 2 diabetes and stroke present as metabolic syndrome. 
Metabolic risk factors include hypertension, abdominal obesity, dyslipidaemia, 
increased blood glucose levels, and may also include risk factors such as vascular 
dysfunction, insulin resistance, low levels of high density lipoprotein cholesterol 
(HDL-C) and inflammation. Natural products could play a significant role in drug 
discovery and development with examples including morphine, isolated from the 
opium poppy (Papaver somniferum) and artemisinin, from Artemisia afra [3–5]. 
Nutraceuticals are foods or supplements with health benefits [6]. To this end, a 
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number of nutraceuticals including fruits, vegetables, tea and herbal infusions have 
shown health benefits. Approximately 80% of the emerging world relies on herbal 
supplements [7]. This may often be a more accessible form of health or self-care, 
due to a lack of access to modern medicine, an alternative to modern medicine or 
due to the high cost of treatment of modern medicine. This practice may involve the 
use of herbs or plants, including polyphenol rich rooibos (Aspalathus linearis) and 
honeybush (Cyclopia spp.), indigenous South African plant species with reported 
health benefits [8]. Many nutraceuticals contain polyphenols, the most abundant 
antioxidants in the diet which could help in the prevention of neurodegenerative 
diseases, diabetes, cancer, and cardiovascular disease [9]. Oxidative stress is a key 
process occurring in these diseases and is marked by imbalances between oxidants 
and the availability of antioxidants as well as perturbations in redox signalling 
mechanisms [10, 11]. Drugs used in the treatment of cardiovascular disease and 
obesity often have side effects, hence there is a need for better tolerated, safer 
and more natural treatment options [12]. A number of epidemiological studies 
and meta-analyses show some cardiovascular benefits with the intake of tea [13]. 
Furthermore, a review of some clinical studies show benefits of tea consumption in 
reducing cardiovascular risk factors, especially in overweight or obese subjects [14]. 
Rooibos and honeybush have a number of reported health properties, many of them 
targeting risk factors for the development of cardiovascular disease. The purpose of 
this paper was to review the role of rooibos and honeybush as potential nutraceuti-
cals in the treatment of cardiovascular disease.
2. Risk factors for cardiovascular disease
A multitude of risk factors predispose to the onset of cardiovascular disease. This 
includes unmodifiable risk factors, such as increasing age, male gender, ethnicity, 
family history and genetics [15]. Modifiable risk factors include tobacco smoking, an 
unhealthy diet, a sedentary lifestyle, high alcohol intake, high blood pressure, being 
overweight or having central obesity, dyslipidaemia, impaired glucose tolerance or 
diabetes [15]. Diabetes not only quadrupled from 1980 to 2014 but approximately 
57% of diabetic women and 67% of diabetic men are likely to present with cardio-
vascular disease by the age of 50 [1, 16]. Metabolic syndrome is largely preventable 
and includes a number of clinical findings which when occurring together, increase 
the risk of diabetes and cardiovascular disease. These include central obesity with 
any of the following risk factors including increased triglycerides, fasting plasma 
glucose, blood pressure and reduced HDL cholesterol levels [17]. Metabolic syn-
drome is also accompanied by changes in neuroendocrine and autonomic function 
[18]. It is known that early life stressors can predispose to disease outcome in later 
life, including cardiovascular disease [19]. Chronic stress influences cardiovascular 
outcome and anxiety and depression are also risk factors for cardiovascular dis-
ease [20–22]. This leads to changes in glucocorticoids and mineralocorticoids via 
modulation of the hypothalamic pituitary axis (HPA) [18]. Xenobiotics, including 
drugs and herbal infusions are metabolised by drug metabolising enzymes such 
as the phase I, cytochrome P450 system, which also influences the formation of 
steroid hormones [23]. CYP21A2 are precursors to both mineralocorticoids such as 
aldosterone and glucocorticoids such as cortisol and cortisone. Interestingly, rooibos 
flavonoids aspalathin and nothofagin inhibits CYP21A2 but not CYP11B1, which is 
responsible for converting 11-deoxycortisol to cortisol [24]. Substrate conversion of 
CYP117A1 and CYP21A2 was also inhibited by rooibos but other flavonoids such as 
rutin, orientin and vitexin were unable to inhibit CYP21A2. Rutin, under forskolin-
induced stress, was the best inhibitor of steroid production followed by nothofagin 
29
Rooibos (Aspalathus linearis) and Honeybush (Cyclopia spp.): From Bush Teas to Potential…
DOI: http://dx.doi.org/10.5772/intechopen.86410
and vitexin and lastly by aspalathin and nothofagin [24]. The observed effects 
for steroid inhibition were attributed to structural differences in these rooibos 
flavonoids. Rooibos also decreased rat glucocorticoids by decreasing the corticos-
terone, deoxycorticosterone as well as the corticosterone: testosterone ratio [25]. In 
the accompanying human study the cortisol: corticosterone ratio was reduced by 
rooibos, which also inhibited 11 β-hydroxysteroid dehydrogenase type 1 (11βHSD1). 
This enzyme catalyses the conversion of cortisone to cortisol and is associated with 
risk factors for cardiovascular disease [26]. In a stress model using steroid producing 
H295R cells, rooibos and rutin were able to reduce cortisol levels. The inhibition of 
mineralocorticoid and glucocorticoid steroids by rooibos and the dihydrochalcones 
aspalathin and nothofagin were also demonstrated in H295R cells [27]. This suggests 
that rooibos may offer a possible therapeutic role in the management of cardio-
vascular complications relating from stress, by altering the biosynthesis of steroid 
hormones via the HPA axis. Inhibition of 11βHSD1 has been suggested as a potential 
target mechanism for drugs to modulate the metabolic syndrome; therefore, this 
could be further explored in the context of rooibos or even honeybush. The car-
diovascular complications of metabolic syndrome include coronary artery disease, 
peripheral vascular disease, hypertension as well as heart failure [28]. Primary 
management of metabolic syndrome is structured around lifestyle and dietary 
changes, including regular physical activity and a modest 5–10% initial reduction in 
caloric intake, failing which the use of pharmaceutical drugs may also be prescribed 
[17]. Approximately 1.9 billion people were overweight in 2016, of which 650 mil-
lion people were obese [29]. A sedentary lifestyle, excess calories, a high fat diet and 
genetics contribute to the development of obesity, which is characterised by a body 
mass index greater (BMI) >30 kg/m2 [30]. Urbanisation and a reduction in physical 
activity, along with an energy-rich Western diet, have contributed to the increase in 
cardiovascular disease in developing countries [31]. As a largely preventable dis-
order, obesity increases the risk of type 2 diabetes mellitus, cancer, cardiovascular 
disease, infertility, respiratory illnesses and a number of other health issues. In fact, 
obesity is not only a major independent risk factor but also an independent predic-
tor for cardiovascular disease [32]. Strategies to avoid unnecessary deaths could 
include therapeutics that are safe, easily accessible and cost-effective. Rooibos and 
honeybush are relatively safe but long term clinical studies considering their safety 
are lacking [33, 34]. Two clinical case reports recommended caution in rooibos 
consumption but patients had consumed infusions containing rooibos and other 
herbs, thus the effects of these preparations and potential interactions between 
them need to be considered [35, 36]. Rooibos and honeybush are caffeine free and 
have low tannin levels making them ideal beverages for health conscious people, 
pregnant women and young children [37–39]. These plants may therefore be viable 
options in the future, provided sufficient evidence is generated to support their use 
as nutraceuticals capable of reducing cardiovascular risk.
3. Origin, distribution and markets for rooibos and honeybush
Rooibos [Aspalathus linearis L. (Burm.f.) R. Dahlgren (Leguminosae)] is a 
member of the fynbos biome, which contains needle-like leguminous plants. It 
occurs in the Cederberg area of the Western Cape, and in South Africa it is one of the 
most widely consumed herbal teas or tisanes. Its marketing potential was realized by 
Benjamin Gunzberg in 1904 and since then its popularity has steadily risen worldwide 
[40]. The top five export markets for rooibos are Germany, Japan, the Netherlands, 
the United Kingdom and the United States of America [41]. Rooibos is used as herbal 
infusion, health beverage, an ingredient in skin care products and cosmetics as well 
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family history and genetics [15]. Modifiable risk factors include tobacco smoking, an 
unhealthy diet, a sedentary lifestyle, high alcohol intake, high blood pressure, being 
overweight or having central obesity, dyslipidaemia, impaired glucose tolerance or 
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life, including cardiovascular disease [19]. Chronic stress influences cardiovascular 
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and vitexin and lastly by aspalathin and nothofagin [24]. The observed effects 
for steroid inhibition were attributed to structural differences in these rooibos 
flavonoids. Rooibos also decreased rat glucocorticoids by decreasing the corticos-
terone, deoxycorticosterone as well as the corticosterone: testosterone ratio [25]. In 
the accompanying human study the cortisol: corticosterone ratio was reduced by 
rooibos, which also inhibited 11 β-hydroxysteroid dehydrogenase type 1 (11βHSD1). 
This enzyme catalyses the conversion of cortisone to cortisol and is associated with 
risk factors for cardiovascular disease [26]. In a stress model using steroid producing 
H295R cells, rooibos and rutin were able to reduce cortisol levels. The inhibition of 
mineralocorticoid and glucocorticoid steroids by rooibos and the dihydrochalcones 
aspalathin and nothofagin were also demonstrated in H295R cells [27]. This suggests 
that rooibos may offer a possible therapeutic role in the management of cardio-
vascular complications relating from stress, by altering the biosynthesis of steroid 
hormones via the HPA axis. Inhibition of 11βHSD1 has been suggested as a potential 
target mechanism for drugs to modulate the metabolic syndrome; therefore, this 
could be further explored in the context of rooibos or even honeybush. The car-
diovascular complications of metabolic syndrome include coronary artery disease, 
peripheral vascular disease, hypertension as well as heart failure [28]. Primary 
management of metabolic syndrome is structured around lifestyle and dietary 
changes, including regular physical activity and a modest 5–10% initial reduction in 
caloric intake, failing which the use of pharmaceutical drugs may also be prescribed 
[17]. Approximately 1.9 billion people were overweight in 2016, of which 650 mil-
lion people were obese [29]. A sedentary lifestyle, excess calories, a high fat diet and 
genetics contribute to the development of obesity, which is characterised by a body 
mass index greater (BMI) >30 kg/m2 [30]. Urbanisation and a reduction in physical 
activity, along with an energy-rich Western diet, have contributed to the increase in 
cardiovascular disease in developing countries [31]. As a largely preventable dis-
order, obesity increases the risk of type 2 diabetes mellitus, cancer, cardiovascular 
disease, infertility, respiratory illnesses and a number of other health issues. In fact, 
obesity is not only a major independent risk factor but also an independent predic-
tor for cardiovascular disease [32]. Strategies to avoid unnecessary deaths could 
include therapeutics that are safe, easily accessible and cost-effective. Rooibos and 
honeybush are relatively safe but long term clinical studies considering their safety 
are lacking [33, 34]. Two clinical case reports recommended caution in rooibos 
consumption but patients had consumed infusions containing rooibos and other 
herbs, thus the effects of these preparations and potential interactions between 
them need to be considered [35, 36]. Rooibos and honeybush are caffeine free and 
have low tannin levels making them ideal beverages for health conscious people, 
pregnant women and young children [37–39]. These plants may therefore be viable 
options in the future, provided sufficient evidence is generated to support their use 
as nutraceuticals capable of reducing cardiovascular risk.
3. Origin, distribution and markets for rooibos and honeybush
Rooibos [Aspalathus linearis L. (Burm.f.) R. Dahlgren (Leguminosae)] is a 
member of the fynbos biome, which contains needle-like leguminous plants. It 
occurs in the Cederberg area of the Western Cape, and in South Africa it is one of the 
most widely consumed herbal teas or tisanes. Its marketing potential was realized by 
Benjamin Gunzberg in 1904 and since then its popularity has steadily risen worldwide 
[40]. The top five export markets for rooibos are Germany, Japan, the Netherlands, 
the United Kingdom and the United States of America [41]. Rooibos is used as herbal 
infusion, health beverage, an ingredient in skin care products and cosmetics as well 
Nutraceuticals - Past, Present and Future
30
as a flavourant and colouring agent in a number of food applications. Honeybush 
(Cyclopia spp.), another member of the fynbos biome, is a bushy shrub found 
between the Piketberg area in the West, and Port Elizabeth in the East of South Africa 
(Figure 1). The year 1996 welcomed the first commercial harvests for honeybush, 
followed by the establishment of the South African Honeybush Tea Association 
(SAHTA) to manage the farming and sustainability practices as well as commercial 
interests of honeybush. After harvesting of rooibos or honeybush crops, leaves and 
stems are cut into small pieces, moistened and are fermented, either on open heaps 
or alternatively for honeybush also using an oven or fermentation tank. This is 
followed by drying of the fermented rooibos or honeybush. Fermentation of these 
plants is however associated with a change in phenolic composition as well as colour 
compared, to the green or unfermented plants which undergoes considerably less 
oxidation [42, 43]. The main contributors to the commercial market out of the 24 spe-
cies of Cyclopia are C. intermedia, C. genistoides and C. subternata. C. intermedia has 
the largest market share; however, it is harvested from the wild, making the future 
sustainability and profitability of the crop problematic [44]. Honeybush is a budding 
commercial interest, used mainly as a tisane with great potential for development and 
is exported to countries such as the Netherlands, Germany and Japan [45].
4. Polyphenols that may be responsible for beneficial effects
Polyphenols are secondary plant metabolites commonly occurring in the diet in 
tea, coffee, wine, fruit, vegetables and cereals. The four main types of polyphenols, 
namely stilbenes, phenolic acids, flavonoids and lignins, can be classified according to 
the number of polyphenol rings and various chemical groups associated with the rings 
[46]. Flavonoids share a C3-C6-C3 backbone and the classification system includes 
groups such as the flavonols, flavones, isoflavones, flavanones, antho-cyanidins, and 
flavanols [46]. A number of studies have reported a reduction in the risk of cardiovas-
cular disease with the intake of polyphenols [47]. The most prevalent polyphenols in 
rooibos include aspalathin, nothofagin, orientin, iso-orientin, vitexin and isovitexin, 
isoquercitrin and rutin [48, 49]. Aspalathin and aspalalinin are two unique dihydro-
chalcones in rooibos, with the former having been widely researched to date for its 
antioxidant and other health promoting properties [50, 51]. The flavonoid precursor 
in rooibos, Z-2-(β-ᴅ-glucopyranosyloxy)-3-phenylpropenoic acid (PPAG), has also 
received considerable attention for its anti-diabetic properties [52]. In Cyclopia species, 
the xanthones mangiferin, isomangiferin and the flavanone hesperidin are predomi-
nant [43, 53]. Mangiferin is not unique to honeybush, and also occurs in mangoes 
(Mangifera indica) and plants such as Pyrrosia sheareri and Anemarrhena asphodeloides 
[54–56]. Bioavailability refers to the amount of the substance that is ingested that is 
available for metabolism [46]. It involves a number of processes, including intestinal 
absorption, plasma kinetics, metabolism, binding to plasma albumin and excretion 
Figure 1. 
Honeybush plant in flower. Image courtesy of the SAHTA.
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by the liver and kidneys [46]. Factors affecting bioavailability include isomeric form, 
processing methods, the type of compound and matrices surrounding the compound. 
The bioavailability of rooibos and honeybush is poor [57, 58]. The potential benefits 
attributed to their intake may therefore be hampered by poor bioavailability and also 
affect their maximal efficacy. Recently, the use of nanoencapsulation methods have 
been explored in order to increase the bioavailability and stability of aspalathin which 
could possibly promote the use of more effective nutraceuticals [59]. Since fermenta-
tion reduces polyphenol content, a number of studies have explored the benefits 
of unfermented, green rooibos or so called aspalathin rich extracts of rooibos in an 
attempt to elucidate the health promoting properties of the tisane [60, 61]. Others have 
looked at the effects of single isolate polyphenols from rooibos and honeybush such 
as aspalathin and mangiferin, to explore their functional benefits and identify a more 
targeted therapeutic option (Figure 2) [63, 64].
5. Antioxidant effects
Oxidative stress occurs due to an imbalance in the production of reactive oxygen 
species (ROS) and the availability of ROS scavengers. This may occur due to an excess of 
unstable reactive species including free radicals, such as reactive oxygen, reactive 
chlorine, reactive nitrogen and non-radical species, all of which may interact with cells, 
causing cellular damage [65]. Oxidative stress contributes to the pathobiology of cancer, 
cardiovascular disease, ageing, diabetes and atherosclerosis; therefore, it is plausible that 
dietary sources of antioxidants may be useful in reducing oxidative stress. Aerobic 
organisms are therefore reliant on innate antioxidant defences, e.g., superoxide dis-
mutase (SOD), catalase (CAT), glutathione peroxidase (GPX), reduced glutathione 
(GSH), uric acid, albumin and peroxiredoxins, to deal with large quantities of ROS in an 
attempt to reduce oxidative stress. Mitochondria are key generators of ROS in aerobic 
organisms, producing them as they generate energy; however, ROS are also important in 
cell signalling and released by macrophages to promote immunological attacks [66]. 
Xenobiotics, including rooibos and honeybush, are metabolised by the cytochrome 
P450 family and in the process, radicals are also produced and further detoxification 
processes facilitate their removal [67]. In cardiovascular disease, oxidative stress may 
manifest as dysfunction in the vascular endothelium or cardiac myocytes, and may arise 
due to increased intracellular Ca2+ as a result of ROS [68]. Oxidative stress associated 
with hyperglycaemia may occur from the glycation of proteins and the formation of 
advanced glycation end products, the auto-oxidation of glucose and the polyol pathway. 
Figure 2. 
Chemical structures of aspalathin (a) and mangiferin (b) showing phenol rings [62].
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by the liver and kidneys [46]. Factors affecting bioavailability include isomeric form, 
processing methods, the type of compound and matrices surrounding the compound. 
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affect their maximal efficacy. Recently, the use of nanoencapsulation methods have 
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targeted therapeutic option (Figure 2) [63, 64].
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species (ROS) and the availability of ROS scavengers. This may occur due to an excess of 
unstable reactive species including free radicals, such as reactive oxygen, reactive 
chlorine, reactive nitrogen and non-radical species, all of which may interact with cells, 
causing cellular damage [65]. Oxidative stress contributes to the pathobiology of cancer, 
cardiovascular disease, ageing, diabetes and atherosclerosis; therefore, it is plausible that 
dietary sources of antioxidants may be useful in reducing oxidative stress. Aerobic 
organisms are therefore reliant on innate antioxidant defences, e.g., superoxide dis-
mutase (SOD), catalase (CAT), glutathione peroxidase (GPX), reduced glutathione 
(GSH), uric acid, albumin and peroxiredoxins, to deal with large quantities of ROS in an 
attempt to reduce oxidative stress. Mitochondria are key generators of ROS in aerobic 
organisms, producing them as they generate energy; however, ROS are also important in 
cell signalling and released by macrophages to promote immunological attacks [66]. 
Xenobiotics, including rooibos and honeybush, are metabolised by the cytochrome 
P450 family and in the process, radicals are also produced and further detoxification 
processes facilitate their removal [67]. In cardiovascular disease, oxidative stress may 
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with hyperglycaemia may occur from the glycation of proteins and the formation of 
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Figure 2. 
Chemical structures of aspalathin (a) and mangiferin (b) showing phenol rings [62].
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In rodent models of streptozotocin (STZ)-induced diabetes, rooibos exerted antioxidant 
effects through increases in the activity of superoxide dismutase, catalase, glutathione 
peroxidase and decreasing lipid peroxidation [64, 69, 70]. Rooibos also decreased 
advanced glycation end products but clinical markers of diabetes such as fructosamine, 
glycated haemoglobin and glucose were unaffected [70]. Nuclear factor erythroid 
2-related factor 2 (Nrf2), a critical regulator of the antioxidant response of the cell, 
facilitates the removal of oxidants through increased antioxidant enzyme activity [67]. 
The regulator of Nrf2, Kelch-like ECH-associated protein 1 (Keap 1), has oxidative and 
electrophilic sensitive cysteine residues which upon activation allows for dissociation 
and activation of Nrf2 [71]. In H9c2 cardiomyocytes, aspalathin (1 μM) increased the 
expression of Nrf2, and antioxidant genes and enzymes, including SOD, CAT, GPX and 
peroxiredoxins [64]. The expression of cytoprotective genes including heme oxygenase 
1 (H0-1), NAD(P)H dehydrogenase (quinone 1), uncoupling protein 2 and apoptotic 
genes such as B-cell lymphoma 2 (Bcl-2) were also increased after aspalathin treatment. 
Uncoupling protein (UCP)3 and caspase 8, were however decreased. This suggests 
cellular survival due to reduced caspase 8, an important trigger for cell death [72]. UCP3 
and UCP2 act in concert in the mitochondrial antioxidant response with UCP2 appear-
ing to play a greater cytoprotective role in cardiomyocytes [73]. In the diabetic (db/db) 
mouse model, aspalathin increased Nrf2 expression as well as its downstream gene 
targets [74]. High dose aspalathin (130 mg/kg) also ameliorated the effects of hypergly-
caemia in the heart by reducing the expected left ventricular enlargement. It could not 
however reduce fasting plasma glucose levels compared to metformin in these mice. The 
study confirmed the role of Nrf2 in the antioxidant response of the cell, strengthened 
the case for the potential use of nutraceuticals such as aspalathin in the treatment of 
diabetes, and also provides evidence for the differential effects observed with isolates 
compared to whole extracts of plants. Oxidative stress and inflammation co-exists in a 
number of diseases. The relationship between the two appears complex and is suggested 
to be a possible reason why antioxidant supplements in clinical trials have been unsuc-
cessful [75]. In humans, no clear evidence of the antioxidant effects of flavonoids or 
pro-oxidant effects exist [76]. Supplementation of six cups of rooibos per day over a 
6 week period in adults with increased cardiovascular risk increased plasma total 
polyphenols, reduced glutathione (GSH), and increased the GSH: oxidized glutathione 
(GSSG) ratio compared to the control period [77]. Furthermore, TBARS and conjugated 
dienes were reduced, indicating a reduction in oxidative stress after rooibos consump-
tion. Ferric reducing antioxidant power (FRAP), oxygen radical absorbance capacity 
(ORAC) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonate (ABTS) were unaf-
fected. It is however known that assays for the measurement of antioxidant status can be 
difficult to compare and may also be non-specific and complicated by the instability of 
the species they are measuring [78]. Flavanoids and other polyphenols in honeybush are 
responsible for its antioxidant effects [79]. Fermentation of honeybush and rooibos 
however reduces antioxidant activity [80]. Mangiferin was the most effective scavenger 
of ABTS˙+ and in terms of its ability to reduce ferric ion, than the flavanone eriocitrin or 
the flavone luteolin [43]. This could be due to the hydrophilic nature of mangiferin, 
which is a glucoside. In an in vitro study using skin cells, aqueous extracts of Cyclopia 
subternata sp. exhibited the highest ABTS˙+ scavenging ability compared to other 
unfermented species of rooibos and Camellia sinensis [53]. In addition, rooibos, honey-
bush and Chinese green tea demonstrated ferric reducing antioxidant power (FRAP) 
and oxygen radical absorbance capacity (ORAC) abilities. Rooibos and honeybush also 
had better ORAC values than green tea, while rooibos aqueous extracts had the highest 
FRAP. In another model using hairless SKH-1 mice, unfermented honeybush and 
mangiferin had the highest FRAP compared to the fermented honeybush and hesperi-
din, and also the highest total antioxidant capacity [63]. Fermented and unfermented 
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honeybush as well as mangiferin and hesperidin also protected against ultraviolet (UV) 
B-induced lipid peroxidation. Fermented and unfermented extracts of honeybush as 
well as hesperidin increased SOD and CAT activity, while mangiferin increased SOD but 
not catalase activity [63]. When Chinese green tea, rooibos and honeybush were 
evaluated for their ability to reduce lipid peroxidation, unfermented extracts generally 
offered better protection against lipid peroxidation but green tea offered the highest 
level of protection compared to the other infusions [53]. Mangiferin activated phospha-
tidylinositol 3-kinase (PI3K) induced protein kinase b (PKB/Akt) and Nrf2 signalling 
pathways, thus decreasing oxidative stress in an in vivo model using human kidney cells 
exposed to tert-butyl hydroperoxide [81]. The activities of SOD, CAT, GPX and the 
non-enzymatic intracellular antioxidant GSH were also enhanced and lipid peroxidation 
was decreased. When compared to vitamin C, ROS scavenging ability as measured by 
the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method and FRAP was 
decreased at lower concentrations compared to vitamin C, which was used as the 
positive control. The expression of Nrf2, HO-1, SOD, Akt and GSK-β and the mechanis-
tic target of rapamycin (mTOR) and cyclin D were also increased by exposure to 
mangiferin. In an STZ-induced diabetic Wistar rat model, mangiferin improved 
antioxidant status and reduced apoptosis and inflammation [82]. This could be due to 
modulation of the AGE-RAGE/MAPK signalling pathways. Advanced glycation end 
products (AGEs), which are increased in diabetes, lead to upregulation and activation of 
the receptor for advanced glycation end products (RAGE). This interaction causes 
inflammation and oxidative stress, through increases in the production of ROS, leading 
to lipid peroxidation. AGEs can also inhibit peroxisome proliferator activated receptor 
(PPAR)γ, a regulator in inflammation as well as the metabolism of lipids and glucose 
[83]. In the study mangiferin also displayed potential as a therapeutic in preventing AGE 
mediated lipogenesis. Antioxidants such as β-carotene, α-tocopherol and ascorbate were 
unsuccessful in reducing incidences of cardiovascular [84] and other diseases such as 
cancer [85], in fact appearing to increase risk in some cases, e.g., with vitamin C, 
x-tocopherol and beta-carotene [86–88]. Antioxidant supplementation to alleviate 
oxidative stress could however be affected by other factors such as the dose of the 
antioxidant, timing of the intervention, interactions with other antioxidants, whether it 
as administered as an isolate or a whole extract, the type of extract, the model as well as 
the methods that are used to detect oxidative stress. Rooibos and honeybush exert 
antioxidant effects by scavenging free radicals, chelating metal ions, or upregulating 
indigenous antioxidant enzymes. The aromatic ring structures of polyphenols also 
contain free hydroxyl groups which contribute to their antioxidant ability. The struc-
tural differences between rooibos polyphenols may thus also explain differences in 
antioxidant activity of these compounds [89]. The antioxidant activity of rooibos and 
honeybush polyphenols may also be explained by their ability to increase the activity of 
antioxidant enzymes, through upregulation of Nrf2, PI3K and other signalling pathways 
involved in cell survival. It may also be explained by their ability to act as antioxidants 
themselves, exerting differential physiological effects. The antioxidant effects of rooibos 
and honeybush and their polyphenols have been extensively studied in detail elsewhere 
and some of these effects are discussed here under the anti-inflammatory, anti-obesity, 
anti-diabetic and cardiovascular effects of these nutraceuticals (Tables 1–4).
6. Anti-inflammatory effects
Inflammation and oxidative stress form a common thread in the metabolic syn-
drome, type 2 diabetes and cardiovascular disease [132, 133]. The rooibos flavonoid 
orientin from rooibos reduced the number of mast cells in colon sections as well as 
Nutraceuticals - Past, Present and Future
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In rodent models of streptozotocin (STZ)-induced diabetes, rooibos exerted antioxidant 
effects through increases in the activity of superoxide dismutase, catalase, glutathione 
peroxidase and decreasing lipid peroxidation [64, 69, 70]. Rooibos also decreased 
advanced glycation end products but clinical markers of diabetes such as fructosamine, 
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2-related factor 2 (Nrf2), a critical regulator of the antioxidant response of the cell, 
facilitates the removal of oxidants through increased antioxidant enzyme activity [67]. 
The regulator of Nrf2, Kelch-like ECH-associated protein 1 (Keap 1), has oxidative and 
electrophilic sensitive cysteine residues which upon activation allows for dissociation 
and activation of Nrf2 [71]. In H9c2 cardiomyocytes, aspalathin (1 μM) increased the 
expression of Nrf2, and antioxidant genes and enzymes, including SOD, CAT, GPX and 
peroxiredoxins [64]. The expression of cytoprotective genes including heme oxygenase 
1 (H0-1), NAD(P)H dehydrogenase (quinone 1), uncoupling protein 2 and apoptotic 
genes such as B-cell lymphoma 2 (Bcl-2) were also increased after aspalathin treatment. 
Uncoupling protein (UCP)3 and caspase 8, were however decreased. This suggests 
cellular survival due to reduced caspase 8, an important trigger for cell death [72]. UCP3 
and UCP2 act in concert in the mitochondrial antioxidant response with UCP2 appear-
ing to play a greater cytoprotective role in cardiomyocytes [73]. In the diabetic (db/db) 
mouse model, aspalathin increased Nrf2 expression as well as its downstream gene 
targets [74]. High dose aspalathin (130 mg/kg) also ameliorated the effects of hypergly-
caemia in the heart by reducing the expected left ventricular enlargement. It could not 
however reduce fasting plasma glucose levels compared to metformin in these mice. The 
study confirmed the role of Nrf2 in the antioxidant response of the cell, strengthened 
the case for the potential use of nutraceuticals such as aspalathin in the treatment of 
diabetes, and also provides evidence for the differential effects observed with isolates 
compared to whole extracts of plants. Oxidative stress and inflammation co-exists in a 
number of diseases. The relationship between the two appears complex and is suggested 
to be a possible reason why antioxidant supplements in clinical trials have been unsuc-
cessful [75]. In humans, no clear evidence of the antioxidant effects of flavonoids or 
pro-oxidant effects exist [76]. Supplementation of six cups of rooibos per day over a 
6 week period in adults with increased cardiovascular risk increased plasma total 
polyphenols, reduced glutathione (GSH), and increased the GSH: oxidized glutathione 
(GSSG) ratio compared to the control period [77]. Furthermore, TBARS and conjugated 
dienes were reduced, indicating a reduction in oxidative stress after rooibos consump-
tion. Ferric reducing antioxidant power (FRAP), oxygen radical absorbance capacity 
(ORAC) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonate (ABTS) were unaf-
fected. It is however known that assays for the measurement of antioxidant status can be 
difficult to compare and may also be non-specific and complicated by the instability of 
the species they are measuring [78]. Flavanoids and other polyphenols in honeybush are 
responsible for its antioxidant effects [79]. Fermentation of honeybush and rooibos 
however reduces antioxidant activity [80]. Mangiferin was the most effective scavenger 
of ABTS˙+ and in terms of its ability to reduce ferric ion, than the flavanone eriocitrin or 
the flavone luteolin [43]. This could be due to the hydrophilic nature of mangiferin, 
which is a glucoside. In an in vitro study using skin cells, aqueous extracts of Cyclopia 
subternata sp. exhibited the highest ABTS˙+ scavenging ability compared to other 
unfermented species of rooibos and Camellia sinensis [53]. In addition, rooibos, honey-
bush and Chinese green tea demonstrated ferric reducing antioxidant power (FRAP) 
and oxygen radical absorbance capacity (ORAC) abilities. Rooibos and honeybush also 
had better ORAC values than green tea, while rooibos aqueous extracts had the highest 
FRAP. In another model using hairless SKH-1 mice, unfermented honeybush and 
mangiferin had the highest FRAP compared to the fermented honeybush and hesperi-
din, and also the highest total antioxidant capacity [63]. Fermented and unfermented 
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honeybush as well as mangiferin and hesperidin also protected against ultraviolet (UV) 
B-induced lipid peroxidation. Fermented and unfermented extracts of honeybush as 
well as hesperidin increased SOD and CAT activity, while mangiferin increased SOD but 
not catalase activity [63]. When Chinese green tea, rooibos and honeybush were 
evaluated for their ability to reduce lipid peroxidation, unfermented extracts generally 
offered better protection against lipid peroxidation but green tea offered the highest 
level of protection compared to the other infusions [53]. Mangiferin activated phospha-
tidylinositol 3-kinase (PI3K) induced protein kinase b (PKB/Akt) and Nrf2 signalling 
pathways, thus decreasing oxidative stress in an in vivo model using human kidney cells 
exposed to tert-butyl hydroperoxide [81]. The activities of SOD, CAT, GPX and the 
non-enzymatic intracellular antioxidant GSH were also enhanced and lipid peroxidation 
was decreased. When compared to vitamin C, ROS scavenging ability as measured by 
the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method and FRAP was 
decreased at lower concentrations compared to vitamin C, which was used as the 
positive control. The expression of Nrf2, HO-1, SOD, Akt and GSK-β and the mechanis-
tic target of rapamycin (mTOR) and cyclin D were also increased by exposure to 
mangiferin. In an STZ-induced diabetic Wistar rat model, mangiferin improved 
antioxidant status and reduced apoptosis and inflammation [82]. This could be due to 
modulation of the AGE-RAGE/MAPK signalling pathways. Advanced glycation end 
products (AGEs), which are increased in diabetes, lead to upregulation and activation of 
the receptor for advanced glycation end products (RAGE). This interaction causes 
inflammation and oxidative stress, through increases in the production of ROS, leading 
to lipid peroxidation. AGEs can also inhibit peroxisome proliferator activated receptor 
(PPAR)γ, a regulator in inflammation as well as the metabolism of lipids and glucose 
[83]. In the study mangiferin also displayed potential as a therapeutic in preventing AGE 
mediated lipogenesis. Antioxidants such as β-carotene, α-tocopherol and ascorbate were 
unsuccessful in reducing incidences of cardiovascular [84] and other diseases such as 
cancer [85], in fact appearing to increase risk in some cases, e.g., with vitamin C, 
x-tocopherol and beta-carotene [86–88]. Antioxidant supplementation to alleviate 
oxidative stress could however be affected by other factors such as the dose of the 
antioxidant, timing of the intervention, interactions with other antioxidants, whether it 
as administered as an isolate or a whole extract, the type of extract, the model as well as 
the methods that are used to detect oxidative stress. Rooibos and honeybush exert 
antioxidant effects by scavenging free radicals, chelating metal ions, or upregulating 
indigenous antioxidant enzymes. The aromatic ring structures of polyphenols also 
contain free hydroxyl groups which contribute to their antioxidant ability. The struc-
tural differences between rooibos polyphenols may thus also explain differences in 
antioxidant activity of these compounds [89]. The antioxidant activity of rooibos and 
honeybush polyphenols may also be explained by their ability to increase the activity of 
antioxidant enzymes, through upregulation of Nrf2, PI3K and other signalling pathways 
involved in cell survival. It may also be explained by their ability to act as antioxidants 
themselves, exerting differential physiological effects. The antioxidant effects of rooibos 
and honeybush and their polyphenols have been extensively studied in detail elsewhere 
and some of these effects are discussed here under the anti-inflammatory, anti-obesity, 
anti-diabetic and cardiovascular effects of these nutraceuticals (Tables 1–4).
6. Anti-inflammatory effects
Inflammation and oxidative stress form a common thread in the metabolic syn-
drome, type 2 diabetes and cardiovascular disease [132, 133]. The rooibos flavonoid 
orientin from rooibos reduced the number of mast cells in colon sections as well as 
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NFK-β, TNF-α, IL-6, iNOS and COX2, reflecting its anti-inflammatory potential [92]. 
Aspalathin and nothofagin inhibited LPS-mediated expression of the lipopolysaccha-
ride (LPS) receptor (TLR4) and LPS-mediated barrier disruption. This occurred by 
increasing barrier integrity and inhibiting the expression of cell adhesion molecules 
(CAMs) and reducing neutrophil adhesion and migration in human umbilical vein 
endothelial cells [95]. The barrier protective effects of aspalathin and nothofagin were 
confirmed in a mouse model, in which the dihydrochalcones reduced LPS-induced 
mortality. This suggests that aspalathin and nothofagin can be regarded as potential 
therapeutics against vascular inflammation. The protective effects of aspalathin and 
nothofagin in a systemic inflammatory response induced by caecal ligation included 
decreases in inflammatory markers, including TNFα-expression NF-κB, NO and IL-6 
production, enhanced antioxidant activity and decreased lipid peroxidation. [91]. 
The anti-inflammatory effects of rooibos and honeybush may involve a reduction in 
inflammatory cytokines such as IL-6, TNF-α, COX2 [91, 92, 94]. It may also involve a 
reduction in neutrophil adhesion, and other mechanisms [96], Table 1.
7. Anti-obesity effects
Obesity and overweight are major risk factors for cardiovascular disease and 
type 2 diabetes. Insulin resistance, a key finding in the metabolic syndrome, is char-
acterised by alterations in glucose uptake in insulin sensitive tissues such as the liver, 
skeletal muscle and adipose tissue [134]. Non-alcoholic fatty liver disease (NAFLD), 
characterised by fat accumulation in the liver, is an independent predictor of the 
metabolic syndrome which influences the progression of cardiovascular disease 
[135]. Since NAFLD is complex, utilising therapeutic strategies with multiple tar-
gets may be beneficial. The PI3K/Akt pathway is a complex insulin regulated path-
way involved in glucose and lipid metabolism, as well as other cellular processes, 
including protein synthesis, cell signalling cell growth and apoptosis [136]. In type 
2 diabetes and obesity, inhibition of the pathway interferes with beta cell function 
and insulin secretion, exacerbating insulin resistance. A green rooibos extract 
reduced lipid accumulation as well as lipolysis in C3A liver cells [102]. Rooibos also 
ameliorated palmitate-induced insulin resistance, by activating phosphorylated 
PKB/Akt and 5′ adenosine monophosphate-activated protein kinase (AMPK), as 
well as increasing glucose transporter (GLUT)2 expression. Furthermore, fatty 
acid oxidation was enhanced by increasing FOXO1, decreasing malonyl-CoA 
decarboxylase, increasing carnitine palmitoyl transferase 1 (CPT1) and increasing 
acetyl CoA carboxylase in insulin deficient cells. In the accompanying obese insulin 
resistant rat model, only a high dose (195 mg/kg) of green rooibos extract (GRE) 
could reduce insulin levels and the HOMA-IR index. No significant differences were 
detected in blood glucose, body weights or food intake. Insulin receptor and insulin 
receptor substrates 1, and 2 were however upregulated by GRE, suggesting that 
GRE may be beneficial in ameliorating obesity-induced insulin resistance. In 3T-L1 
adipocytes, palmitate-induced insulin resistance was ameliorated by both aspal-
athin, as well as GRE [104]. This was accompanied by increases in Akt activation 
and decreases in nuclear factor (NF)-κB, IRS1 and AMP phosphorylation. GLUT4 
expression was enhanced by the GRE but not aspalathin, suggesting that the whole 
extract rather than the isolated compound may be beneficial in providing a more 
multi-targeted therapeutic approach in improving palmitate-induced effects on 
glucose and lipids. A number of other rooibos polyphenols, such as the C-glycosidic 
flavones orientin, iso-orientin and luteolin, have anti-obesity effects, as reflected 
by their inhibition of pancreatic lipase, which is responsible for digesting and 
absorbing triglycerides [137]. Fermented rooibos also inhibited lipid accumulation 
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NFK-β, TNF-α, IL-6, iNOS and COX2, reflecting its anti-inflammatory potential [92]. 
Aspalathin and nothofagin inhibited LPS-mediated expression of the lipopolysaccha-
ride (LPS) receptor (TLR4) and LPS-mediated barrier disruption. This occurred by 
increasing barrier integrity and inhibiting the expression of cell adhesion molecules 
(CAMs) and reducing neutrophil adhesion and migration in human umbilical vein 
endothelial cells [95]. The barrier protective effects of aspalathin and nothofagin were 
confirmed in a mouse model, in which the dihydrochalcones reduced LPS-induced 
mortality. This suggests that aspalathin and nothofagin can be regarded as potential 
therapeutics against vascular inflammation. The protective effects of aspalathin and 
nothofagin in a systemic inflammatory response induced by caecal ligation included 
decreases in inflammatory markers, including TNFα-expression NF-κB, NO and IL-6 
production, enhanced antioxidant activity and decreased lipid peroxidation. [91]. 
The anti-inflammatory effects of rooibos and honeybush may involve a reduction in 
inflammatory cytokines such as IL-6, TNF-α, COX2 [91, 92, 94]. It may also involve a 
reduction in neutrophil adhesion, and other mechanisms [96], Table 1.
7. Anti-obesity effects
Obesity and overweight are major risk factors for cardiovascular disease and 
type 2 diabetes. Insulin resistance, a key finding in the metabolic syndrome, is char-
acterised by alterations in glucose uptake in insulin sensitive tissues such as the liver, 
skeletal muscle and adipose tissue [134]. Non-alcoholic fatty liver disease (NAFLD), 
characterised by fat accumulation in the liver, is an independent predictor of the 
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expression was enhanced by the GRE but not aspalathin, suggesting that the whole 
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glucose and lipids. A number of other rooibos polyphenols, such as the C-glycosidic 
flavones orientin, iso-orientin and luteolin, have anti-obesity effects, as reflected 
by their inhibition of pancreatic lipase, which is responsible for digesting and 
absorbing triglycerides [137]. Fermented rooibos also inhibited lipid accumulation 
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in 3T3-L1 adipocytes [105]. Z-2-(β-ᴅ-glucopyranosyloxy)-3-phenylpropenoic 
acid (PPAG), increases glucose uptake, as demonstrated in Chang cells [52]. In 
their in vivo model of obese insulin resistant rats, basal fasting glucose decreased 
and glucose tolerance was improved by PPAG. Increases in mRNA expression of 
genes involved in glucose (GLUT1 and GLUT4) and insulin metabolism (IR) and 
others such as PPARα and SOCS3 in the liver were also seen. PPARα regulates the 
action of fatty acids in the liver, suggesting that insulin signalling, glucose and lipid 
metabolism may be altered by PPAG. SOCS3 associates with various proteins to 
inhibit cytokine signals, e.g., leptin, growth hormone, IL-6, leukaemia inhibitory 
factor (LIF) as well as insulin [138]. It may therefore mediate leptin resistance, 
which occurs in obesity but is also regulated by leptin, which may partially explain 
these findings. Administration of rooibos to LDL receptor deficient (Ldlr−/−) mice 
reduced liver steatosis and white adipose tissue and increased brown adipose tissue 
in high fat diet rats. Macrophage recruitment was decreased but no difference was 
seen in adipocyte size or number in the rooibos supplemented group. Furthermore, 
there appeared to be no liver toxicity, and free fatty acids, triglycerides and choles-
terol were reduced by rooibos in the high fat diet group [108]. In humans, rooibos 
reduced oxidative stress, improved HDL-C, and triacylglycerol and low density 
lipoprotein cholesterol (LDL-C) in adults at risk of developing cardiovascular 
disease. [77]. These results suggest that rooibos and flavonoids in rooibos, such 
as aspalathin, may be potential adjuvants in the management of the metabolic 
syndrome. The anti-obesity effects of Cyclopia intermedia, C. subternata and C. 
maculata are limited but have been studied in 3T3-L1 adipocytes [106, 107, 139]. 
C. maculata and C. subternata decreased intracellular lipid and triglycerides and 
increased PPARγ, a regulator of glucose and lipid metabolism [107]. Their anti-
obesity effects also include increased release of glycerol [106]. Hormone sensitive 
lipase (HSL) expression, which is regulated by SIRT1a, a rate limiter of lipolysis, 
was also increased by fermented C. maculata. Furthermore, perilipin expression, 
which appears to play a key role in the metabolism of lipids and lipolysis of adipose 
tissue was upregulated [140]. C. intermedia increased HSL, SIRT1, UCP3 as well as 
PPARγ expression in 3T3-L1 adipocytes [139]. The authors attributed increases in 
SIRT1 and PPARγ to be indicative of changes from white to brown adipose tissue, 
however the expression of UCP1, which characterises brown adipose tissue was not 
measured in the study [141]. While the exact function is unclear, UCP3 may protect 
against lipotoxicity of the mitochondria [142]. In the parallel obese db/db mouse 
model, no increases in body weight gain were seen with C. intermedia treatment, 
and neither food nor water consumption was affected [139]. Extracts of mangiferin 
and other polyphenols isolated from plants containing components similar to that 
found in honeybush have proven useful in understanding their mechanisms of 
action and how they could be used as nutraceuticals in the treatment of cardiovas-
cular disease. In a double-blind randomised placebo controlled clinical trial, man-
giferin (150 mg/day) from mangoes, was given to 97 overweight, hyperlipidaemic 
patients over a period of 12 weeks. Increased high density lipoprotein cholesterol 
(HDL-C), L-carnitine, as well as decreases in total cholesterol, low density lipopro-
tein cholesterol (LDL-C) and triglycerides were obtained in the patients [143]. No 
alterations in liver and kidney function markers were seen, suggesting that chronic 
treatment over 12 weeks was safe in human participants. Since the metabolic syn-
drome is so complex, providing a multi-targeted approach, such as through affect-
ing the PI3K/Akt pathway may be somewhat beneficial. The anti-obesity effects are 
further described in Table 2. The limited available information on the anti-obesity 
effects of rooibos and honeybush however, suggests that more research is needed to 
fully understand and enable the translation of these effects from animals to man.
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8. Anti-diabetic effects
Diabetic hyperglycaemia involves macro-and microvascular complications [144]. 
Free radicals are also produced, promoting oxidative stress [145]. Evidence suggests that 
rooibos and its polyphenols may reduce oxidative stress associated with the patho-
genesis of diabetes [34, 69]. A meta-analysis and systematic review narrowed down 
to 12 peer-reviewed studies reported a reduction in blood glucose levels in diabetic 
rodent models that had received either rooibos or its polyphenols, while no clinical 
trials have investigated the effects of rooibos in the context of type 2 diabetes [146]. 
Rooibos decreases fasting blood glucose and improves glucose tolerance [117]. The 
anti-diabetic actions may be related to the expression of genes responsible for glucose 
uptake (GLUT1, GLUT2), insulin signalling (IR), as well as other genes such as PPRα in 
the liver in a model of obese insulin resistant rats treated with PPAG [52]. The involve-
ment of insulin dependent GLUT4, in skeletal muscle has also been reported [111]. 
Rooibos may be exerting anti-diabetic effects by affecting the metabolism and uptake 
of glucose. Aspalathin influences key genes involved in the metabolism of lipids, insulin 
resistance, inflammation and apoptosis, possibly reversing metabolic abnormalities by 
involving PPARγ, Adipoq, IL-6/Jak2 pathway and Bcl-2 [74]. PPAG increased beta cell 
mass and delayed hyperglycaemia in STZ-diabetic mice [147]. This was accompanied by 
increases in anti-apoptotic B-cell lymphoma 2 (Bcl-2), but no antioxidant effect, and in 
human islet cells PPAG also decreased cell death. This suggests that PPAG increases beta 
cell mass by decreasing apoptosis and increasing Bcl-2 as reflected in both STZ diabetic 
and obese mouse models [114, 148]. In the absence of insulin, GRE also increased 
phosphorylation of both AMPK and Akt, in L6 skeletal myotubules. Activation of 
AMPK could be a therapeutic strategy in the treatment of obese and type 2 diabetics, 
as animal studies suggest a dysregulation of AMPK in these states. The mechanism 
for the amelioration of diabetic complications in rodents by rooibos and honeybush 
may also be due α-glucosidase inhibition; or SGLT2 inhibiting potential of rooibos and 
honeybush or their respective flavonoids [119, 149–151]. α-Glucosidase is an enzyme 
present on the intestinal brush border where it digests starch, increasing blood glucose 
[152]. Anti-diabetic drugs, therefore commonly utilize strategies such as α-glucosidase 
inhibition or SGLT2 inhibition to facilitate their actions [152, 153]. The dihydrochalcone 
phlorizin, an SGLT2 inhibitor, provides a basis to explore natural plant based agents 
for use in the management of diabetes [154]. Strategies to target SGLT2 rather than 
SGLT1 is also associated with reduced drug toxicity as found in studies of phlorizin and 
anti-diabetic drugs [153]. In an STZ-diabetic model, unfermented extracts of Cyclopia 
maculata improved glucose tolerance, fasting glucose, β-cell area, triglyceride levels as 
well as the insulin: glucagon ratio. Plasma nitrite was reduced but no alterations were 
seen in other markers of nitrotyrosine and lipid peroxidation or the serum antioxidant 
enzymes [155]. Mangiferin and naringenin from Salacia oblonga also reduced blood 
glucose, normalised AST and ALT levels, improved antioxidant status and decreased 
protein carbonyl levels, glycogen and TBARS in the liver. Beta cell damage in the pan-
creas was also ameliorated by the compounds. It was proposed that activation of PPARγ 
and GLUT4, which was also accompanied by insulin sensitisation, may be partially 
responsible for the anti-diabetic effects [156]. Since naringenin is also found in hon-
eybush, it suggests that extracts from honeybush could possibly also produce similar 
effects. Mangiferin from Anemarrhena asphodeloides Bunge reduced blood glucose levels 
and ameliorated hyperinsulinemia, the anti-diabetic properties possibly due to a reduc-
tion in insulin resistance in these rats [157]. Furthermore, mangiferin and naringenin 
isolated from Salacia oblonga reduced blood glucose levels, and increased GLUT4 and 
PPARγ expression, suggesting increased insulin sensitisation and demonstrating the 
anti-diabetic properties of the polyphenols. In conclusion, the anti-diabetic effects of 
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which occurs in obesity but is also regulated by leptin, which may partially explain 
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PPARγ expression in 3T3-L1 adipocytes [139]. The authors attributed increases in 
SIRT1 and PPARγ to be indicative of changes from white to brown adipose tissue, 
however the expression of UCP1, which characterises brown adipose tissue was not 
measured in the study [141]. While the exact function is unclear, UCP3 may protect 
against lipotoxicity of the mitochondria [142]. In the parallel obese db/db mouse 
model, no increases in body weight gain were seen with C. intermedia treatment, 
and neither food nor water consumption was affected [139]. Extracts of mangiferin 
and other polyphenols isolated from plants containing components similar to that 
found in honeybush have proven useful in understanding their mechanisms of 
action and how they could be used as nutraceuticals in the treatment of cardiovas-
cular disease. In a double-blind randomised placebo controlled clinical trial, man-
giferin (150 mg/day) from mangoes, was given to 97 overweight, hyperlipidaemic 
patients over a period of 12 weeks. Increased high density lipoprotein cholesterol 
(HDL-C), L-carnitine, as well as decreases in total cholesterol, low density lipopro-
tein cholesterol (LDL-C) and triglycerides were obtained in the patients [143]. No 
alterations in liver and kidney function markers were seen, suggesting that chronic 
treatment over 12 weeks was safe in human participants. Since the metabolic syn-
drome is so complex, providing a multi-targeted approach, such as through affect-
ing the PI3K/Akt pathway may be somewhat beneficial. The anti-obesity effects are 
further described in Table 2. The limited available information on the anti-obesity 
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rooibos and honeybush (Table 3) are mediated by complex signalling pathways that 
affect glucose and lipid metabolism as well as oxidative stress.
9. Cardiovascular effects
Angiotensin converting enzyme (ACE) inhibitors reduce blood pressure by 
inhibiting the conversion of angiotensin to angiotensin II, the latter being a potent 
vasoconstrictor which increases blood pressure through a variety of mechanisms [158]. 
Angiotensin II can also interact with the angiotensin I receptor, enhancing ROS 
 production, which contributes to endothelial dysfunction by inactivating vasodila-
tory nitric oxide [158]. Endothelial dysfunction is commonly associated with risk 
factors of cardiovascular disease, including obesity and type 2 diabetes [159]. It also 
precedes atherosclerosis, which involves a number of complex processes such as the 
release of pro-inflammatory cytokines and inflammation, oxidation of LDL as well as 
macrophage recruitment and platelet adhesion [158]. Cardiovascular protective effects 
of rooibos have also been established in a number of studies (Table 4). In an in vitro 
human  umbilical vein endothelial cell (HUVEC) study, rooibos could not inhibit ACE 
but increases in nitric oxide were detected [125]. ACE-inhibition was also determined 
in 17 healthy volunteers receiving a single oral dose of rooibos [124]. Inhibition of ACE 
occurred up to 60 min after ingestion but no change in blood pressure or nitric oxide was 
detected. ACE-inhibitory effects have also been reported for rooibos and honeybush and 
some of their flavonoids [131]. This effect on ACE could be due to the presence of the  
C2〓C3 double bond, the catechol group at the B-ring and the cetone group on C4 on 
the C-ring of flavonoids [131]. The best ACE-inhibitor in HUVEC’s was luteolin, 
followed by quercetin, rutin, kaempferol, rhoifolin and apigenin K. The honeybush 
flavonoids genistein and hesperetin also displayed ACE-inhibitory effects but these were 
less potent than luteolin. Rooibos probably inhibits ACE using a mixed type of inhibi-
tion, which binds to the enzyme’s active and allosteric sites [126]. Organic fractions of, 
as well as flavonoids in rooibos such as chrysoeriol and rutin inhibited spontaneous and 
low and/or high K+-induced contractions in models utilising jejunum and bronchial 
smooth muscle [130, 160]. Anti-contractile effects were reportedly due to the opening 
of K+ channels as well as a Ca2+ antagonistic action. These studies were not done in vas-
cular smooth muscle, but it is possible that rooibos could exert antihypertensive effects 
via similar mechanisms in vascular smooth muscle. It also caused mild reduction of 
atrial force and rate of spontaneous contractions in the Guinea pig and decreased blood 
pressure in anaesthetised rats [130]. In comparison, isolated compounds of rooibos 
tested in jejunal, tracheal and aortic preparations showed variable effects. In adults with 
cardiovascular risk factors, six cups of rooibos was able to increase antioxidant status by 
increasing the GSH: GSSG ratio and decrease lipid peroxidation by decreasing TBARS 
and conjugated dienes [77]. Furthermore, increases in the healthy HDL cholesterol were 
also seen. In a recent study using a high fat diet to induce obesity in Wistar rats, treat-
ment with an enriched GRE, containing large quantities of aspalathin, improved glucose 
tolerance, vascular function, as determined by aortic vascular contraction-relaxation 
studies and enhanced the antioxidant status. Modest improvements in blood pressure 
were also seen in a recent study in obese rats, suggesting cardiovascular benefits with the 
intake of the rooibos [161]. Fermented rooibos also improved vascular function in nico-
tine exposed rats [162]. Since tobacco smoking is a major risk factor for cardiovascular 
disease, this suggests a possible therapeutic role for rooibos in the reduction of cardio-
vascular complications associated with tobacco smoking, such as vascular dysfunction 
or oxidative stress. Cardioprotective effects of rooibos and its flavonoids typically appear 
to involve a reduction in lipid peroxidation and upregulation of the antioxidant enzymes 
through Nrf2 activation, and a reduction in apoptosis which may also be associated with 
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increases in the Bcl-2: Bax ratio [77, 122, 129]. The anti-inflammatory effects of rooibos, 
also support its role as a cardioprotective agent (Table 1). No literature investigating the 
vascular modulating effects of honeybush are currently available and anti-inflammatory 
effects on HUVECs are discussed above. Decreases in VLDL, LDL-C and increases in 
HDL-C by naringenin and mangiferin from Salacia sp. however suggests the potential 
of similar isolates from honeybush to ameliorate endothelial dysfunction [156].
10. Conclusions and perspectives
Rooibos and honeybush have a number of health benefits. The evidence for their use 
as functional nutraceuticals is reflected in anti-diabetic, anti-inflammatory, antioxi-
dant, anti-obesity, and vascular effects in animal and in vitro studies. The translation 
of these results into human medical care has however been limited. The inability to 
translate animal studies to that of humans may be due to the result of the controlled 
genetic background and environmental conditions of animals used as models to study 
disease [163]. Given the unstable nature of ROS and the limitations in assays used to 
detect oxidative stress, it is noteworthy to remember that intervention studies may 
only as good as the biomarkers used to measure the intervention. As we investigate the 
therapeutic role of rooibos or honeybush in the treatment of cardiovascular disease, it is 
evident that we are only but scratching the surface. These plants have complex chemical 
compositions and while isolating single components could be beneficial, the interplay 
and additive effects of other components in whole extracts could be more beneficial 
[111]. The mechanisms behind these benefits involve numerous signalling pathways 
that regulate their effects. Understanding these complexities may be what is needed to 
promote their transition from bush teas to nutraceutical therapy against cardiovascular 
disease but until then we may as well enjoy a cuppa.
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evident that we are only but scratching the surface. These plants have complex chemical 
compositions and while isolating single components could be beneficial, the interplay 
and additive effects of other components in whole extracts could be more beneficial 
[111]. The mechanisms behind these benefits involve numerous signalling pathways 
that regulate their effects. Understanding these complexities may be what is needed to 
promote their transition from bush teas to nutraceutical therapy against cardiovascular 
disease but until then we may as well enjoy a cuppa.
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Probiotics and Other Bioactive 
Compounds with Proven 
Effect against Obesity and 
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1. Foods, technology, and metabolic syndrome
Overweight and obesity are defined as “abnormal or excessive fat accumulation 
that may impair health” [1]. Since 1975, obesity has almost tripled worldwide so 
that in 2016, 39% of the adult population and 18% of children and adolescents were 
overweight. Very often, a high body mass index (BMI ≥ 25–30) is associated with 
other metabolic abnormalities, such as high blood pressure (hypertension), high 
blood sugar (hyperglycemia), high serum triglycerides, and low serum high-density 
lipoprotein (HDL) [2]. The occurrence of at least three of these interconnected 
physiological, biochemical, clinical, and metabolic factors that directly increase the 
risk of atherosclerotic cardiovascular disease, cancer, and type 2 diabetes is known 
as metabolic syndrome [3]. The International Diabetes Federation estimates that 
one-quarter of the world’s adult population suffers from this syndrome, with little 
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lipoprotein (HDL) [2]. The occurrence of at least three of these interconnected 
physiological, biochemical, clinical, and metabolic factors that directly increase the 
risk of atherosclerotic cardiovascular disease, cancer, and type 2 diabetes is known 
as metabolic syndrome [3]. The International Diabetes Federation estimates that 
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difference between developed and developing countries. Main factors contributing 
to it include, beyond the genetic susceptibility, the increased consumption of calo-
rie-dense food and the scarce physical activity. Given that metabolic syndrome can 
occur in several forms, according to the combination of the different components, it 
is apparently difficult to treat it pharmacologically, being lifestyle change the most 
effective preventive approach. However, the fact that a low-grade chronic inflam-
matory state accompanies the metabolic syndrome in any of its forms suggests that 
anti-inflammatory therapies could have a place in its prevention and treatment [4].
Inflammation is a response of the body’s immune system to harmful stimuli. In 
the case of metabolic syndrome, inflammation takes place in response to imbalance 
of blood glucose and insulin levels or insulin resistance, which leads to unhealthy 
high concentration of unused sugar in the bloodstream that is sent to the liver, 
muscle, or pancreas [5, 6]. Once there, the sugar is converted into fat, thus lead-
ing to progressive adipocyte enlargement. Hypertrophy reduces blood supply to 
adipocytes and causes hypoxia. Subsequent necrosis and macrophage infiltration 
into adipose tissue lead to overproduction of reactive oxygen species (ROS), 
low-density lipoproteins (LDLs), inflammatory cytokines (tumor necrosis factor-
alpha, interleukin-6, adiponectin, etc.), and C-reactive protein (CRP). High-fat 
diets, frequently consumed by obese individuals, aggravate this problem both 
directly, when the fat is rich in saturated fatty acids, and indirectly, through effects 
on the microbiota and intestinal permeability [5]. The normal blood plasma con-
centration of CRP varies between 0.08 and 0.3 mg/dL in healthy adults and reaches 
values between 2 and 10 mg/dL in individuals suffering from metabolic syndrome. 
High levels of the inflammatory marker CRP in blood are associated with increased 
odds of having plaque in the carotid arteries and, therefore, with increased risk of 
myocardial infarction and stroke [7].
In addition to CRP, some dietary food components involved as intermediates in 
various metabolic pathways appear altered in population with metabolic syndrome, 
making possible its use as biomarkers. Polyunsaturated fatty acids (PUFA), specifi-
cally eicosapentaenoic acid (20:5 n-3; EPA) and docosahexaenoic acid (22:6 n-3; 
DHA), are inversely related to metabolic syndrome in adults [8]; several studies have 
stablished an association between this syndrome and selenium blood concentration 
[9] or serum levels of vitamin B12 [10]; Urrunaga-Pastor et al. [11] also found an 
association between vitamin D deficiency and hyperinsulinemia; adults with meta-
bolic syndrome also have suboptimal concentrations of several antioxidants (retinyl 
esters, vitamin C, and all carotenoid concentrations, except lycopene), partly due 
to the lower intake of fruit and vegetables by these individuals [12]. These results 
reinforce the relationship between diet and the incidence of metabolic syndrome.
Evidence from prospective observational in vitro and in vivo studies (preclini-
cal and clinical trials) has converged to support the importance of individual 
nutrient or food intake and dietary patterns in the prevention and management of 
obesity and metabolic syndrome. In vitro studies seek to determine the biochemi-
cal mechanisms at the cellular level as physiological ones, which are involved in 
the proper functioning both at the transcriptional and protein expression in the 
pancreas, skeletal muscle, liver, and adipose tissue. In vivo studies allow establish-
ing a cause-effect relationship in experimental animals (preclinical trials) or in 
humans (clinical trials). While in vitro or animal in vivo studies are standardized 
and there are countless works done, even today a standard profile for clinical trials 
in humans with metabolic syndrome has not yet been established. Clinical trials 
about therapeutic efficacy for metabolic syndrome are scarce and concentrated in 
the last 8 years in high-income countries (USA, Italy, and Spain). Interventions that 
affect three or more factors and evaluate various outcome variables are reduced, 
highlighting the lifestyle factors (diet and physical activity) as the most important 
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in this multifactorial syndrome [13]. Specifically, a low intake of saturated and total 
fat; reduced consumption of sodium, simple sugars, and high glycemic index foods; 
and increased intake of fruits, vegetables, legumes, and whole grains are suggested 
to be the most effective actions in reducing the incidence of obesity and cardio-
vascular disease. However, the urban lifestyle leads us to mainly consume foods 
in processed form, which reinforces the decisive role that the food industry plays 
in the promotion of healthy diets. In fact, in recent years the supply of functional 
foods with a reduced content of fat, sugar or salt, as well as that of functional foods 
formulated with phytosterols or polyunsaturated fatty acids has increased consider-
ably. In order to achieve this, not only traditional techniques of food formulation 
and blending or cultivation and breeding are involved but also more recent ones, 
such as microencapsulation, vacuum impregnation, or coating with edible films 
[14]. Moreover, the increasing knowledge about the negative impact that process-
ing and cooking techniques have on the concentration and functionality of the 
active compounds naturally present in foods has encouraged the use of alternative 
techniques, such as the application of high-pressure homogenization replacing the 
pasteurization or freeze-drying instead of hot air drying.
Later in this book chapter, the most relevant bioactive compounds with proven 
effect against any disorder associated with the metabolic syndrome are listed. 
Focusing on probiotic microorganisms and phytochemical compounds, evidences 
obtained from in vitro, in vivo, or clinical studies in the last 10 years have been 
compiled. Finally, new functional foods made from lulo fruit are suggested as being 
suitable for metabolic syndrome prevention and/or amelioration.
2. Food components against metabolic syndrome
Main food components considered in the literature as having potential amelio-
rating effect on any disorder associated with metabolic syndrome may be included 
in one of the following groups:
• Fiber, both soluble (e.g., pectins, beta-glucans, naturally occurring gums, inu-
lin, psyllium) and insoluble (e.g., cellulose, hemicellulose, lignin), is reported 
to have laxative properties and to mitigate both hypercholesterolemia and 
hyperglycemia [15]. When fermented by probiotic bacteria, prebiotic fiber (fiber 
that resists digestion in the stomach and the small intestine and reaches the 
colon intact) breaks down into short-chain fatty acids (butyrate, acetate, and 
propionate), which are reported to enhance glucose and fat metabolism [16].
• Monounsaturated fats, polyunsaturated fats (both omega-3 and omega-6), plant 
sterols, and essential fatty acids instead of saturated fats and trans-fatty acids are 
proved to be effective in decreasing total cholesterol and increasing the blood 
level of high-density lipoproteins (HDLs) [17].
• Vitamin E and C consumption is associated to a reduction of vascular risk by 
decreasing oxidative stress (lipid peroxidation) and proinflammatory cyto-
kines [17]. Improved vitamin C status is hypothesized to alleviate endotoxemia 
and its consequent proinflammatory responses that are suggested to initiate 
insulin resistance and related metabolic disorders; on the contrary, inadequate 
vitamin C status contributes to small intestinal bacterial overgrowth, trans-
cytosis of enteric bacteria, and an elevation of circulating lipopolysaccharide, 
which elicits a low-grade inflammatory response [18]. As for vitamin D, it 
reduces the intestinal absorption of fat by increasing that of calcium [17].
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such as microencapsulation, vacuum impregnation, or coating with edible films 
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lin, psyllium) and insoluble (e.g., cellulose, hemicellulose, lignin), is reported 
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hyperglycemia [15]. When fermented by probiotic bacteria, prebiotic fiber (fiber 
that resists digestion in the stomach and the small intestine and reaches the 
colon intact) breaks down into short-chain fatty acids (butyrate, acetate, and 
propionate), which are reported to enhance glucose and fat metabolism [16].
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sterols, and essential fatty acids instead of saturated fats and trans-fatty acids are 
proved to be effective in decreasing total cholesterol and increasing the blood 
level of high-density lipoproteins (HDLs) [17].
• Vitamin E and C consumption is associated to a reduction of vascular risk by 
decreasing oxidative stress (lipid peroxidation) and proinflammatory cyto-
kines [17]. Improved vitamin C status is hypothesized to alleviate endotoxemia 
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reduces the intestinal absorption of fat by increasing that of calcium [17].
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• Bioactive peptides, having a size range of 2–50 amino acids, have potential to 
regulate blood pressure and glycemia, reduce cholesterol level and body mass, 
and scavenge free radicals [19]. Lactotripeptides isoleucine-proline-proline 
and valine-proline-proline, whose concentrations increase during the ripening 
process of cheese, are particularly considered as strong antihypertensive agents 
[20]. In the case of obesity, foods that contain bioactive peptides provide a 
satiating effect and lead to appetite suppression.
• Minerals’ (selenium, magnesium, and zinc) ability to decline metabolic 
syndrome is related with their antioxidant properties and their participation 
in insulin synthesis and regulation [20]. Moreover, calcium intake (1200 mg/
day) has been demonstrated to increase fat mass loss in overweight and obese 
adults [21]. Mechanisms to explain this effect include that during low calcium 
intake, more calcium enters adipose tissues cells and subsequently stimulates 
the expression of lipogenic genes in parallel with suppressing lipolysis [22]. 
Also, calcium increases fecal fat loss by binding to fat in the lumen and forming 
non-absorbed complexes [23]. This ability of calcium to decrease lipogenesis 
may be enhanced due to a synergistic effect with other components in dairy 
products (vitamin D and angiotensin-converting enzyme inhibitors) [21].
• Essential amino acids, mainly histidine and glycine, are associated with a 
decrease in insulin resistance and blood pressure, respectively, although 
conclusive evidence is lacking and additional studies are needed [17].
• Phytochemicals, mainly polyphenols (phenolic acids, curcuminoids, stilbenes, 
lignans, flavonoids, flavonols, flavones, anthocyanins, etc.) but also other 
bioactive components present in small quantities in fruits and vegetables 
(triterpenes, carotenoids, etc.), have demonstrated anti-inflammatory, anti-
oxidative, antiadiposity, and cardioprotective functions in a huge amount of 
studies [24–28]. Some phytochemicals, among which are caffeine, ephedrine, 
capsaicin, and salicylic acid, also act as thermogenic compounds that produce 
heat from lipids and fats, thus burning extra calories and preventing the 
accumulation of fat in body tissues [20].
• Probiotics are microorganisms that improve the availability and digestibility of 
nutrients while maintaining the balance of intestinal microflora in the gut [20]. 
Mainly belonging to the Lactobacillus and Bifidobacterium genera, probiotics 
emerge as prospective biotherapies in the management of metabolic disorders 
including obesity and diabetes by counteracting the adverse effects of a high-
fat diet [29].
2.1 Phytochemicals
Phytochemicals are naturally occurring plant chemicals that, beyond providing 
plants with color, odor, and flavor, can influence chemical processes within human 
bodies in a beneficial way. Main phytochemicals under research include carotenoids 
(β-carotene, lycopene, lutein, zeaxanthin) and polyphenols, which include phenolic 
acids, flavonoids, and stilbenes/lignans [30]. Flavonoids can be further divided into 
groups based on their similar chemical structure, such as anthocyanins, flavones, 
flavanones, isoflavones, flavonols, and flavanols. Flavanols further are classified as 
catechins, epicatechins, and proanthocyanidins.
Phytochemical compounds have gained popularity in recent years due to their 
broadly documented effect in cancer prevention among other biological effects, 
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such as the prevention and treatment of obesity, cholesterol, and diabetes [31]. 
Mechanisms employed by phytochemicals in ameliorating metabolic syndrome risk 
factors are diverse and dependent on their particular chemical structure. Whereas 
catechins mainly induce fat oxidation and improve endothelial function, cyanidins 
and theaflavins inhibit enzymes involved in the synthesis of fatty acids and triglyc-
erides. Other phytochemicals, such as gallic acid, quercetin, and capsaicin, reduce 
preadipocyte proliferation by induction of cell apoptosis, while low-molecular 
proanthocyanidins have the ability to inhibit the activity of specific angiotensin-
converting enzyme. Having a similar chemical structure, isoflavones can also 
influence the activity of human estrogens.
For some bioactive components, several in vitro and in vivo (either animals or 
humans) studies have been performed; however, as evidenced in Tables 1–3, results 
differ among them. While in vitro or animal studies usually yield positive results, 
clinical human studies are still inconclusive. The lack of standardization or aspects 
related to the dose or duration of supplementation may be the cause of these results. 
Moreover, studies both in vitro and with animals (Tables 1 and 2) have been carried 
out with synthetic components (only spermidine was obtained directly from lulo 
fruit), while in vivo studies with humans have been carried out mainly with extracts 
including the bioactive compounds (Table 3).
Phytochemical(s) Methodology Beneficial effect(s) Reference
Synthesis naringenin 3T3-L1 cell line and Pemphigus 
vulgaris-treated HaCaT cell line.
Naringenin was added to the 
cell growing media in a dose 
of 25 μg/mL, and effect was 
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out with synthetic components (only spermidine was obtained directly from lulo 
fruit), while in vivo studies with humans have been carried out mainly with extracts 
including the bioactive compounds (Table 3).
Phytochemical(s) Methodology Beneficial effect(s) Reference
Synthesis naringenin 3T3-L1 cell line and Pemphigus 
vulgaris-treated HaCaT cell line.
Naringenin was added to the 
cell growing media in a dose 
of 25 μg/mL, and effect was 










acid, ursolic acid, 
celastrol, maslinic 
acid, ilexgenin A)
3 T3-L1 cell line or 10 T1/2 cells 
and primary fat SVF cells or 
HepG2 cells




lipolysis, and decreased 
adipocyte differentiation
[26]






ethanolic lulo pulp 
extract)












IC50 ≥ 500 μM for naringenin, 
rutin, hesperidin, resveratrol, 
and naringin
Quercetin efficiently 
inhibited cell population 
growth and increased 
induction of apoptosis
[36]





induced apoptosis, and 
reduced lipogenesis and 
proliferation, thereby 
contributing to reduce lipid 
accumulation. Reduced 
inflammatory response and 
improved insulin sensitivity
[37]
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Phytochemical(s) Methodology Beneficial effect(s) Reference
Ajoene Mature 3T3-L1 adipocytes
Ajoene at 200 μM decreased cell 
viability in 50% after 24 hours 
of treatment
Influenced the regulation of 
fat cell number
[38]
Green tea catechins 3 T3-L1 cells
Epigallocatechin or 
epigallocatechin gallate was 
added to the cell growing 
media in a dose from 1, 10, 
50, 100, 200, and 200 μM for 
some hours until some days 
(8–16 days)





Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vitro studies.
Phytochemical(s) Methodology Beneficial effect(s) Reference
Naringenin Rats and mice
10 mg/kg∙day by oral 
gavage for 4 weeks; 
0.1% in an experimental 
diet for 6 months; 1% 
and 3% in a high-fat 









50 mg/kg∙day by oral 
gavage for 4 weeks
Attenuated insulin resistance, 







acid, ursolic acid, 
α, β-amyrin, 
carbenoxolone, asiatic 





kg∙day, once daily, 
10 weeks) to fructose-
fed rats; ursolic acid-
treated fat-fed mice at a 
dose of 50 or 200 mg/kg 
of body weight (orally 
for 8 weeks); lupeol at 
0.67 g/kg, given orally 
for 7 weeks
Decreased fatty acid synthesis, 
triglyceride synthesis and plasma 
triglycerides, leptin and free fatty 
acids, and also triglyceride content 
in skeletal muscle
Reduced fatty liver, adipocyte size, 
hepatic steatosis, insulin resistance, 
inflammation, oxidative stress, 
body weight, atherosclerosis, and 
hypertension
Decreased cholesterol synthesis, 
total cholesterol, VLDL and LDL-




Carvacrol was added to 
the diet in a 0.1% (w/w) 
(equivalent to 100 mg/
kg body weight) for 
10 weeks
Prevented obesity by decreasing 
body weight gain, visceral fat-pad 
weights, and plasma lipid levels; 
also inhibited visceral adipogenesis 
and attenuated the production of 
pro-inflammatory cytokines in 
visceral adipose tissues
[41]




supplemented with 0.5% 
(w/w) oryzanol or 0.5% 
(w/w) ferulic acid for 
7 weeks
Decreased in body weight, 
improved blood glucose 
metabolism, may be beneficial 




Probiotics and Other Bioactive Compounds with Proven Effect against Obesity…
DOI: http://dx.doi.org/10.5772/intechopen.85482
Phytochemical(s) Methodology Beneficial effect(s) Reference
Resveratrol A randomized, double-blind, placebo-
controlled clinical trial was carried out in 
24 patients with diagnosis of metabolic 
syndrome
12 patients received trans-resveratrol 
(500 mg) three times per day before 
meals for 90 days
Decreased weight, 
body mass index, 
fat mass, waist 
circumference, 









randomized clinical trial was carried 
out in 80 patients with a diagnosis of 
metabolic syndrome
80 patients with metabolic syndrome 
received 1800 mg of artichoke leaf 






Oligonol extract Randomized double-blind, placebo-
controlled study with 18 subjects.
All subjects took two capsules of Oligonol 






Pomegranate juice A randomized, double-blind, placebo-
controlled clinical trial was carried out 
in 20 obese [body mass index (BMI) 
30.0–39.9] adults
10 patients received 120 mL of 
pomegranate juice or placebo while in a 
fasted state before breakfast every day for 
1 month
Did not modify 
insulin secretion 
and sensitivity 
in patients with 
obesity; however, the 
natural evolution to 
increased weight and 
adiposity was halted
[47]
Phytochemical(s) Methodology Beneficial effect(s) Reference
Curcuminoids Rats
Rats were fed 
with high-fat diets 
with curcuminoid 
supplement at 
concentrations of 30, 60, 
and 90 mg per kilogram 
of body weight every day 
for 12 weeks
Decreased plasma free fatty 
acid levels and improves cardiac 
autonomic nervous system activity 
in obesity
Contributed to lower body fat and 
body weight gain
Improved obesity-associated 
inflammation and associated 
metabolic disorders such as 




Quercetin Rats and mice
Rats and mice fed with a 
Western diet containing 
0.05% quercetin for 
20 weeks
Decreased body weight, visceral 
fat, blood glucose, free cholesterol, 
total antioxidant status, lipid 
accumulation, and systolic blood 
pressure
[24]
Green tea catechins Rats and mice
Different dose-time 
treatment: from 0.5–4% 
of different catechins for 
6–22 weeks
Decreased body weight, total lipids, 
cholesterol, and triglycerides in 
liver and plasma. Also improved 
glucose homeostasis: increased 
glucose tolerance and decreased 
serum glucose, insulin resistance, 




Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vivo (preclinical trials) studies.
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Ajoene at 200 μM decreased cell 
viability in 50% after 24 hours 
of treatment
Influenced the regulation of 
fat cell number
[38]
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epigallocatechin gallate was 
added to the cell growing 
media in a dose from 1, 10, 
50, 100, 200, and 200 μM for 
some hours until some days 
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0.1% in an experimental 
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and 3% in a high-fat 









50 mg/kg∙day by oral 
gavage for 4 weeks
Attenuated insulin resistance, 







acid, ursolic acid, 
α, β-amyrin, 
carbenoxolone, asiatic 





kg∙day, once daily, 
10 weeks) to fructose-
fed rats; ursolic acid-
treated fat-fed mice at a 
dose of 50 or 200 mg/kg 
of body weight (orally 
for 8 weeks); lupeol at 
0.67 g/kg, given orally 
for 7 weeks
Decreased fatty acid synthesis, 
triglyceride synthesis and plasma 
triglycerides, leptin and free fatty 
acids, and also triglyceride content 
in skeletal muscle
Reduced fatty liver, adipocyte size, 
hepatic steatosis, insulin resistance, 
inflammation, oxidative stress, 
body weight, atherosclerosis, and 
hypertension
Decreased cholesterol synthesis, 
total cholesterol, VLDL and LDL-




Carvacrol was added to 
the diet in a 0.1% (w/w) 
(equivalent to 100 mg/
kg body weight) for 
10 weeks
Prevented obesity by decreasing 
body weight gain, visceral fat-pad 
weights, and plasma lipid levels; 
also inhibited visceral adipogenesis 
and attenuated the production of 
pro-inflammatory cytokines in 
visceral adipose tissues
[41]




supplemented with 0.5% 
(w/w) oryzanol or 0.5% 
(w/w) ferulic acid for 
7 weeks
Decreased in body weight, 
improved blood glucose 
metabolism, may be beneficial 
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Phytochemical(s) Methodology Beneficial effect(s) Reference
Resveratrol A randomized, double-blind, placebo-
controlled clinical trial was carried out in 
24 patients with diagnosis of metabolic 
syndrome
12 patients received trans-resveratrol 
(500 mg) three times per day before 
meals for 90 days
Decreased weight, 
body mass index, 
fat mass, waist 
circumference, 









randomized clinical trial was carried 
out in 80 patients with a diagnosis of 
metabolic syndrome
80 patients with metabolic syndrome 
received 1800 mg of artichoke leaf 






Oligonol extract Randomized double-blind, placebo-
controlled study with 18 subjects.
All subjects took two capsules of Oligonol 






Pomegranate juice A randomized, double-blind, placebo-
controlled clinical trial was carried out 
in 20 obese [body mass index (BMI) 
30.0–39.9] adults
10 patients received 120 mL of 
pomegranate juice or placebo while in a 
fasted state before breakfast every day for 
1 month
Did not modify 
insulin secretion 
and sensitivity 
in patients with 
obesity; however, the 
natural evolution to 
increased weight and 
adiposity was halted
[47]
Phytochemical(s) Methodology Beneficial effect(s) Reference
Curcuminoids Rats
Rats were fed 
with high-fat diets 
with curcuminoid 
supplement at 
concentrations of 30, 60, 
and 90 mg per kilogram 
of body weight every day 
for 12 weeks
Decreased plasma free fatty 
acid levels and improves cardiac 
autonomic nervous system activity 
in obesity
Contributed to lower body fat and 
body weight gain
Improved obesity-associated 
inflammation and associated 
metabolic disorders such as 




Quercetin Rats and mice
Rats and mice fed with a 
Western diet containing 
0.05% quercetin for 
20 weeks
Decreased body weight, visceral 
fat, blood glucose, free cholesterol, 
total antioxidant status, lipid 
accumulation, and systolic blood 
pressure
[24]
Green tea catechins Rats and mice
Different dose-time 
treatment: from 0.5–4% 
of different catechins for 
6–22 weeks
Decreased body weight, total lipids, 
cholesterol, and triglycerides in 
liver and plasma. Also improved 
glucose homeostasis: increased 
glucose tolerance and decreased 
serum glucose, insulin resistance, 




Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vivo (preclinical trials) studies.
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In vitro studies achieve 50% of cell population growth inhibition with active 
compound amount of ppm, and, in some cases (some flavonoids, ajoene, cat-
echins), a dose-time-dependent effect is detected. These dose-time-dependent 
effects, together with the multivariate effects observed in most cases, are largely due 
to the antioxidant properties of the phytochemicals considered. Flavonoids tested 
on cell population growth were well correlated with their antioxidant activity [36].
The doses used in the preclinical studies were much higher than those used 
in the clinical trials, and the limitations in the ingested doses may be the cause of 
the ineffective results. Kobori et al. [24] concluded that in vitro anti-aggregatory 
effects of flavonoids are caused by concentrations that cannot be attained in vivo by 
dietary consumption.
In most preclinical studies, imbalances are induced in mice with a high fructose 
diet, and the effect that the active component has on these induced disorders is 
determined. Also in the clinical studies performed with positive results, the compo-
nent of interest was provided as part of a low-fat diet to patients with physiological 
alterations associated with metabolic syndrome. In these conditions the results show 
a palliative effect but in no case a preventive effect. Thus, quercetin supplementa-
tion did not affect the antioxidant status under healthy, normal conditions [24].
Sometimes solubility and bioavailability are a major limitation factor. As an 
example, pentacyclic triterpenes such as ursolic acid are poorly bioavailable because 
of poor aqueous solubility and permeability through biological membranes [26]. 
These limit their biological effects. Some strategies have increased bioavailability. 
For example, on comparing the oral bioavailability of ursolic acid microcrystals 
and nanocrystals to its coarse suspension in rats, ursolic acid microcrystals and 
nanocrystals exhibited 1.40- and 2.56-fold enhancement, respectively. Also, a new 
Phytochemical(s) Methodology Beneficial effect(s) Reference
Cocoa extract Double-blind, randomized, placebo-
controlled parallel nutritional 
intervention with 50 obese volunteers 
[30.59(2.33) kg/m2].
Meals supplemented with 1.4 g/day cocoa 
extract for 4 weeks
A marginal decrease 
(P = 0.072) in 
oxidized bases was 
observed, which 





Various randomized, double-blind, 
placebo-controlled clinical trials.
Some studies with different dose-time 
treatment: from 38 to 600 mg/day of 
different catechins for 6–24 weeks
Not all studies have 




has also shown no 
influence on body 
weight, body mass 
index, fat mass, 
and waist and hip 
circumference
[27]
Black seeds and 
turmeric
Double-blind randomized controlled trial
Black seeds (1.5 g/day), turmeric (2.4 g/
day), its combination (900 mg black 
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product from polyphenols of lychee has been developed. Oligonol, a unique low-
molecular-weight polyphenol, was developed to enhance absorption of polyphenols 
from the intestines. It contains 15.7% polyphenol monomer ((+)-catechin, (−)-epi-
catechin, etc.) and 13.3% polyphenol dimer (procyanidin B2, etc.), while lychee 
fruit-derived polyphenol contains 6.4% polyphenol monomer and 9.9% polyphenol 
dimer [46].
Concluding from above, translational studies from animal observations to 
human clinical trials and ultimately community interventions are needed to further 
confirm the effects of phytochemicals and foods rich in these bioactive compounds. 
The technological development should be aimed at the implementation of strategies 
that increase the bioavailability of active components with proven activity and that 
allow to provide the adequate doses avoiding toxicity problems.
2.2 Probiotics
Probiotics are defined as live microorganisms which, when administered in 
adequate amounts, confer a health benefit on the host [50]. Evidence from the latest 
studies in which probiotic efficiency in metabolic disorder management is assessed 
by both in vitro and in animal or human subjects is compiled in Tables 4 and 5.
Regarding the strains employed in the management of several inflammatory dis-
eases, they usually belong to the Lactobacillus and Bifidobacterium genera, although 
Pediococcus pentosaceus LP28, Bacteroides uniformis CECT 7771, and Akkermansia 
muciniphila have also been proved to have anti-obesity effects [65]. In general, doses 
Probiotic organism Methodology Beneficial effect(s) Reference
Lactobacillus 
plantarum Ln4 
isolated from napa 
cabbage kimchi
3T3-L1 adipocytes Inhibited adipogenesis 
and stimulated glucose 
uptake
[51]
Mice fed on a standard diet or 
a high-fat diet (5–7 mice per 
group) supplemented or not with 
5 × 108 CFU/day for 5 weeks
Reduced diet-induced 





10 rats fed on a normal diet and 
30 rats fed on a high-energy 
diet supplemented or not 




inflammation factors and 
increasing antioxidant 
enzymes in the serum
[52]









paracasei NTU 101 
originally isolated 
from infant
3T3-L1 pre-adipocyte model Fermented tea powder 
promoted lipase activity 
in adipocytes, which 
thereby improves the 
lipolytic effect
[53]
Rats fed for 8 weeks on a 
normal diet or a high-fat diet 
supplemented or not with:
• Unfermented tea powder
• (12.5 mg EGCG/day) Fermented 
tea powder
• (12.5–25 mg EGCG/day plus 
3.75–7 × 1010 CFU/day) NTU 101 
powder
• (7.5 × 1010 CFU/day)
• EGCG powder (25 mg/day)
NTU 101-fermented tea 
had a more significant 
effect on the reduction 
of body weight gain and 
body fat content than the 
unfermented tea
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In vitro studies achieve 50% of cell population growth inhibition with active 
compound amount of ppm, and, in some cases (some flavonoids, ajoene, cat-
echins), a dose-time-dependent effect is detected. These dose-time-dependent 
effects, together with the multivariate effects observed in most cases, are largely due 
to the antioxidant properties of the phytochemicals considered. Flavonoids tested 
on cell population growth were well correlated with their antioxidant activity [36].
The doses used in the preclinical studies were much higher than those used 
in the clinical trials, and the limitations in the ingested doses may be the cause of 
the ineffective results. Kobori et al. [24] concluded that in vitro anti-aggregatory 
effects of flavonoids are caused by concentrations that cannot be attained in vivo by 
dietary consumption.
In most preclinical studies, imbalances are induced in mice with a high fructose 
diet, and the effect that the active component has on these induced disorders is 
determined. Also in the clinical studies performed with positive results, the compo-
nent of interest was provided as part of a low-fat diet to patients with physiological 
alterations associated with metabolic syndrome. In these conditions the results show 
a palliative effect but in no case a preventive effect. Thus, quercetin supplementa-
tion did not affect the antioxidant status under healthy, normal conditions [24].
Sometimes solubility and bioavailability are a major limitation factor. As an 
example, pentacyclic triterpenes such as ursolic acid are poorly bioavailable because 
of poor aqueous solubility and permeability through biological membranes [26]. 
These limit their biological effects. Some strategies have increased bioavailability. 
For example, on comparing the oral bioavailability of ursolic acid microcrystals 
and nanocrystals to its coarse suspension in rats, ursolic acid microcrystals and 
nanocrystals exhibited 1.40- and 2.56-fold enhancement, respectively. Also, a new 
Phytochemical(s) Methodology Beneficial effect(s) Reference
Cocoa extract Double-blind, randomized, placebo-
controlled parallel nutritional 
intervention with 50 obese volunteers 
[30.59(2.33) kg/m2].
Meals supplemented with 1.4 g/day cocoa 
extract for 4 weeks
A marginal decrease 
(P = 0.072) in 
oxidized bases was 
observed, which 





Various randomized, double-blind, 
placebo-controlled clinical trials.
Some studies with different dose-time 
treatment: from 38 to 600 mg/day of 
different catechins for 6–24 weeks
Not all studies have 




has also shown no 
influence on body 
weight, body mass 
index, fat mass, 
and waist and hip 
circumference
[27]
Black seeds and 
turmeric
Double-blind randomized controlled trial
Black seeds (1.5 g/day), turmeric (2.4 g/
day), its combination (900 mg black 
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product from polyphenols of lychee has been developed. Oligonol, a unique low-
molecular-weight polyphenol, was developed to enhance absorption of polyphenols 
from the intestines. It contains 15.7% polyphenol monomer ((+)-catechin, (−)-epi-
catechin, etc.) and 13.3% polyphenol dimer (procyanidin B2, etc.), while lychee 
fruit-derived polyphenol contains 6.4% polyphenol monomer and 9.9% polyphenol 
dimer [46].
Concluding from above, translational studies from animal observations to 
human clinical trials and ultimately community interventions are needed to further 
confirm the effects of phytochemicals and foods rich in these bioactive compounds. 
The technological development should be aimed at the implementation of strategies 
that increase the bioavailability of active components with proven activity and that 
allow to provide the adequate doses avoiding toxicity problems.
2.2 Probiotics
Probiotics are defined as live microorganisms which, when administered in 
adequate amounts, confer a health benefit on the host [50]. Evidence from the latest 
studies in which probiotic efficiency in metabolic disorder management is assessed 
by both in vitro and in animal or human subjects is compiled in Tables 4 and 5.
Regarding the strains employed in the management of several inflammatory dis-
eases, they usually belong to the Lactobacillus and Bifidobacterium genera, although 
Pediococcus pentosaceus LP28, Bacteroides uniformis CECT 7771, and Akkermansia 
muciniphila have also been proved to have anti-obesity effects [65]. In general, doses 
Probiotic organism Methodology Beneficial effect(s) Reference
Lactobacillus 
plantarum Ln4 
isolated from napa 
cabbage kimchi
3T3-L1 adipocytes Inhibited adipogenesis 
and stimulated glucose 
uptake
[51]
Mice fed on a standard diet or 
a high-fat diet (5–7 mice per 
group) supplemented or not with 
5 × 108 CFU/day for 5 weeks
Reduced diet-induced 





10 rats fed on a normal diet and 
30 rats fed on a high-energy 
diet supplemented or not 




inflammation factors and 
increasing antioxidant 
enzymes in the serum
[52]









paracasei NTU 101 
originally isolated 
from infant
3T3-L1 pre-adipocyte model Fermented tea powder 
promoted lipase activity 
in adipocytes, which 
thereby improves the 
lipolytic effect
[53]
Rats fed for 8 weeks on a 
normal diet or a high-fat diet 
supplemented or not with:
• Unfermented tea powder
• (12.5 mg EGCG/day) Fermented 
tea powder
• (12.5–25 mg EGCG/day plus 
3.75–7 × 1010 CFU/day) NTU 101 
powder
• (7.5 × 1010 CFU/day)
• EGCG powder (25 mg/day)
NTU 101-fermented tea 
had a more significant 
effect on the reduction 
of body weight gain and 
body fat content than the 
unfermented tea
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greater than 108 CFU/day were orally administered to the drinking water or by oral 
gavage of the lyophilized bacterial powder in water (in animal studies) as well as 
in the form of capsules or fermented milk products (in human studies). Probiotic 
supplementation in rat and mouse studies usually applies to both diet-induced 
obese individuals and lean individuals fed on a high-fat diet, thus showing the 
effect of probiotics in both the treatment and the prevention of several metabolic 
abnormalities. However, human studies are basically applied to overweight or obese 
healthy individuals, submitted or not to energy restriction and/or regular exercise. 
As regards in vitro studies, treatment of 3T3-L1 pre-adipocytes with test substances 
during their differentiation stage is the most common technique.
Probiotic organism Methodology Beneficial effect(s) Reference
Lactobacillus 
fermentum strain 
4B1 isolated from 
fermented rice and 
shrimp compared to a 
commonly prescribed 
weight loss drug
35 obese induced mice. Daily dose: 
none, 12 mg/kg orlistat (Xenical®) 
or 2.5 × 1010 CFU/kg for 21 days
Prevented obesity in lean 
hosts and reduced body 
weight gain and adipose 
tissue weight in mice 
receiving the high-fat 
diet
[54]
Heat-killed and live 
Lactobacillus reuteri 
GMNL-263
Rats fed for 12 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 2 × 109 
cells/day for 12 weeks
Both heat-killed and live 
cells prevented obesity, 
insulin resistance, 
and hepatosteatosis 
in high-fat diet rats 
by suppressing the 
inflammatory response 
and the expressions of 
specific cytokines
[55]
Live or pasteurized 
Akkermansia 
muciniphila




capacity to reduce fat 
mass development, 
insulin resistance, and 







longum SPM 1205, 
and Bifidobacterium 
longum SPM 1207
36 rats fed for 5 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 
108–109 CFU(1:1:1)/day
Reduced body weight 
and fat gain, as well 
as total cholesterol, 
HDL-cholesterol, and 
LDL-cholesterol levels 




ATCC PTA 4659, 
Lactobacillus reuteri 
DSM 17938, and 
Lactobacillus reuteri 
L6798
40 mice fed on a high-fat diet for 
12 weeks supplemented or not with 
109 CFU/day of a specific strain
Strain ATCC prevented 
obesity, lowered blood 
insulin level, and 
affected liver steatosis 
in hypercholesterolemic 




isolated from longan 
fruit and Lactobacillus 
plantarum SN13T
5 lean control and 30 diet-induced 
obese mice fed for 6 weeks 
with a regular diet or a high-fat 
diet supplemented or not with 
1.25 × 109 CFU/g of a specific strain
Live LP28 reduced body 
weight gain and liver 
lipid contents, whereas 
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Probiotic organism Methodology Beneficial effect(s) Reference
DUOLAC 7 including 
S. thermophilus KCTC 
11870BP, L. plantarum 
KCTC 10782BP, L. 
acidophilus KCTC 
11906BP, L. rhamnosus 
KCTC 12202BP, B. 
lactis KCTC 11904BP B. 
longum KCTC 12200BP, 
and B. breve KCTC 
12201BP
(5 × 1012 CFU/capsule)
A randomized, double-blinded, 
placebo-controlled study in 
50 female aged 19–65 with 
BMI > 25 kg/m2 and waist 
circumference > 85 cm following 
usual dietary intake and lifestyle 
receiving Bofutsushosan (3 g per 
administration) and probiotics 
(1 capsule) or Bofutsushosan and 
placebo twice per day for 8 weeks
Probiotics increased 
HDL cholesterol 
level and effectively 
modified the 
composition of gut 
microbiota
Bifidobacterium 
breve was the only 
strain showing a 
significant tendency 
of declination of 
endotoxin level, so 
it was suggested as a 
promising probiotic 





in capsules (1.62 × 108 
CFU/capsule) with 
a mix 70:30, v/v of 
oligofructose and inulin 
(300 mg/capsule)
A double-blind, placebo-
controlled, randomized trial in 
125 healthy overweight men and 
women (age between 18 and 55, 
BMI between 29 and 41 kg/m2) 
following a supervised diet and 
consuming two capsules per day 
or placebo for 24 weeks
LPR supplementation 
accentuated 
body-weight loss in 
women submitted to 
energy restriction; 
this effect persisted 
in the subsequent 
maintenance 
phase, when energy 
restriction was not 
further imposed
[61]
L. plantarum TENSIA 
(DSM 21380) isolated 
from the gastrointestinal 
tract of healthy Estonian 
children added to cheese 
milk in amounts of 
1.5 × 1011 CFU/g before 
renneting
A randomized, double-blind, 
placebo-controlled, parallel-
designed study in 40 subjects with 
metabolic syndrome following a 
hypocaloric diet supplemented 
with 50 g/day of probiotic or 
control cheese for 3 weeks
The hypocaloric diet 
supplemented with 
the probiotic cheese 
reduced BMI, arterial 
blood pressure, 
and the risk of 
metabolic syndrome 
in obese patients with 
hypertension
[62]






trial in which 87 subjects (BMI of 
24.2–30.7 kg/m2 and abdominal 
visceral fat area of 81.2–178.5 cm2) 
were randomly assigned to 
consume 200 g/day of fermented 
milk with or without LG2055 for 
12 weeks while maintaining their 
habitual mode of living




fat areas as well 
as body weight, 











blind crossover clinical 
investigation with 28 healthy but 
overweight individuals (BMI 
between 25 and 32 kg/m2)
Probiotic consumption 
altered intestinal 
microflora in a manner 
that was associated 
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greater than 108 CFU/day were orally administered to the drinking water or by oral 
gavage of the lyophilized bacterial powder in water (in animal studies) as well as 
in the form of capsules or fermented milk products (in human studies). Probiotic 
supplementation in rat and mouse studies usually applies to both diet-induced 
obese individuals and lean individuals fed on a high-fat diet, thus showing the 
effect of probiotics in both the treatment and the prevention of several metabolic 
abnormalities. However, human studies are basically applied to overweight or obese 
healthy individuals, submitted or not to energy restriction and/or regular exercise. 
As regards in vitro studies, treatment of 3T3-L1 pre-adipocytes with test substances 
during their differentiation stage is the most common technique.
Probiotic organism Methodology Beneficial effect(s) Reference
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4B1 isolated from 
fermented rice and 
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commonly prescribed 
weight loss drug
35 obese induced mice. Daily dose: 
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or 2.5 × 1010 CFU/kg for 21 days
Prevented obesity in lean 
hosts and reduced body 
weight gain and adipose 
tissue weight in mice 
receiving the high-fat 
diet
[54]
Heat-killed and live 
Lactobacillus reuteri 
GMNL-263
Rats fed for 12 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 2 × 109 
cells/day for 12 weeks
Both heat-killed and live 
cells prevented obesity, 
insulin resistance, 
and hepatosteatosis 
in high-fat diet rats 
by suppressing the 
inflammatory response 
and the expressions of 
specific cytokines
[55]
Live or pasteurized 
Akkermansia 
muciniphila




capacity to reduce fat 
mass development, 
insulin resistance, and 







longum SPM 1205, 
and Bifidobacterium 
longum SPM 1207
36 rats fed for 5 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 
108–109 CFU(1:1:1)/day
Reduced body weight 
and fat gain, as well 
as total cholesterol, 
HDL-cholesterol, and 
LDL-cholesterol levels 




ATCC PTA 4659, 
Lactobacillus reuteri 
DSM 17938, and 
Lactobacillus reuteri 
L6798
40 mice fed on a high-fat diet for 
12 weeks supplemented or not with 
109 CFU/day of a specific strain
Strain ATCC prevented 
obesity, lowered blood 
insulin level, and 
affected liver steatosis 
in hypercholesterolemic 




isolated from longan 
fruit and Lactobacillus 
plantarum SN13T
5 lean control and 30 diet-induced 
obese mice fed for 6 weeks 
with a regular diet or a high-fat 
diet supplemented or not with 
1.25 × 109 CFU/g of a specific strain
Live LP28 reduced body 
weight gain and liver 
lipid contents, whereas 
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Probiotic organism Methodology Beneficial effect(s) Reference
DUOLAC 7 including 
S. thermophilus KCTC 
11870BP, L. plantarum 
KCTC 10782BP, L. 
acidophilus KCTC 
11906BP, L. rhamnosus 
KCTC 12202BP, B. 
lactis KCTC 11904BP B. 
longum KCTC 12200BP, 
and B. breve KCTC 
12201BP
(5 × 1012 CFU/capsule)
A randomized, double-blinded, 
placebo-controlled study in 
50 female aged 19–65 with 
BMI > 25 kg/m2 and waist 
circumference > 85 cm following 
usual dietary intake and lifestyle 
receiving Bofutsushosan (3 g per 
administration) and probiotics 
(1 capsule) or Bofutsushosan and 
placebo twice per day for 8 weeks
Probiotics increased 
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level and effectively 
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endotoxin level, so 
it was suggested as a 
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in capsules (1.62 × 108 
CFU/capsule) with 
a mix 70:30, v/v of 
oligofructose and inulin 
(300 mg/capsule)
A double-blind, placebo-
controlled, randomized trial in 
125 healthy overweight men and 
women (age between 18 and 55, 
BMI between 29 and 41 kg/m2) 
following a supervised diet and 
consuming two capsules per day 
or placebo for 24 weeks
LPR supplementation 
accentuated 
body-weight loss in 
women submitted to 
energy restriction; 
this effect persisted 
in the subsequent 
maintenance 
phase, when energy 
restriction was not 
further imposed
[61]
L. plantarum TENSIA 
(DSM 21380) isolated 
from the gastrointestinal 
tract of healthy Estonian 
children added to cheese 
milk in amounts of 
1.5 × 1011 CFU/g before 
renneting
A randomized, double-blind, 
placebo-controlled, parallel-
designed study in 40 subjects with 
metabolic syndrome following a 
hypocaloric diet supplemented 
with 50 g/day of probiotic or 
control cheese for 3 weeks
The hypocaloric diet 
supplemented with 
the probiotic cheese 
reduced BMI, arterial 
blood pressure, 
and the risk of 
metabolic syndrome 
in obese patients with 
hypertension
[62]






trial in which 87 subjects (BMI of 
24.2–30.7 kg/m2 and abdominal 
visceral fat area of 81.2–178.5 cm2) 
were randomly assigned to 
consume 200 g/day of fermented 
milk with or without LG2055 for 
12 weeks while maintaining their 
habitual mode of living




fat areas as well 
as body weight, 











blind crossover clinical 
investigation with 28 healthy but 
overweight individuals (BMI 
between 25 and 32 kg/m2)
Probiotic consumption 
altered intestinal 
microflora in a manner 
that was associated 
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Among the analytical determinations, the most representative are changes in the 
body weight and the body fat content as well as main serum biochemical param-
eters (glucose, insulin, leptin, lipids, lipoproteins, and inflammatory indicators). 
Postmortem determinations, such as the liver weight or the adipose tissue histology, 
are also common in animal studies. Finally, since probiotics are known to increase 
the bacterial diversity of intestinal microflora, in vivo studies usually include viable 
counts in fecal samples and evaluation of intestinal survival. In fact, a lot of recent 
research relates gut microbiota composition with almost every chronic disease: from 
gastrointestinal diseases to obesity, diabetes, cancer, and even neurological and 
neurodegenerative disorders such as depression, autism, anxiety, and Parkinson’s 
disease [66]. Not only does a certain microbiota predispose to suffer certain dis-
eases, but also the incidence of a certain disorder modifies the gut microbiota of an 
individual. In overweight/obese subjects, Bacteroides, Parabacteroides, Ruminococcus, 
Campylobacter, Dialister, Porphyromonas, Staphylococcus, and Anaerostipes are 
the dominant genera linked to a low diversity of species, while Faecalibacterium, 
Bifidobacterium, Lactobacillus, Butyrivibrio, Alistipes, Akkermansia, Coprococcus, and 
Methanobrevibacter are predominant in lean individuals with a high bacterial diver-
sity [67]. Apparently, the intestinal microflora of obese subjects is more efficient 
at extracting energy from a given diet than that of lean individuals, thus leading 
to increased energy storage and adiposity [65]. Moreover, beneficial intestinal 
microflora is known to produce short-chain fatty acids (e.g., acetate, butyrate, and 
propionate) from indigestible polysaccharides, which may act as energy substrates 
as well as regulators of satiety and food intake. Last but not least, Lactobacilli and 
Bifidobacteria are known to synthesize bioactive isomers of conjugated linoleic 
acid with antidiabetic, anti-atherosclerotic, immunomodulatory, and anti-obesity 
properties [68]. In other words, low bacterial diversity in obese individuals is 
associated with a reduction in butyrate-producing bacteria, a reduction in hydrogen 
and methane production, an increase in mucus degradation, and an increase in 
the potential to manage oxidative stress. Since intestinal microflora composition is 
strongly affected by dietary patterns, studies evaluating the effect of certain food 
components on the growth of bacteria with beneficial effect on metabolic syndrome 
and obesity, particularly Akkermansia muciniphila and Faecalibacterium prausnitzii, 
are of great interest. Increasing the intestinal population of these two species has 
become a real opportunity to decrease alterations associated with obesity and meta-
bolic disorders [69]. In addition to this, high-fat diet treatment has been proven to 
induce metabolic changes that impair gut barrier function in rats [55].
Together with increasing gut microbiota diversity, the production by fermenta-
tive action of those bioactive molecules involved in the metabolic pathways that 
trigger the metabolic syndrome has also taken a lot of interest in the last years. In 
particular, many studies focus on the phenolic compound bioconversion by food fer-
mentation into other components with greater beneficial effect on the abnormalities 
associated with metabolic syndrome. As an example, Wang et al. [53] proved that 
the use of Lactobacillus paracasei subsp. paracasei strain NTU 101 in the fermentation 
of green tea and Houttuynia cordata leaves increased the levels of epigallocatechin 
gallate (EGCG), epigallocatechin (EGC), and chlorogenic acid, which enhanced the 
probiotic effect on body fat reduction. These results show the synergistic or comple-
mentary effect between the two bioactive compounds: the probiotic strain increases 
gut microbiota diversity and enhances intestinal absorption, while the EGCG acid 
promotes the lipolysis process. Zarrati et al. [70] also reported a synergistic effect 
between a weight loss diet and probiotic yogurt in overweight and obese individuals.
It should be noted that in order to exert their health benefits, probiotics do not 
necessarily have to be alive. In fact, heat-killed Lactobacillus reuteri GMNL 263 was 
as effective as live Lactobacillus reuteri GMNL 263 in attenuating obesity-induced 
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metabolic abnormalities in high-fat diet-induced rats by reducing insulin resistance 
and hepatic steatosis formation [55]. Also both heat-killed Lactobacillus planta-
rum strain Ln4 and freeze-dried cultured MRS broth significantly reduced lipid 
accumulation and stimulated glucose uptake in 3T3-L1 adipocytes [51]. Finally, 
Plovier et al. [56] found that pasteurization enhanced the capacity of Akkermansia 
muciniphila to reduce fat mass development, insulin resistance, and dyslipidemia 
in mice. It seems that a specific protein isolated from the outer membrane of 
Akkermansia muciniphila is stable at temperatures used for pasteurization and 
improves the gut barrier, thus being the main responsible factor of the beneficial 
effect of the bacteria on health.
Of all the studies analyzed, it is concluded that many microorganisms have 
the potential for development as therapeutic probiotics for obesity and associated 
disorders. However, due to the strain specificity of probiotic microbes in exerting 
their beneficial effects, bacterial strains of the same species have different effects on 
adiposity and insulin sensitivity.
3.  Case study: functional food development from lulo fruit with 
potential effect against metabolic syndrome
The lulo fruit (Solanum quitoense Lam.), also known as “naranjilla,” is an impor-
tant native Andean crop. Grown and consumed mainly in Colombia, Ecuador, 
and Central America, the plant produces a spherical, 3–8-cm-diameter fruit with 
orange skin (epicarp) covered by short, stiff, and thorny hairs or spines. The internal 
structure of the fruit is similar to that of the tomato fruit: a very juicy, acidic, and 
translucent yellow-green pulp (mesocarp and endocarp) that is located in four 
compartments separated by membranous partitions [71]. In Colombia, lulo is an 
economically important crop which, in 2015, was grown in a total area of 10,623 ha, 
with a total yield of 82,354 tons and an average yield of 9.6 tons/ha [72]. Although the 
principal market of this crop is in the producing countries themselves, it has gained 
interest in recent years in national and international markets due to its organoleptic 
properties and its nutritional value. In fact, lulo has an intense and refreshing taste 
and is rich in proteins, vitamin C, fiber, and antioxidant compounds, such as all-
trans-β-carotene, lutein and zeaxanthin, chlorogenic acids, and flavonol glycosides 
[73–76], in addition to iron, calcium, phosphorus, and some precursors of vitamin 
A [77] (Table 6 [78]). In particular, fruit carotenoids present in lulo fruit have been 
associated to the prevention of several illnesses, including hypertension, obesity, 
and cardiovascular diseases [79–81]. Also the potential of lulo as an antihypertensive 
agent is related to its content in N1,N4,N8-tris (dihydrocaffeoyl) spermidine and 
N1,N8-bis (dihydrocaffeoyl) spermidine (actually bioactive amines), which are 
bitter active compounds with inhibitory activity against the angiotensin-converting 
enzyme (ACE-1) that indirectly increases the blood pressure by causing blood vessels 
to constrict [35]. In turn, when evaluating the antihypertensive activity of some 
compounds of the lulo fruit by means of chemical computation techniques, the 
researchers of the Natural Additives of Aroma and Color group from the Chemistry 
Department of the Universidad Nacional de Colombia found that this was between 
10 and 20 times higher than that of the drugs traditionally used to treat hypertension.
Based on the considerations made above, the lulo fruit comes to be a promis-
ing alternative with regard to the prevention and relief of hypertension-related 
diseases. However, being a highly perishable fruit, technological transformation 
processes are indispensable to take advantage of its beneficial properties by as 
many consumers as possible. According to this, the group of Functional Foods of 
the University Institute of Food Engineering for Development of the Polytechnic 
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University of Valencia (Spain), in conjunction with the group of Biodiversity 
Evaluation and Use of the Technological University of Chocó (Colombia), is work-
ing on the development of new functional foods from lulo fruit (Solanum quitoense 
Lam). On the one hand, a stable lulo juice with improved antioxidant properties 
has been obtained by means of the application of moderate high homogenization 
pressures (from 50 to 150 MPa) instead of traditional thermal pasteurization. The 
same juice has proved to be a suitable impregnation liquid for the enrichment of 
other fruits with a porous structure, such as Granny Smith apples. The lulo fruit 
itself was found to have a high impregnation capacity, which implies susceptibility 
to be enriched with different bioactive compounds. Finally, after fermentation with 
Lactobacillus reuteri, selected for being one of the strains with proven effect against 
the metabolic syndrome, the number of viable counts in lulo juice resulted to be 
high enough to claim that it also may exert a probiotic effect. Most relevant results 
in relation to these advances are shown next.
3.1  Enhancing antioxidant properties of lulo juice by means of moderate  
high-pressure homogenization
This section shows the effect that homogenization pressures in the range of 
50–150 MPa have on main physicochemical properties, including the total content 
of phenols and flavonoids and the antioxidant activity measured by both DPPH and 
ABTS methods. To obtain the juice, washed and without peduncle lulo fruits were 
crushed for 10 min in a blender (Phillips Avance Collection Standmixer, 800W 2L). 
The liquefied product was then filtered with a stainless steel sieve of 500 μm nomi-
nal aperture. When necessary, the juice was homogenized at 50, 100 or 150 MPa in 
a laboratory scale high-pressure homogenizer (Panda Plus 2000, GEA-Niro Soavi, 
Parma, Italy).
Proximates Minerals Vitamins
Carb 5.9 g Ca 8 mg Folate 3 μg
Fiber 1.1 g Mg 11 mg Vit B3 1.45 mg
Protein 0.44 g P 12 mg Vit B5 0.22 mg
Sugars 3.74 g K 200 mg Vit B1 0.05 mg
Fat 0.22 g Na 4 mg Vit B6 0.11 mg
Water 93.05 g Cu 0.03 mg Vit C 3.2 mg
Energy 25 cal Fe 0.35 mg α-Carotene 4 μm
Mn 0.07 mg β-Carotene 333 μm
Se 0.4 μg β-Cryptoxanthin 10 μm







Values expressed for 100 g of fresh fruit.
Table 6. 
Nutrition facts of lulo fruit.
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As it can be observed in Table 7, neither the soluble solid content nor the pH 
or the density of the lulo juices was significantly affected by homogenization 
pressure. On the contrary, the consistency index (K) increased significantly after 
the homogenization step, which is directly related to particle size reduction. As 
regards the average size of particles, it was maximum in the non-homogenized juice 
(251 ± 5 μm) and minimum in the juice homogenized at 150 MPa (57.94 ± 0.14 μm). 
Therefore, homogenization increased the amount of solids in suspension and, 
consequently, the stability of the cloud.
As regards the antioxidant properties of lulo juice, the fruit’s own transforma-
tion into juice significantly reduced both total phenol and total flavonoid contents, 
which were probably separated from the juice together with the bagasse during the 
filtration step. However, the concentration of such compounds increased slightly 
(from 1.03 ± 0.16 to 1.28 ± 0.07 mg GAE/g for phenols and from 0.35 ± 0.24 to 
0.570 ± 0.011 mg QE/g for flavonoids) after juice homogenization at 150 MPa 
and the subsequent reduction in the average particle size. Similar trends were 
observed when analyzing the total antioxidant activity by both the ABTS and the 
DPPH methods and when quantifying spermidine by HPLC analysis. For the latter 
compound, concentration increased from 1.86 ppm in non-homogenized lulo juice 
to 2.04 ppm in lulo juice homogenized at 150 MPa.
Regarding the ability of the homogenized lulo juice treated at 150 MPa to 
impregnate Granny Smith apples sliced, it was found to be similar to that of an 
isotonic sucrose solution. In this way, the bioactive compounds present in lulo juice 
may become part of the vacuum impregnated fruit composition. To be more pre-
cise, around 0.22 m3 of lulo juice homogenized at 150 MPa could be incorporated to 
every m3 of fresh apple.
3.2 Lulo fruit as a food matrix for vacuum impregnation and food property 
improvement
In this section, impregnation properties of lulo fruit are discussed. Vacuum 
impregnation being a matrix engineering technique allows to introduce desirable 
compounds into the porous structure of foods by applying a pressure gradient [14]. 
Among the impregnation parameters, the volume of the external liquid that can be 
incorporated into the cellular tissue in a controlled way (i.e., X, in m3/m3) stands 
out, which informs about the feasibility of incorporating physiologically active com-
pounds into its porous structure for the formulation of new products with enhanced 
functional properties. Hence, unpeeled lulo fruit was cut into 5 mm thick slices and 
immersed in an isotonic sucrose solution (aw = 0.994 ± 0.003). Vacuum impreg-
nation was carried out in a pilot plant scale equipment located at the University 
Institute of Food Engineering for Development of the Universitat Politècnica de 
Homogenization 
pressure
Brix pH ρ (g/cm3) K (Pa sn) n
0 MPa 6.57 ± 0.12a 3.13 ± 0.02a 1.04 ± 0.02a 0.39 ± 0.12a 0.44 ± 0.06b
50 MPa 6.4 ± 0.4a 3.12 ± 0.02a 1.06 ± 0.04a 0.9 ± 0.4b 0.37 ± 0.04a
100 MPa 6.33 ± 0.15a 3.18 ± 0.03a 1.07 ± 0.02a 0.79 ± 0.02ab 0.37 ± 0.03a
150 MPa 6.4 ± 0.4a 3.15 ± 0.02a 1.09 ± 0.02a 1.3 ± 0.5b 0.34 ± 0.04a
abc… different superscripts in the same column indicate statistically significant differences (p < 0.05).
Table 7. 
Effect of homogenization pressure on pH, soluble solid content (brix), apparent density (ρ), and rheological 
properties of lulo juice.
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Values expressed for 100 g of fresh fruit.
Table 6. 
Nutrition facts of lulo fruit.
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As it can be observed in Table 7, neither the soluble solid content nor the pH 
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(251 ± 5 μm) and minimum in the juice homogenized at 150 MPa (57.94 ± 0.14 μm). 
Therefore, homogenization increased the amount of solids in suspension and, 
consequently, the stability of the cloud.
As regards the antioxidant properties of lulo juice, the fruit’s own transforma-
tion into juice significantly reduced both total phenol and total flavonoid contents, 
which were probably separated from the juice together with the bagasse during the 
filtration step. However, the concentration of such compounds increased slightly 
(from 1.03 ± 0.16 to 1.28 ± 0.07 mg GAE/g for phenols and from 0.35 ± 0.24 to 
0.570 ± 0.011 mg QE/g for flavonoids) after juice homogenization at 150 MPa 
and the subsequent reduction in the average particle size. Similar trends were 
observed when analyzing the total antioxidant activity by both the ABTS and the 
DPPH methods and when quantifying spermidine by HPLC analysis. For the latter 
compound, concentration increased from 1.86 ppm in non-homogenized lulo juice 
to 2.04 ppm in lulo juice homogenized at 150 MPa.
Regarding the ability of the homogenized lulo juice treated at 150 MPa to 
impregnate Granny Smith apples sliced, it was found to be similar to that of an 
isotonic sucrose solution. In this way, the bioactive compounds present in lulo juice 
may become part of the vacuum impregnated fruit composition. To be more pre-
cise, around 0.22 m3 of lulo juice homogenized at 150 MPa could be incorporated to 
every m3 of fresh apple.
3.2 Lulo fruit as a food matrix for vacuum impregnation and food property 
improvement
In this section, impregnation properties of lulo fruit are discussed. Vacuum 
impregnation being a matrix engineering technique allows to introduce desirable 
compounds into the porous structure of foods by applying a pressure gradient [14]. 
Among the impregnation parameters, the volume of the external liquid that can be 
incorporated into the cellular tissue in a controlled way (i.e., X, in m3/m3) stands 
out, which informs about the feasibility of incorporating physiologically active com-
pounds into its porous structure for the formulation of new products with enhanced 
functional properties. Hence, unpeeled lulo fruit was cut into 5 mm thick slices and 
immersed in an isotonic sucrose solution (aw = 0.994 ± 0.003). Vacuum impreg-
nation was carried out in a pilot plant scale equipment located at the University 
Institute of Food Engineering for Development of the Universitat Politècnica de 
Homogenization 
pressure
Brix pH ρ (g/cm3) K (Pa sn) n
0 MPa 6.57 ± 0.12a 3.13 ± 0.02a 1.04 ± 0.02a 0.39 ± 0.12a 0.44 ± 0.06b
50 MPa 6.4 ± 0.4a 3.12 ± 0.02a 1.06 ± 0.04a 0.9 ± 0.4b 0.37 ± 0.04a
100 MPa 6.33 ± 0.15a 3.18 ± 0.03a 1.07 ± 0.02a 0.79 ± 0.02ab 0.37 ± 0.03a
150 MPa 6.4 ± 0.4a 3.15 ± 0.02a 1.09 ± 0.02a 1.3 ± 0.5b 0.34 ± 0.04a
abc… different superscripts in the same column indicate statistically significant differences (p < 0.05).
Table 7. 
Effect of homogenization pressure on pH, soluble solid content (brix), apparent density (ρ), and rheological 
properties of lulo juice.
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València (Spain). This equipment consists of a stainless steel vacuum chamber con-
nected to a liquid ring pump (SIHI model LOHE-25007). The vessel containing the 
impregnating solution was placed into the vacuum chamber, and the lulo samples 
were immersed in the liquid by means of a pneumatic arm operated by a compressor 
(COMBA, 1,5 HP de 25 L). The working conditions were set at 50 mbar for 10 min 
and atmospheric pressure for 10 min more. In each trial, the weight change of the 
samples was recorded according to the procedure described by [82], thus allowing 
to calculate the characteristic impregnation parameters of the lulo fruit.
As it is shown in Table 8, the different batches analyzed behaved in a similar way 
during the vacuum impregnation step. Positive values of parameters X1 (between 
1 and 5%) and X (between 8.6 and 16%) indicate that the impregnating liquid 
entered the porous structure after both the vacuum and the atmospheric steps. 
Likewise, positive values of parameters γ1 (between 3.9 and 7.1%) and γ (between 
2.9 and 6.6%) indicate a volumetric expansion of the lulo matrix after both the 
vacuum and the atmospheric steps. Compared to other fruits and vegetables [83], 
the volume fraction of fresh lulo that was filled with the impregnating solution 
at the end of the process (X, in m3/100 m3) was significantly lower than that of 
Granny Smith apple (21.0 ± 0.9) or Soraya aubergine (64 ± 2) but considerably 
higher than that of Chandler strawberry (6.4 ± 0.3), Hayward kiwifruit (0.7 ± 0.5), 
or Bulida apricot (2.2 ± 0.2). Despite such differences, the lulo matrix can be 
considered as suitable to be enriched with other active compounds by means of the 
vacuum impregnation technique.
3.3 Probiotic food development from lulo fruit
The growing number of consumers with lactose intolerance, high cholesterol 
levels, and/or following vegetarian or vegan diets has encouraged the recent use of 
fruits and vegetables as probiotic carriers in the development of new functional 
foods. Fruit and vegetable juices are especially suitable for the growing of probiotic 
microorganisms since they inherently contain beneficial nutrients and have taste 
profiles that are pleasing to all the age groups [84]. In addition, due to their fast 
passage through the digestive tract, the viability of probiotic cells in the juices is 
hardly affected by the harsh acidic environment of stomach [85]. However, these 
food matrices do not always fulfill the pH or the essential amino acids and vitamins 
required for the optimum growth of most LAB with proven probiotic effect. This 
section evaluates the possibility of using the non-homogenized lulo juice as a 
medium for the growth of Lactobacillus reuteri CECT 925T. For this purpose, the 
lulo juice obtained by the procedure described above was pasteurized at 75°C for 
Batch X1 γ1 X γ εe
1 5 ± 7a 5 ± 4a 8.8 ± 1.6a 3 ± 3a 6 ± 4a
2 2.1 ± 1.8a 6 ± 5a 10 ± 3a 5 ± 4a 6 ± 5a
3 2 ± 4a 5 ± 2a 11 ± 2ab 3.7 ± 0.9a 8 ± 2a
4 1 ± 1.4a 3.9 ± 0.9a 16 ± 6b 6.6 ± 1.0a 9 ± 6a
5 2.5 ± 1.3a 7.1 ± 1.0a 8.6 ± 0.9a 2.9 ± 0.8a 6.3 ± 1.2a
abc… different superscripts in the same column indicate statistically significant differences (p ≤ 0.05).
X1 and X stand for the volume fraction of fresh sample impregnated at the end of the vacuum step and at the end of 
the atmospheric step, respectively; γ1 and γ stand for the relative volume deformation of fresh sample at the end of the 
vacuum step and at the end of the atmospheric step, respectively; εe stands for the effective porosity.
Table 8. 
Vacuum impregnation response of lulo fruit slices (5 mm thick).
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2.5 min before being inoculated with 4 mL/L of MRS broth containing the active 
microorganism in a concentration of 108 CFU/mL. After 24 hours of incubation 
at 37°C, viable counts in the juice were of the order of 106 CFU/mL. Although this 
value was high enough to make an EU-based health claim [86], it was significantly 
lower to that obtained in mandarin juice inoculated with either Lactobacillus 
salivarius spp. salivarius CECT 4063 or Lactobacillus acidophilus CECT 903 [87].
In a further step, the lulo juice containing the probiotic was employed as impreg-
nating liquid for the vacuum impregnation of Granny Smith apple slices (5 mm 
thick). In this way, the probiotic was introduced into a solid matrix without disturb-
ing its organized cellular structure. However, since only 20% of the initial volume 
of the apple is filled with the impregnation liquid during the vacuum impregnation 
step, the probiotic content in the impregnated apple was not greater than 105 CFU/g. 
Subsequent lyophilisation of the vacuum impregnated apples did not increase the 
Lactobacillus reuteri content as expected by water removal and subsequent weight 
loss, it being lower than 106 CFU/g in the liophylized sample. Probiotic counts in 
both the lulo juice and the impregnated apple snack could be improved by adding 
certain ingredients (e.g., prebiotics, cryprotectants, soygerm powder, yeast extract, 
etc.) and/or applying specific processing technologies that can improve microorgan-
ism survival such as microencapsulation or sublethal homogenization. In any case, 
it should be interesting to evaluate through both in vivo and in vitro studies the anti-
hypertensive activity of Lactobacillus reuteri in the products designed, since it could 
be enhanced due to a synergistic effect with the spermidine from the lulo juice.
4. Market and consumer trends toward functional foods
Revolution in living standard, eating habits, and increased health awareness has 
shifted consumer’s acceptance toward nutritious, healthy, and disease-preventive food 
with wider health benefits. Consumer is becoming more and more conscious about 
the role of food in life extension, well-being, and prevention of chronic diseases [87].
Specific consumer characteristics, such as demographic background or personal 
motivation to participate in pro-health activities, play a remarkable role in func-
tional food acceptance and consumption. Some sociodemographic characteristics 
such as gender, education, and age are the most important factors related to the 
acceptance of functional food. In addition, apart from health benefits, the carrier 
and the origin of functional components play an important role in making the 
decision to purchase functional products, consumers being more likely to purchase 
those functional components found naturally in foods. Other factors, such as 
organoleptic attributes, convenience, or label information, are found to be essential 
for consumer’s acceptance. In his study, Kraus [88] concludes that consumers are 
not willing to sacrifice taste and general pleasure of eating and also states that 
naturalness of a product is very important.
Particularly for probiotics, a major challenge for these products is product 
acceptability by consumers with regard to sensory criteria. Traditionally, health 
benefits of probiotics were based in the consumption of fermented dairy products; 
however, lactose intolerance, cholesterol content, and allergic milk proteins have 
limited the growth of dairy probiotics. Besides, the increase in vegetarian consum-
ers in both developed and developing countries has also contributed to a growing 
demand for plant-based probiotic products [87]. According to Panghal et al. [89], 
fruits are healthy and refreshing and have good taste and flavor profile and can 
be suitable for probiotics. They are an ideal medium to develop functional foods 
and have more nutritional values due to the presence of various phytochemicals, 
antioxidants, no cholesterol, vitamins, mineral content, and dietary fibers. Besides, 
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2.5 min before being inoculated with 4 mL/L of MRS broth containing the active 
microorganism in a concentration of 108 CFU/mL. After 24 hours of incubation 
at 37°C, viable counts in the juice were of the order of 106 CFU/mL. Although this 
value was high enough to make an EU-based health claim [86], it was significantly 
lower to that obtained in mandarin juice inoculated with either Lactobacillus 
salivarius spp. salivarius CECT 4063 or Lactobacillus acidophilus CECT 903 [87].
In a further step, the lulo juice containing the probiotic was employed as impreg-
nating liquid for the vacuum impregnation of Granny Smith apple slices (5 mm 
thick). In this way, the probiotic was introduced into a solid matrix without disturb-
ing its organized cellular structure. However, since only 20% of the initial volume 
of the apple is filled with the impregnation liquid during the vacuum impregnation 
step, the probiotic content in the impregnated apple was not greater than 105 CFU/g. 
Subsequent lyophilisation of the vacuum impregnated apples did not increase the 
Lactobacillus reuteri content as expected by water removal and subsequent weight 
loss, it being lower than 106 CFU/g in the liophylized sample. Probiotic counts in 
both the lulo juice and the impregnated apple snack could be improved by adding 
certain ingredients (e.g., prebiotics, cryprotectants, soygerm powder, yeast extract, 
etc.) and/or applying specific processing technologies that can improve microorgan-
ism survival such as microencapsulation or sublethal homogenization. In any case, 
it should be interesting to evaluate through both in vivo and in vitro studies the anti-
hypertensive activity of Lactobacillus reuteri in the products designed, since it could 
be enhanced due to a synergistic effect with the spermidine from the lulo juice.
4. Market and consumer trends toward functional foods
Revolution in living standard, eating habits, and increased health awareness has 
shifted consumer’s acceptance toward nutritious, healthy, and disease-preventive food 
with wider health benefits. Consumer is becoming more and more conscious about 
the role of food in life extension, well-being, and prevention of chronic diseases [87].
Specific consumer characteristics, such as demographic background or personal 
motivation to participate in pro-health activities, play a remarkable role in func-
tional food acceptance and consumption. Some sociodemographic characteristics 
such as gender, education, and age are the most important factors related to the 
acceptance of functional food. In addition, apart from health benefits, the carrier 
and the origin of functional components play an important role in making the 
decision to purchase functional products, consumers being more likely to purchase 
those functional components found naturally in foods. Other factors, such as 
organoleptic attributes, convenience, or label information, are found to be essential 
for consumer’s acceptance. In his study, Kraus [88] concludes that consumers are 
not willing to sacrifice taste and general pleasure of eating and also states that 
naturalness of a product is very important.
Particularly for probiotics, a major challenge for these products is product 
acceptability by consumers with regard to sensory criteria. Traditionally, health 
benefits of probiotics were based in the consumption of fermented dairy products; 
however, lactose intolerance, cholesterol content, and allergic milk proteins have 
limited the growth of dairy probiotics. Besides, the increase in vegetarian consum-
ers in both developed and developing countries has also contributed to a growing 
demand for plant-based probiotic products [87]. According to Panghal et al. [89], 
fruits are healthy and refreshing and have good taste and flavor profile and can 
be suitable for probiotics. They are an ideal medium to develop functional foods 
and have more nutritional values due to the presence of various phytochemicals, 
antioxidants, no cholesterol, vitamins, mineral content, and dietary fibers. Besides, 
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economic reasons for the developing countries also require the search for an alter-
native to dairy products with good nutrients along with health-promoting factors, 
e.g., fruits, vegetables, cereal, legume, etc., and products which lack cholesterol 
content but are rich in protein, starches, minerals, fiber, vitamins, and antioxidants.
Nowadays an increasing trend in the Western society is consumer interest and 
focus toward natural and organic products, where the use of synthetic additives is 
limited. It has been suggested that natural ingredients with strong antioxidant activity 
could be used to design novel functional beverages. An increased interest relies upon 
the fortification with polyphenols due to their beneficial role against cardiovascular 
diseases, type 2 diabetes, and obesity, among other conditions. The combination of 
prebiotics, and also phenols with probiotic microorganisms, represents an innovative 
biotechnology to enlarge the functional food market and especially beverages [90].
According to Grand View Research [91], the global functional food market was 
higher than 129 billion dollars (US) in 2015, and it is expected to increase up to 250 
billion in 2024. Growing consciousness among consumers on their health and proper 
diet, together with the prospect of reducing or even eliminating nutrition-related 
diseases, is responsible of this market trend. Society is becoming more and more con-
scious on the impact that changing dietary patterns may have in the incidence of type 
2 diabetes, coronary heart disease, cancer, periodontal disease, and obesity. In this 
regard, functional foods are believed to play an outstanding role. In addition, increas-
ing healthcare cost, along with the desire of improving later years among the geriatric 
population, has driven the growth of the functional food industry worldwide.
The global functional food market includes that of carotenoids, dietary fibers, 
fatty acids, minerals, prebiotics and probiotics, vitamins, minerals, phytochemicals, 
enzymes, and antioxidants in general. Market revenue of all these products sepa-
rately is also expected to increase in the coming years. For example, dietary fibers, 
which are considered to prevent obesity and diabetes, are expected to grow by 8.4% 
in the next 8 years. Other phytochemicals, such as flavonoids, held a share of over 
30% in terms of market value. Although these have been commonly consumed in 
their natural form, consumer’s habits have led to their use in the form of functional 
food products which are aimed at preventing diet-related chronic diseases including 
those related to the metabolic syndrome. North America accounts for the largest 
market in flavonoids, the Asia Pacific demand was over 110 million US Dollars 
in 2015, and Europe is expected to grow, although at a slower pace. In any case, 
prevalence of diabetes, obesity, and chronic diseases is likely to propel demand for 
these nutritional foods and beverages in Europe.
With regard to probiotics, there is also a growing concern on awareness in their 
functional health benefits against different conditions, including those related to 
the metabolic syndrome such as obesity or type 2 diabetes [92]. The global probiotic 
market was thought to be worth 35.5 billion dollars in 2016, with predictions of this 
increasing up to 65 billion dollars by 2024 [93]. As reported by Lumina intelligence 
[92], a survey of Ganeden on consumers concluded that almost 80% of consumers 
preferred to consume probiotics in food and beverage products than in supple-
ments. This is of special value taking into account that consumer preference is a 
key currency for measuring product success and predicting upcoming tendencies. 
North America demand for probiotics is expected to increase by 7.9% from 2016 to 
2025, whereas the European market will grow at a pace of 7.3%. As for Asia Pacific 
countries, the probiotics industry is also expected to increase significantly.
Probiotics have achieved a prominent position in the global food market. Among 
the countries that have shown growth in the probiotic market, Europe represents the 
largest and fastest growing market, followed by Japan. Currently, there is a wide range 
of probiotic products offered by companies such as BioGaia Biologics AB, Christian 
Hansen A/S, ConAgra Functional Foods, Danisco, Groupe Danone, or Lifeway [87].
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5. Conclusions
The huge increase in obesity and consequently of physiological disorders associ-
ated with this has led to a massive increase in research work conducted in this area 
over the past 10 years. The relationship between diet and the incidence of metabolic 
syndrome is clearly contrasted. Although this relationship is tremendously complex 
and it is hardly affected by other variables related to lifestyle, specific works estab-
lish phytochemicals and probiotics as two of the active components present in food, 
which have the greatest effect on prevention and in the reduction of symptoms 
associated with metabolic syndrome.
Currently, the technological development achieved by the food industry allows 
both the design and development of specific foods that include active components in 
their composition as well as the application of specific techniques that increase the 
functional value of natural foods. The use of these advances in the right direction 
can be decisive in the solution of health problems related to obesity. Specifically, the 
applications of moderate homogenization pressures or food formulation techniques, 
such as vacuum impregnation, are presented as possibilities to develop liquid and/
or solid foods that combine the presence of phytochemicals and probiotics with 
demonstrated effectiveness against obesity in natural foods such as lulo fruit.
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5. Conclusions
The huge increase in obesity and consequently of physiological disorders associ-
ated with this has led to a massive increase in research work conducted in this area 
over the past 10 years. The relationship between diet and the incidence of metabolic 
syndrome is clearly contrasted. Although this relationship is tremendously complex 
and it is hardly affected by other variables related to lifestyle, specific works estab-
lish phytochemicals and probiotics as two of the active components present in food, 
which have the greatest effect on prevention and in the reduction of symptoms 
associated with metabolic syndrome.
Currently, the technological development achieved by the food industry allows 
both the design and development of specific foods that include active components in 
their composition as well as the application of specific techniques that increase the 
functional value of natural foods. The use of these advances in the right direction 
can be decisive in the solution of health problems related to obesity. Specifically, the 
applications of moderate homogenization pressures or food formulation techniques, 
such as vacuum impregnation, are presented as possibilities to develop liquid and/
or solid foods that combine the presence of phytochemicals and probiotics with 
demonstrated effectiveness against obesity in natural foods such as lulo fruit.
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1. Introduction
There is a general belief among elite athletes and their coaches that overtrain-
ing causes resistance to infection. Epidemiological studies report that symptoms 
of respiratory tract infection increases in 1–2 weeks after strenuous endurance 
competitions. The highest percentages of patients were athletes who exceeded their 
training threshold level that is associated with the training load [1, 2]. The biologi-
cal balance of body organs improves the health of the host, improving performance 
and increasing power of the immune system [3]. Probiotics are a group of living 
microorganisms that improve health by improving biological balance when added 
to foods or consumed as supplements. These organisms increase immune system 
function and enhance host defense against harmful microorganisms. The benefits 
of probiotics such as reducing toxins, increase immunity and resistance to infection, 
produce vitamins and nutrients, organic acids, reduce allergic reactions, respiratory 
infections, reduce the symptoms of irritable bowel syndrome, arthritis, rheuma-
toid and modulating immune responses have been shown in many studies [4, 5]. 
Overwhelming exercise undertaken by athletes or military personnel diminishes 
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immune system function and increase gastrointestinal complaints, as well as 
increasing the risk of disease and infections [6–8]. In many studies, reduced immu-
nity after chronic fatigue has been seen in over trained athletes [9–11]. Nieman 
et al. (2000) showed that regular and continuous exercise enhances the strength of 
athletes’ immune system; while undertaking heavy and alternate physical activities 
had the reverse impact. Also, some research shows that excessive exercise also dam-
ages the immune system is impaired [12, 13].
The humoral immunity in athletes is often studied by mucosal immunoglobulin 
measurements, especially the changes in the secretion of IgA and IgM from tissue 
was reported in sporting activities [13]. Due to reduction of immunoglobulins 
in sport activities (and increased risk of infection in the upper respiratory tract) 
investigating the IgA and IgM is important [14]. Because the antibodies secre-
tion, the lymphocytes have a very important role in the immune system [15]. 
Monocytes are the largest cells in the bloodstream and involved in phagocytosis in 
the early stages of the immune response. Also, monocytes produce the cytokines 
that activate lymphocytes and consequently stimulate inflammation [16]. Immune 
system malfunctions might be caused by stress, sleep disorder, exercise, and nega-
tive energy balance. Hard exercises raise neutrophil count; however, they decrease 
lymphocyte count, natural killer cell activity (NK cell) via disturbance with oxida-
tive burst, neutrophil function, immunoglobulin’s level and antimicrobial proteins 
level in saliva.
The effects of probiotics bacteria in improving immune function and prevent-
ing disease have been shown in numerous studies [6, 17–19]. The Lactobacillus 
and Bifidobacterium produce bactericidal and bacteriostatic agents such as lactic 
acid that can prevent pathogenic bacteria growth. Therefore probiotics reduce 
tissue inflammation directly or with antagonistic effects on pathogens [20, 21]. It 
has been shown that probiotics stimulate interferon-A secretion and this leads to 
increasing host phagocytic capacity [22, 23]. Kotani et al. reported that consuming 
Lactobacillus rised salivary IgA secretion [24]. Therefore, in this study the effects 
of juice supplemented by Bifidobacterium bifidum probiotic (2 × 109 cfu/ml) on 
immune factors including IgA, IgM, lymphocytes, monocytes and CD4 cells count 
were in the men’s sprint athletes was investigated. The results could play an impor-
tant role for athletes to overcome many diseases and infections, especially respira-
tory infections.
Effects of fruit juices supplemented by Bifidobacterium bifidum (BIB2) probi-
otic (2*109 cfu/ml) was assessed on immune system function of sprint athletes. 
Hence, 56 male athletes aged 21 ± 3 years and average weights of 78 ± 5 kg which 
divided into 2 groups: the first group received a glass (200 cc) juices containing 
probiotic daily for 12 weeks and control group received only simple juice (placebo) 
without probiotic. All volunteers had general health and did not smoke. Also they 
were asked not to use any probiotics products and antibiotics during the survey. 
The athletes had three times exercise per week. Before experiment, the probiotic 
characteristics and testing process were explained for all participants. All athletes 
voluntary participated in the experiment.
1.1 Blood sample collection
First, prior to the tests, the blood samples were collected from athletes after fast-
ing, then once a month 24 h after 100 meters running, 8 ml of blood were collected 
from both studied groups in EDTA tubes. The bloods were centrifuged at 5000 rpm 
for 15 min and serums were collected. The blood cell counting was done using cell 
counter device (BC-2000 Mindray).
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1.2 The IgA and IgM measurements
The IgA and IgM were measured using ELISA methodology using human IgA 
and IgM ELISA Kit (ab137980 and ab137982) according to protocol suggested by 
manufacture (abcam Inc., USA) using ELISA reader (Biotech microplate reader 
ELX800).
1.3 The CD4 cells count measurements
Flow cytometry is a technique for counting microscopic particles. The CD4 cells 
count was measured by flow cytometry technique using BD FACSCalibur system 
and anti-CD4 monoclonal antibody and results were reported based on the percent 
of peripheral blood mononuclear cell (PBMC) in total suspension.
1.4 Statistical analysis
The obtained data were analyzed using Graphpad Prism (version 6.01) software 
with 0.05 significant levels.
2. Results and discussion
The results of present study showed that consuming probiotic supplemented 
fruit juice increased serum IgA level and can be boosted immune system activities 
(Table 1). According to results shown in chart 1, CD4 cells count increased after 
consuming probiotics (Figure 2, Table 1) and it probably affects immune system 
ability to defense against antigens.
Probiotics or their products could have antimicrobial activities or they can pre-
vent colonization of pathogens [4]. They probably have adjuvant effect so they may 
be stimulate phagocytosis done by leucocytes or may be increase IgA and defensins 
secretion. They could be attached to gut immune receptors, thus they inhibit 
competitively pathogenic virus’s or bacteria’s attachment. In addition, competition 
occurs for earning foods and nutrition so with suitable colonization of probiotics, 
we can conquer pathogenic bacteria.
Indigenous bacteria are accepted to add to the immunological protection of 
the host by making a hindrance against colonization by pathogenic microbes. This 
hindrance can be upset by sickness and by utilization of antibiotics, in this way, per-
mitting less demanding access of the host gut by pathogens. It is presently trusted 
Time IgA (cell/μl)
Test group Control group
Means ± SD* Means ± SD
Before test 364.954 ± 25.98 356.234 ± 42.36





The CD4 means ± standard deviation in test and control group.
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that this hindrance can be kept up by giving enhancements containing live ‘alluring’ 
microbes: such supplements are called probiotics [24].
n expansion to making a barrier impact, a few of the metabolic products of 
probiotic bacteria (e.g. lactic acid and a class of anti-microbial proteins named bac-
teriocins, created by a few bacteria) may hinder growth of pathogenic organisms. 
Moreover, the alluring bacteria may compete for nutrients with the pathogens. At 
last, there’s a few prove that probiotic microbes may improve the intestine immune 
reaction against pathogenic microscopic organisms (Figure 1).
Studies in rats and mice uncover that lactic acid bacteria managed orally incre-
ment the numbers of T lymphocytes, CD4þ cells and antibody-secreting cells, 
counting those within the intestinal mucosa, and improve lymphocyte expansion, 
normal killer cell activity, IL-1, TNF and IFN-g generation, antibody production 
(counting secretory IgA), phagocytic activity and the respiratory burst of macro-
phages and the DTH reaction [21].
Hard and continues physical activities CAN decrease immune system function 
and it can lead to infectious diseases [25]. Probiotics have an important role to 
improve and boost an individual’s health via pathogen growth prevention, amino 
Figure 2. 
The CD4 cells count (cell/μl) differences between test and control group in sprint athletes.
Figure 1. 
Potential roles of probiotic bacteria in the human intestinal tract. Probiotic bacteria may act in a variety of 
ways to prevent the growth and colonization of pathogenic bacteria.
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acids and vitamins production, detoxification, cholesterol reduction and allergic 
reaction inhibition [26]. In the present study, the effects of Bifidobactrium bifidum 
(BIB2) probioticwe on immune system factors of IgA and CD4 were evaluated. 
Results revealed significant differences between the control and test group, so that 
swimmers received probiotic juice had higher IgA level and CD4 cells (P < 0.05) 
count than control group (Tables 1 and 2, Figures 2 and 3). These increment might 
accelerate microphage activities and phagocytosis, in turn, boost immune system 
against respiratory infections and diseases [27]. Lee et al. reported that intake of 
Lactobacillus casei and Bifidobacterium improved immune system functions and 
decreased respiratory infections among athletes [28].
West et al. reported that probiotic consumption lead to mucosal immune system 
improvement and also increased CD4 and dendritic cells [29]. In other research 
conducted by Ohashi et al. in the same field showed that increasing IgA level and 
cytokine secretion occurred during probiotic consumption [30]. Furthermore, it 
has been showed that probiotic consumption caused potent increasing in lympho-
cyte and NK cells count in peripheral blood samples and they improved immune 
system and general health while NK cells count reduction was determined during 
hard exercises [31, 32]. These results mentioned above were completely in accor-
dance with our findings. Other studies have been done in the field of relationship 
between CD4 cells and probiotic consumption [33–35]. For example, Jensen et al. 
reported that consumption of Bifidobactrium bifidum probiotic increased CD4 
cell, improved immune system functions and had anti-inflammatory effects [34]. 
Besides, findings obtained by Selbovitz et al. about the effects of probiotic on 
individuals suffered from acquired immune deficiency syndrome (AIDS) showed 
that probiotics could boost immune defense against viruses and could prevent virus 
transmission [35].
Lactobacillus and Bifidobacterium are normal inhabitants of the human adult 
gastrointestinal tract. Complex interactions occur between probiotic bacteria and 
the different constituents of the intestinal ecosystem (resident microflora and 
epithelial and immune cells). Mucosal epithelial surfaces, such as the gastrointes-
tinal tract or respiratory tract that host a wide variety of different microorganisms 
from the external environment, are suitable sites for the onset of infection with 
pathogens. These levels are not protected. Different mechanisms of defense are 
involved in permanent and effective monitoring. Secretive secretion system plays 
an important role in this regard. IgA secretion (sIgA) is the dominant enzyme of 
the antibody in the secretion of the mammalian intestine. Most IgA is produced 
from suprapathic plasma cells that produce IgA polymer with the J chain (pIgA). 
Time IgA (μg/dl) IgM (μg/dl)
Test group Control group Test group Control group
Means ± SD* Means ± SD Means ± SD Means ± SD
Before test 230 ± 47 210 ± 56 143 ± 28 129 ± 73
First month 237 ± 48 185 ± 78 147 ± 75 132 ± 84
Second month 248 ± 75 193 ± 65 150 ± 62 135 ± 46




The IgA and IgM means ± standard deviation in test and control group.
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Epithelial cells express the specific Ig receptor (pIgR). They are very important 
for the selective transfer of immunoglobulins to the lumen of the intestine. 
Immunoglobulin classes IgG and IgM are also present in the intestinal secretions, 
but vary in amounts and isotypes based on animal species. SIgA has many benefits. 
The dimer and tetrameric forms of IgA contain 4 to 8 antigen binding sites and 
have several “rewards” agents similar to IgM. IgA is more resistant to the activity 
of proteolytic enzymes that occur in gastrointestinal secretions [18]. IgA-antigen 
complexes do not activate the complement with inflammatory outcomes. Thanks to 
the content of mannan oligosaccharide side chains, sIgA could inhibit the adherence 
of bacteria with type I fimbriae to epithelial cells regardless of any specific antibody 
response. The typical response of the secretory immune system is the production 
of specific secretory IgA antibodies against luminal antigens to prevent other later 
responses on the epithelial surface. This process is called the immune exclusion and 
provides non-inflammatory protection in the mucous membrane. The integrity 
of the epithelial layer, the production of mucus, glycolipid, cytoprotein peptides 
and antibiotic-like agents are other host protection systems [29]. Protective micro-
flora makes boundary impacts against risky pathogens and makes administrative 
specialists, such as brief and biofine fatty acids of bacteria. This impact moreover 
incorporates competition for receptors and metabolic foundations. It is more 
stamped but less caught on by the part of intestinal microflora within the modula-
tion of homeostasis. The mucosal layer of the digestive tract is known as one of the 
biggest immune organs known to all sorts of immune cells [12]. It is conceivable to 
characterize anatomically the acceptance and effector parts of the immune reaction 
interior of the mucosal immune system. The most acceptance places are Peyer’s 
patches restricted along the total little digestive tract. Lymphoid and accessory 
cells of Peyer’s patches are secured by the follicular epithelium with M cells that 
serve as antigen preparing cells within the intestinal divider. Lymphocyte migra-
tion is important for the transport of immunological information between the 
different compartments of the intestinal immune system. The dendritic cells are 
the primary antigen particular cells depleting from the guts after mesenteric lymph 
node resection, afterward specially T-cells recycled through the intestine wall. After 
movement into the intestinal lamina propria, the lymphocytes may enter the space 
between the epithelial cells where they are present as intra-epithelial lymphocytes. 
Figure 3. 
The IgA concentration (mg/dl) differences between test and control group in sprint athletes.
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These intra-epithelial lymphocytes (IEL) may collectively constitute up to 27% of 
the epithelial cell populace and 40% of the peripheral T-cell populace. A tall extent 
of these cells is CD8+ (77% in pigs, 24% in sheep). They vary from blood T-cells. 
For case, they are CD90–, CD5– and carry an isoform of CD45 not found on periph-
eral blood T-cells. The division of the intestine wall from 5-day-old pigs come about 
in a 10-fold lower add up to lymphocyte surrender compared with grown-up pigs 
where 26.8 × 106 intra-epithelial lymphocytes and 35.2 × 106 add up to lymphocytes 
per g of tissue were gathered. Intestinal epithelial cells (IEC). They also contrib-
ute to the “education” of thymus independent subpopulations of intra-epithelial 
lymphocytes. Bacterial dependent activation of intestinal epithelial cells requires a 
direct contact with IEC and likely the interaction of surface molecules. For the start 
of the nearby resistant reaction and the actuation of particular T-cells, the entry of 
luminal antigens over the epithelial boundary is vital. Peyer’s patches, or other lym-
phoid totals secured with a specialized epithelium layer with M cells are the most 
put for antigen section and T-cell actuation. The other sorts of immune cells such 
as macrophages, dendritic cells and enterocytes are moreover included within the 
handling of antigen at the mucosal level. T-lymphocytes from the intestinal lamina 
propria are ceaselessly beneath the antigen impact in vivo. They are actuated (IL-2 
receptor expression, CD95) and viably respond to infection. Permanent antigen 
stimulation is responsible for the proliferation, maturation, and migration of T-cells 
to distant tissues where they act as effector cells in the immune response. T-cells 
produce lymphokines responsible for the aggregation of other types of immune cells 
(B cells, inflammatory cells) and for the modification of their microenvironment. 
One of the most important lymphokines is interferon γ (IFN-γ) produced by acti-
vated T-cells. It activates effector cells such as macrophages or epithelial cells (IEC) 
[29]. Murine IEC express MHC class II and ICAM-1 molecules and they display the 
antigen to T lymphocytes. This work is altered by the physiological or pathological 
status of the host. IEC are able to create in vitro a wide range of pro-inflammatory 
cytokines such as IL-8, MCP-1, TNF-α and GM-CSF in case they are affected by 
intrusive pathogenic bacteria. IL-8 and MCP are chemokines that pull in and actu-
ate neutrophils and monocytes. TNF-α activate immune and inflammatory cells 
and GM-CSF incorporates a synergistic impact on cell actuation. The infiltration of 
the tissue with inflammatory effector cells to annihilate pathogens is continuously 
associated with a certain level of tissue harm. Subsequently the actuation is strictly 
controlled by external signals such as IFN-γ or TNF-α and by surface molecules like 
CD54 or CD95, which are able to enact or to discourage the actuation of IEC. There’s 
a clear contrast between Gram-negative non-pathogenic microbes and lactic-acid 
bacteria (LAB) in their interaction with IEC. In coordinate interaction with IEC 
both types of bacteria actuate IFN-γ, but the stimulating impact of LAB is confined 
to the cellular surface molecule expression. The molecular mechanism responsible 
for these impacts of Gram-negative bacteria and LAB is not caught on. The capac-
ity of Gram-negative bacteria to improve the expression of IFN-γ receptors on IEC 
increments the affectability of these cells to enactment with IFN-γ. On the other 
hand, LAB can stimulate IEC for successive actuation with this lymphokine, which 
is critical in local immune homeostasis. Permanent antigen stimulation of mucosal 
surfaces could create inflammatory lesions of the tissue. The homeostatic mecha-
nisms should be active in the mucous layer to prohibit such undesirable effects. 
Apoptosis as programmed cell death shows one of the homeostatic mechanisms. 
Most of the T-lymphocytes in lamina propria are cells carrying a surface molecule – Fas 
that shifts apoptotic signals when it reacts with Fas ligand expressed on activated 
T-cells. Some T-cells also express Fas and Fas ligands that are potentially reactive 
with IEC or other T-cells [36].
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Consumption of Bifidobactrium bifidum probiotic improves immune system 
defense ability against viruses such as influenza and enteroviruses [37, 38]. Also, these 
results were confirmed by Hu et al. [39]. Our findings indicated that consumption of 
Bifidobactrium bifidum (BIB2) probiotic increases CD4 cells count and they possibly 
improve the immune system response. According to results of present study and 
researches have been mentioned before, daily consumption of probiotics products 
could improve general health of individuals without any side effects. The results 
of this study show that probiotic juice containing Bifidobactrium bifidum probiotic 
supplementation affecting athletes sprint immune factors and showed significant dif-
ferences with the control group. According to the survey was taken before the tests the 
participants feel a better perception of juice Probiotics than the Probiotics capsules.
In the present study athletes who consume probiotic showed the monocyte and 
lymphocyte cells significantly higher than control group (Figures 4 and 5, Table 3). 
Kekkonen et al. showed that in runners who take probiotics lower respiratory infec-
tions and gastrointestinal symptoms were reported, but the study did not find any 
effect of changes in monocyte cells that are inconsistent with our results [6].
West et al. reported the protective effect of probiotics on respiratory infections. 
In professional athletes who practice a lot in the long and intensive period, body 
temperature increased, the secretion of IgA confusion is created and therefore inter-
feres in mucosal immunity [29]. Cox investigated the effect of probiotic Lactobacillus 
fermentum for 4 months on the Champ elite endurance. Unlike the results of this 
study did not observe any change in serum IgA, which can be because of the spe-
cies and strains of bacteria [7]. Ashraf et al. showed that probiotics strengthen the 
immune system without causing an inflammatory response and immune modulators 
and directly affects the mucosal immune system. They suggested that probiotics as a 
natural and healthy food can increase stress resistance and immunity [40]. Probiotics 
can increase IgA antibody secretion, increase in phagocytic activity of macrophages 
and enhance the specific immune effects [41]. In study by Sakai et al. the effect of 
Lactobacillus gasseri on stimulating the production of IgA was shown [42].
Zhao and colleagues showed that Lactobacillus plantarum and Bacillus subtilis 
increase activity of lysozyme, superoxide (SOD) and the concentration of IgM 
Figure 4. 
The monocytes percentage differences between test and control group in sprint athletes.
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Figure 5. 
The lymphocyte percentage differences between test and control group in sprint.
Time Monocyte (%) Lymphocyte (%)
Test group Control group Test group Control group
Means ± SD* Means ± SD Means ± SD Means ± SD
Before test 3.85± 0.36 3.78 ± 0.42 32.7 ± 5.6 34.3 ± 4.8
First month 4.30± 0.65 3.77 ± 0.25 34.7 ± 6.4 33.6 ± 7.2
Second month 5.10± 0.42 3.78 ± 0.24 35.5 ± 5.7 33.1 ± 6.4




The monocyte and lymphocytes means ± standard deviation in test and control group.
Figure 6. 
The IgM concentration (mg/dl) count differences between test and control group in sprint athletes.
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that was consistent with our results [43]. In the present study in the athletes who 
drank juice containing the probiotic, the IgM was significantly higher than control 
group (Figure 6 and Table 2). Probiotic bacteria in reaction with macrophage cells 
in tight junctions of epithelial cells, immune cells and dendritic cells led to the 
development of immune function, then macrophages and dendritic cells also gener-
ate immune responses through it. The dendritic cells spread their teeth between 
intestinal epithelial cells in the intestinal wall and use the probiotics to regulate 
immune function. The reaction of probiotic with intestinal epithelial cells induces 
the secretion of antimicrobial factors and cytokines and leading to activation of B 
and T lymphocytes in the lymphoid tissue of the gastrointestinal tract [6, 44, 32] 
(Tables 4 and 5).
3. Conclusion
The advantageous impacts of probiotics have been illustrated in numerous 
diseases. One of the major mechanisms of probiotic activity is through the control 
of resistant reaction. A few of the prevalently utilized probiotic microorganisms are 
Lactobacillus rhamnosus, Lactobacillus reuteri, bifidobacteria and certain strains of 
Lactobacillus casei, Lactobacillus acidophilus-group, Bacillus coagulans, Escherichia 
coli strain Nissle 1917, certain enterococci, particularly Enterococcus faeciumSF68, 
Time Lymphocyte (%)
Test group Control group
Means ± SD* Means ± SD
Before test 32.7 ± 5.6a,** 34.3 ± 4.8a
First month 37.4 ± 6.4a 33.6 ± 7.2b
Second month 35.5 ± 5.7a 33.1 ± 6.4b
Third month 36.2 ± 7.3a 33.7 ± 6.8b
P-value <0.05
*Standard division.
**Means with same superscript letters in each row are significantly (P < 0.05) different.
Table 5. 
Comparsion the means of lymphocyte percentage between test and control group (n = 3) in sprint athletes.
Time Monocyte (%)
Test group Control group
Means ± SD* Means ± SD
Before test 3.85 ± 0.36** 3.78 ± 0.42*
First month 4.30 ± 0.65* 3.77 ± .025*
Second month 5.01 ± 0.42* 3.78 ± 0.24*
Third month 5.60 ± 1.2 3.91 ± 0.90*
P-value <0.05
*Standard division.
**Means with same superscript letters in each row are significantly (P < 0.05) different.
Table 4. 
Comparsion the means of monocyte percentage between test and control group (n = 3) in sprint athletes.
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and the yeast Saccharomyces boulardii. Bacterial spore formers, generally of the 
class Bacillus dominate the scene. These probiotics are included to foods, especially 
fermented drain items, either separately or in combinations.
As shown below a number of mechanisms are thought to be associated with 
probiotic beneficial effects:
1. Production of inhibitory substances such as H2O2, bacteriocins, organic acids, 
and so on.
2. Blocking of adhesion sites for pathogenic bacteria.
3. Compete with and inhibit growth of potential pathogens,
4. Degradation of toxins as well as the blocking of toxin receptors,
5. Modulate inflammatory immune responses [45].
The results of this study show that the probiotic Bifidobactrium bifidum BIB2) 
juice supplementation can significantly affect some immune system factors includ-
ing IgA, IgM, lymphocytes, monocytes and CD4 cell count in sprint athletes 
compared to control group.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Therapeutic compounds can be derived from various natural sources like plants, 
animals, marine organisms, and microorganisms. Although the marine biota 
accounts for around 50% of the total world biodiversity, but their potential as a 
rich source of bioactive products and their applications in both pharmaceutical and 
nutraceutical industries have only recently been identified through several scientific 
studies. Marine biotechnology is an upcoming area that involves about the study of 
marine microorganisms and animals including algae, sponges, and coral as a novel 
source of bioactive substances that can be used in the treatment of various human 
diseases like cancer, anemia, diarrhea, obesity, diabetes, atopic dermatitis, Crohn’s 
disease, etc. They are also potential sources of natural antioxidants, colors, immuno-
suppressants, enzyme inhibitors, hypocholesterolemic agents, vitamins, enzymes, 
and antibiotics. However, marine microorganisms have not yet been given the atten-
tion they deserve and a very limited scientific data is available on bioactive potential 
of marine microorganisms. There is still scope for a higher magnitude of research 
and investigation to explore the potential of both marine organisms and marine 
microorganisms as producers of novel drugs. This chapter deals with the exploita-
tion of microbes from marine sources as potential sources for various nutraceuticals 
and their possibilities for applications in variety of diseases and as functional food 
supplement.
Keywords: microbes, nutraceuticals, marine organisms, functional food, 
bioactive compounds
1. Introduction
It is well-known that more than 70% of our planet’s surface is covered by oceans. 
Experts estimate that the biological diversity in marine environment is higher than 
in tropical rain forests. Marine water contains enormous amounts of biodiversity 
which makes it as a source of huge amounts and wide varieties of novel bioactive 
compounds. The majority of the marine microbiota is soft bodied and follows a 
sedentary life style, thus requiring the other means of defense systems mainly by 
producing certain biochemical compounds that are generally toxic to the other ani-
mals. These toxic substances also aid them in detecting their harmful predators, and 
help them to protect themselves from their competitors or they can even paralyze 
their enemies. The biodiversity of marine microflora is overwhelming and there 
is an urgent need to explore and exploit their potential as biotherapeutic agents. 
These biotherapeutic compounds are usually synthesized as secondary metabolites 
by the marine microflora and fauna. The disadvantage is that since these natural 
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Therapeutic compounds can be derived from various natural sources like plants, 
animals, marine organisms, and microorganisms. Although the marine biota 
accounts for around 50% of the total world biodiversity, but their potential as a 
rich source of bioactive products and their applications in both pharmaceutical and 
nutraceutical industries have only recently been identified through several scientific 
studies. Marine biotechnology is an upcoming area that involves about the study of 
marine microorganisms and animals including algae, sponges, and coral as a novel 
source of bioactive substances that can be used in the treatment of various human 
diseases like cancer, anemia, diarrhea, obesity, diabetes, atopic dermatitis, Crohn’s 
disease, etc. They are also potential sources of natural antioxidants, colors, immuno-
suppressants, enzyme inhibitors, hypocholesterolemic agents, vitamins, enzymes, 
and antibiotics. However, marine microorganisms have not yet been given the atten-
tion they deserve and a very limited scientific data is available on bioactive potential 
of marine microorganisms. There is still scope for a higher magnitude of research 
and investigation to explore the potential of both marine organisms and marine 
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and their possibilities for applications in variety of diseases and as functional food 
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1. Introduction
It is well-known that more than 70% of our planet’s surface is covered by oceans. 
Experts estimate that the biological diversity in marine environment is higher than 
in tropical rain forests. Marine water contains enormous amounts of biodiversity 
which makes it as a source of huge amounts and wide varieties of novel bioactive 
compounds. The majority of the marine microbiota is soft bodied and follows a 
sedentary life style, thus requiring the other means of defense systems mainly by 
producing certain biochemical compounds that are generally toxic to the other ani-
mals. These toxic substances also aid them in detecting their harmful predators, and 
help them to protect themselves from their competitors or they can even paralyze 
their enemies. The biodiversity of marine microflora is overwhelming and there 
is an urgent need to explore and exploit their potential as biotherapeutic agents. 
These biotherapeutic compounds are usually synthesized as secondary metabolites 
by the marine microflora and fauna. The disadvantage is that since these natural 
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products are synthesized and released extracellularly into the water so they are 
rapidly diluted and, therefore, their potency should be very high to show any effect. 
It is well-known that a large number of novel bioactive natural compounds are 
found in the oceans, and deep sea possessing various biological properties that can 
be exploited for discovering various drugs with improved efficacy and action in the 
treatment of various human diseases like cancer, anemia, diarrhea, obesity, diabe-
tes, atopic dermatitis, Crohn’s disease, etc. [1, 2].
The oceans are the source of a large group of structurally unique natural 
products that are mainly accumulated in invertebrates such as sponges, tunicates, 
bryozoans, and mollusks.
Macroalgae (or seaweed) are one of the most well-known types of algae used 
in the production of various nutraceuticals or dietary supplements. They are a rich 
source of valuable bioactive substances with both therapeutic and preventative 
effect. They have been used to develop a great variety of food and food ingredients, 
especially in Asian countries including Korea, Japan, and China. It is estimated that 
China and Indonesia are by far the largest seaweed producers with over 23 million 
tons of aggregated production in 2014 [3]. About 2400 natural products have been 
isolated from macroalgae belonging to the classes Rhodophyceae, Phaeophyceae, 
and Chlorophyceae [4]. Presently, seaweeds constitute commercially important 
marine renewable resources which are providing valuable ideas for the development 
of new drugs against diabetes, microbial infections, and inflammations [5]. Algal 
constituents include acids, alkaloids, amines, antibacterial, antifungal, antiviral 
substances, lipids, sterols, steroids, fatty acids, phenolic compounds, phyto-
chromes, pigments, proteins, peptides, amino acids, sugar, alcohols, and vitamins. 
Gracilaria opuntia belongs to the family Rhodophyceae (Red algae) and possesses 
various biological activities.
The potential of marine microorganisms in producing various bioactive metabo-
lites is due to their unique biochemical and physicochemical properties inherited 
by them in order to survive in extreme environmental conditions in the marine 
environment. These unique bioactive “bioceuticals” have tremendous potential for 
use as active pharmaceutical ingredient (API) and in food supplements to design 
various nutraceuticals [6].
Most of the bioactive compounds are having numerous biological activities 
which are found to act as nutraceuticals for humans and animals. Thus, the marine 
microflora contributes an important source of various bioactive constituents. Due 
to the great diversity of the marine flora, the chemistry of its associated bioactive 
compounds is also novel [7]. The marine flora includes a wide range of organisms 
from sponges, tunicates, bryozoans, mollusks to bacteria, microalgae, macroalgae, 
and cyanobacteria. The bioactive metabolites produced as a result of their metabolic 
activity is therefore effective in treatment of both infectious and non-infectious 
diseases.
Marine microflora including algae are widely used in the development of vari-
ous nutraceuticals and are also used as food source or food ingredients [8]. Algae 
include both the micro- and macroforms and both the types are used as nutra-
ceuticals. Microalgae are the most primitive and simply organized algae present 
in marine environment. They are the rich sources of various food nutrients and 
vitamins such as beta-carotene (vitamin A), vitamin C, E, H, B1, B2, B6, and B12, 
astaxanthin, polysaccharides, and polyunsaturated fatty acids [9]. These bioac-
tive compounds are extracted from the microalgae and are used as food additives, 
fortifying infant milk, and other dietary supplements [10]. These compounds 
(especially the tunicate metabolite ET-743) have also shown good pharmacological 
properties and can be used to develop new drugs for cancer treatment. Some other 
compounds such as ziconotide obtained from the mollusk (Conus magus) are used 
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as analgesics and anti-inflammatory. Natural products localized in symbiotic bacte-
ria or cyanobacteria from marine invertebrates exhibits striking structural similari-
ties with the known microbial metabolites; suggesting that bacteria and microalgae 
are involved in their biosynthesis and are the true sources of these metabolites. 
Nowadays, molecular techniques are used to study the microbial diversity in marine 
sponges and to study the involvement of bacteria in the biosynthesis of the bryo-
statins in the bryozoan Bugula neritina [2].
2. Marine microorganisms as source of nutraceuticals
A study reported that some unidentified prokaryotic communities, such as the 
JS1 and DSAG groups, occur widely in organic rich deep marine sediments associ-
ated with methane hydrates along the Pacific Ocean margin. The microflora is 
present in deep marine sediments and their community structure is affected by the 
surrounding geochemical and geological settings. Various studies have shown that 
many classes of microorganisms exist only in the sea [11]. Thus, limited scientific 
data is available on the growth media and culture techniques for culturing these 
marine microbes.
Many pharmaceutical industries have not been able to fully utilize this impor-
tant resource. There is a general belief that marine microorganisms are difficult to 
culture; however, now there are a number of reports that showed that these marine 
microorganisms can be successfully cultured [12]. Thus, now many of the devel-
oped and underdeveloped countries have shifted their research focus on the marine 
habitat and new marine-oriented projects are emerging worldwide. Majority of 
microbes belonging to class bacteria and fungi are now the target of biomedical 
study. The coastal bacterial samples that grow under saline conditions are a source 
of novel antibiotics, antitumor, and anti-inflammatory compounds [13]. The 
symbiotic microbial consortia have also been proven to be a rich source of bioactive 
compounds with pharmaceutical potential. Many bacteria and fungi have been 
sampled from the surfaces of marine plants and the internal tissues of invertebrates, 
and they have been found to be of increasing interest [14].
2.1 Marine bacteria
Marine bacteria are prolific producers of valuable secondary metabolites as 
they thrive in harsh oceanic climates. The marine isolate Pseudomonas, Gram-
negative, γ-proteo-bacteria is not well explored and only a limited number have 
been reported as producers of bioactive compounds. A bacterium strain KMM 
3042 that is aerobic, non-pigmented, produces some bioactive substances such as 
pyrroles, pseudopeptide pyrrolidinedione, phloroglucinol, phenazine, benzalde-
hyde, quinoline, quinolone, phenanthren, phthalate, andrimid, moiramides, zafrin, 
and bushrin [15]. Some of these bioactive compounds are antimicrobial agents, 
and dibutyl phthalate and di-(2-ethylhexyl) phthalate have been reported to be 
cathepsin-B inhibitors [16].
Stenotrophomonas strains isolated from sponge, sea urchin, and ophiura 
specimens showed remarkable antimicrobial and antifungal inhibitory activ-
ity. However, they showed negligible activity against Candida albicans, but 
these strains could substantially inhibit Gram-positive microorganisms. Though 
Stenotrophomonas maltophilia is an opportunistic pathogen, it also possesses biocon-
trolling capabilities [17]. Low molecular weight antimicrobial metabolites have also 
been reported from marine ark shell Anadara broughtoni associated heterotrophic 
bacteria (butanol extracts) that exhibit strong antimicrobial, hemolytic, and 
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products are synthesized and released extracellularly into the water so they are 
rapidly diluted and, therefore, their potency should be very high to show any effect. 
It is well-known that a large number of novel bioactive natural compounds are 
found in the oceans, and deep sea possessing various biological properties that can 
be exploited for discovering various drugs with improved efficacy and action in the 
treatment of various human diseases like cancer, anemia, diarrhea, obesity, diabe-
tes, atopic dermatitis, Crohn’s disease, etc. [1, 2].
The oceans are the source of a large group of structurally unique natural 
products that are mainly accumulated in invertebrates such as sponges, tunicates, 
bryozoans, and mollusks.
Macroalgae (or seaweed) are one of the most well-known types of algae used 
in the production of various nutraceuticals or dietary supplements. They are a rich 
source of valuable bioactive substances with both therapeutic and preventative 
effect. They have been used to develop a great variety of food and food ingredients, 
especially in Asian countries including Korea, Japan, and China. It is estimated that 
China and Indonesia are by far the largest seaweed producers with over 23 million 
tons of aggregated production in 2014 [3]. About 2400 natural products have been 
isolated from macroalgae belonging to the classes Rhodophyceae, Phaeophyceae, 
and Chlorophyceae [4]. Presently, seaweeds constitute commercially important 
marine renewable resources which are providing valuable ideas for the development 
of new drugs against diabetes, microbial infections, and inflammations [5]. Algal 
constituents include acids, alkaloids, amines, antibacterial, antifungal, antiviral 
substances, lipids, sterols, steroids, fatty acids, phenolic compounds, phyto-
chromes, pigments, proteins, peptides, amino acids, sugar, alcohols, and vitamins. 
Gracilaria opuntia belongs to the family Rhodophyceae (Red algae) and possesses 
various biological activities.
The potential of marine microorganisms in producing various bioactive metabo-
lites is due to their unique biochemical and physicochemical properties inherited 
by them in order to survive in extreme environmental conditions in the marine 
environment. These unique bioactive “bioceuticals” have tremendous potential for 
use as active pharmaceutical ingredient (API) and in food supplements to design 
various nutraceuticals [6].
Most of the bioactive compounds are having numerous biological activities 
which are found to act as nutraceuticals for humans and animals. Thus, the marine 
microflora contributes an important source of various bioactive constituents. Due 
to the great diversity of the marine flora, the chemistry of its associated bioactive 
compounds is also novel [7]. The marine flora includes a wide range of organisms 
from sponges, tunicates, bryozoans, mollusks to bacteria, microalgae, macroalgae, 
and cyanobacteria. The bioactive metabolites produced as a result of their metabolic 
activity is therefore effective in treatment of both infectious and non-infectious 
diseases.
Marine microflora including algae are widely used in the development of vari-
ous nutraceuticals and are also used as food source or food ingredients [8]. Algae 
include both the micro- and macroforms and both the types are used as nutra-
ceuticals. Microalgae are the most primitive and simply organized algae present 
in marine environment. They are the rich sources of various food nutrients and 
vitamins such as beta-carotene (vitamin A), vitamin C, E, H, B1, B2, B6, and B12, 
astaxanthin, polysaccharides, and polyunsaturated fatty acids [9]. These bioac-
tive compounds are extracted from the microalgae and are used as food additives, 
fortifying infant milk, and other dietary supplements [10]. These compounds 
(especially the tunicate metabolite ET-743) have also shown good pharmacological 
properties and can be used to develop new drugs for cancer treatment. Some other 
compounds such as ziconotide obtained from the mollusk (Conus magus) are used 
101
Nutraceuticals from Microbes of Marine Sources
DOI: http://dx.doi.org/10.5772/intechopen.82369
as analgesics and anti-inflammatory. Natural products localized in symbiotic bacte-
ria or cyanobacteria from marine invertebrates exhibits striking structural similari-
ties with the known microbial metabolites; suggesting that bacteria and microalgae 
are involved in their biosynthesis and are the true sources of these metabolites. 
Nowadays, molecular techniques are used to study the microbial diversity in marine 
sponges and to study the involvement of bacteria in the biosynthesis of the bryo-
statins in the bryozoan Bugula neritina [2].
2. Marine microorganisms as source of nutraceuticals
A study reported that some unidentified prokaryotic communities, such as the 
JS1 and DSAG groups, occur widely in organic rich deep marine sediments associ-
ated with methane hydrates along the Pacific Ocean margin. The microflora is 
present in deep marine sediments and their community structure is affected by the 
surrounding geochemical and geological settings. Various studies have shown that 
many classes of microorganisms exist only in the sea [11]. Thus, limited scientific 
data is available on the growth media and culture techniques for culturing these 
marine microbes.
Many pharmaceutical industries have not been able to fully utilize this impor-
tant resource. There is a general belief that marine microorganisms are difficult to 
culture; however, now there are a number of reports that showed that these marine 
microorganisms can be successfully cultured [12]. Thus, now many of the devel-
oped and underdeveloped countries have shifted their research focus on the marine 
habitat and new marine-oriented projects are emerging worldwide. Majority of 
microbes belonging to class bacteria and fungi are now the target of biomedical 
study. The coastal bacterial samples that grow under saline conditions are a source 
of novel antibiotics, antitumor, and anti-inflammatory compounds [13]. The 
symbiotic microbial consortia have also been proven to be a rich source of bioactive 
compounds with pharmaceutical potential. Many bacteria and fungi have been 
sampled from the surfaces of marine plants and the internal tissues of invertebrates, 
and they have been found to be of increasing interest [14].
2.1 Marine bacteria
Marine bacteria are prolific producers of valuable secondary metabolites as 
they thrive in harsh oceanic climates. The marine isolate Pseudomonas, Gram-
negative, γ-proteo-bacteria is not well explored and only a limited number have 
been reported as producers of bioactive compounds. A bacterium strain KMM 
3042 that is aerobic, non-pigmented, produces some bioactive substances such as 
pyrroles, pseudopeptide pyrrolidinedione, phloroglucinol, phenazine, benzalde-
hyde, quinoline, quinolone, phenanthren, phthalate, andrimid, moiramides, zafrin, 
and bushrin [15]. Some of these bioactive compounds are antimicrobial agents, 
and dibutyl phthalate and di-(2-ethylhexyl) phthalate have been reported to be 
cathepsin-B inhibitors [16].
Stenotrophomonas strains isolated from sponge, sea urchin, and ophiura 
specimens showed remarkable antimicrobial and antifungal inhibitory activ-
ity. However, they showed negligible activity against Candida albicans, but 
these strains could substantially inhibit Gram-positive microorganisms. Though 
Stenotrophomonas maltophilia is an opportunistic pathogen, it also possesses biocon-
trolling capabilities [17]. Low molecular weight antimicrobial metabolites have also 
been reported from marine ark shell Anadara broughtoni associated heterotrophic 
bacteria (butanol extracts) that exhibit strong antimicrobial, hemolytic, and 
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surface activities [18]. Another recently discovered genus of bioactive substance 
producing marine bacteria is Pseudoalteromonas, the seawater species P. phenolica 
was reported to inhibit methicillin-resistant Staphylococcus aureus (MRSA) strains 
due to the presence of a brominated biphenyl compound, 3,3″,5,5″-tetrabromo-
2,2″-diphenyldiol [19]. Some strains of Pseudoalteromonas luteoviolacea have also 
been shown to inhibit the growth of protists [20]. Other marine invertebrates 
have also been shown to be a source of novel bioactive compound which was later 
identified as a tambjamine (4-methoxypyrrole-containing bioactive compounds) 
like alkaloid and re-designated as YP1 [21]. Pseudoalteromonas tunicate is associated 
with them and produces a yellow pigment that possesses antifungal activity [20, 
22]. These tambjamines are also known to possess antimicrobial, antitumorigenic, 
immunosuppressive, antiproliferative, and ichthyo-deterrent activities [20]. There 
are other evidences that points toward the colonizing bacteria present at the surface 
of higher organisms as the source of these compounds [23]. These studies have been 
further proven by Burke and colleagues by elucidation of YP1 biosynthetic pathway 
in Pseudoalteromonas tunicata [24].
2.2 Marine-derived fungi
Marine fungi have been known to produce a wide variety of bioactive metabo-
lites that possess anticancer, antibacterial, antiplasmodial, anti-inflammatory, and 
antiviral activity [25, 26]. This is due to the presence of some unique and exceptional 
carbon frameworks in them. These novel compounds are used as new lead structures 
for medicine and for plant protection. The detailed procedure for their isolation and 
cultivation from various marine organisms (sponges, algae, and mangrove plants) 
has been given by Kjer et al. [27]. They have also elucidated the structure of second-
ary metabolites produced by these fungi. A novel anthraquinone derivative with 
naphtho [1,2,3-de]chromene-2,7-dione skeleton was isolated from a marine filamen-
tous fungus, Aspergillus glaucus in the Fujian province of China and named asper-
giolide A [28]. It was found to exhibit cytotoxicity against K562 and P388 cell lines. 
Similarly, Penicillium sp., isolated from deep ocean sediment was found to exhibit 
antitumor activities in their alkaloid-rich extracts due to the presence of meleagrin 
D and E and roquefortine H and I. However, they exhibited weak cytotoxicity in 
comparison to the previously reported meleagrin B and meleagrin that functions by 
inducing HL-60 cell apoptosis and can also arrest the cell cycle through G2/M phase, 
respectively. The mode of action was the distinct substitutions on the imidazole ring 
that have a significant influence on the cytotoxicity of these alkaloids [29]. Some 
other novel compounds and metabolites were also isolated and characterized from 
marine fungi Ampelomyces sp. that possesses potent antimicrobial and antifouling 
compounds. The antilarvicidal effect was due to the presence of compound 3-chloro-
2,5-dihydroxybenzyl alcohol that effectively inhibited larval settlement of the 
tubeworm Hydroides elegans and of cyprids of the barnacle Balanus amphitrite. The 
compound is non-toxic and is also a potent antifoulant and/or antibiotic agent [30]. 
Another example of marine-derived fungus Cladosporium sp. also exhibited antibi-
otic and antifouling activity. It was later named as strain F14. The fungus produced 
the bioactive compounds in nutrient enriched cultivation media, in the presence of 
glucose or xylose [31]. Another study reported the marine-derived fungus Fusarium 
sp. (strain 05JANF165) to possess novel antimitotic and antifungal activity from its 
ethanol extracts. This compound was later identified and named as Fusarielin E [32].
Another marine-derived fungus of the genus Pseudallescheria was reported to 
produce a novel antibacterial dioxopiperazine, dehydroxybisdethiobis-methylthio-
gliotoxin from its broth. All three compounds exhibited potent antibacterial 
activity against the methicillin-resistant and multidrug-resistant Staphylococcus 
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aureus, whereas Gliotoxin showed a significant radical scavenging activity against 
1,1-diphenyl-2-picrylhydrazyl (DPPH) [33].
A marine isolate of the fungus Exophiala was also reported to exhibit a mild 
antibacterial activity against Staphylococcus aureus due to the presence of two novel 
antibacterial aspyrone derivatives, viz., Chlorohydroaspyrones A and B, and the 
previously described aspyrone, asperlactone, and penicillic acid from its broth [34].
Marine fungi also exhibited nematicidal effect along with antimicrobial activity. 
The same activity has also been reported from marine ascomycete Lachnum papyra-
ceum (Karst.) [35].
Another marine-derived Phoma herbarum strain was reported with significant 
radical scavenging activity against DPPH due to the presence of halogenated benzo-
quinones (bromochlorogentisylquinones A and B) [36].
2.3 Marine-derived actinomycetes
Actinomycetes are well-known to be the producers of secondary metabolites. 
Many well-known antibiotics, such as streptomycin, erythromycin, and tetracycline, 
with potent biological activities are produced by them [37]. Many marine-derived 
actinomycetes were found to be the producers of novel antitumor [38], antimalarial 
[39], and antimicrobial compounds [40, 41]. Another marine-derived actinomycete 
namely Nocardiopsis lucentensis produced four novel 3-methyl-4-ethylideneproline-
containing peptides called as Lucentamycins A-D from their fermentation broth [42]. 
Only compound Lucentamycins A and B exhibited strong in vitro cytotoxicity against 
HCT-116 human colon carcinoma [42]. In a similar study, marine-derived isolate of 
Streptomyces sp. were found to produce four new derivatives, Mansouramycin A-D, 
and the known 3-methyl-7-(methylamino)-5,8-isoquinolinedione from their ethyl 
acetate extract. These bioactive compounds, exhibited strong cytotoxicity with great 
degree of selectivity for non-small cell lung cancer, breast cancer, melanoma, and 
prostate cancer cells [43] suggesting their potential as anticancer drugs. Similarly, 
Perez and coworkers [44] isolated a macrodiolide Tartrolon D from the fermenta-
tion broths of Streptomyces sp. MDG-04-17-069. The isolated tartrolon was found 
to exhibit strong cytotoxic activity against three human tumor cell lines, viz., lung 
(A549), colon (HT29), and breast (MDA-MB-231) [44]. In yet another study, the 
secondary metabolites of a marine Saccharomonospora sp. yielded a novel alkaloid 
Lodopyridone, was found to be cytotoxic to HCT-116 human colon cancer cells [45].
Besides their antitumor and anticancerous potential, marine actinomycetes 
are also known for their antimicrobial activities also. A marine actinomycete, 
Marinispora was used to isolate a series of chlorinated bisindole pyrroles, 
Lynamicins A–E that exhibited a broad-spectrum antimicrobial activity against 
both the groups of Gram-positive and Gram-negative bacteria. These compounds 
were also effective against important drug-resistant pathogens, such as methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus 
faecium [41]. In a similar study, Carlson et al. [46] isolated the two novel bioactive 
compounds namely dienoyl tetramic acids tirandamycin C and D from the marine 
environmental isolate Streptomyces sp. These compounds were effective against 
vancomycin-resistant Enterococcus faecalis and are structurally similar to the previ-
ously identified compounds Tirandamycins A and B with a slight variation in the 
pattern of pendant oxygenation on the bicyclic ketal system.
Similarly, ethyl acetate extract of Streptomyces sp. isolate B8652 was used to isolate 
Trioxacarcins A, B, and C along with three new derivatives designated as Trioxacarcins 
D, E, and F [47]. These types of trioxacarcins exhibited good antimicrobial, antitumor, 
and antimalarial activity. Similarly, the crude extract of a marine Streptomyces strain 
that was isolated from deep sea sediments, exhibited potent antifouling activity [48].
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surface activities [18]. Another recently discovered genus of bioactive substance 
producing marine bacteria is Pseudoalteromonas, the seawater species P. phenolica 
was reported to inhibit methicillin-resistant Staphylococcus aureus (MRSA) strains 
due to the presence of a brominated biphenyl compound, 3,3″,5,5″-tetrabromo-
2,2″-diphenyldiol [19]. Some strains of Pseudoalteromonas luteoviolacea have also 
been shown to inhibit the growth of protists [20]. Other marine invertebrates 
have also been shown to be a source of novel bioactive compound which was later 
identified as a tambjamine (4-methoxypyrrole-containing bioactive compounds) 
like alkaloid and re-designated as YP1 [21]. Pseudoalteromonas tunicate is associated 
with them and produces a yellow pigment that possesses antifungal activity [20, 
22]. These tambjamines are also known to possess antimicrobial, antitumorigenic, 
immunosuppressive, antiproliferative, and ichthyo-deterrent activities [20]. There 
are other evidences that points toward the colonizing bacteria present at the surface 
of higher organisms as the source of these compounds [23]. These studies have been 
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antiviral activity [25, 26]. This is due to the presence of some unique and exceptional 
carbon frameworks in them. These novel compounds are used as new lead structures 
for medicine and for plant protection. The detailed procedure for their isolation and 
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has been given by Kjer et al. [27]. They have also elucidated the structure of second-
ary metabolites produced by these fungi. A novel anthraquinone derivative with 
naphtho [1,2,3-de]chromene-2,7-dione skeleton was isolated from a marine filamen-
tous fungus, Aspergillus glaucus in the Fujian province of China and named asper-
giolide A [28]. It was found to exhibit cytotoxicity against K562 and P388 cell lines. 
Similarly, Penicillium sp., isolated from deep ocean sediment was found to exhibit 
antitumor activities in their alkaloid-rich extracts due to the presence of meleagrin 
D and E and roquefortine H and I. However, they exhibited weak cytotoxicity in 
comparison to the previously reported meleagrin B and meleagrin that functions by 
inducing HL-60 cell apoptosis and can also arrest the cell cycle through G2/M phase, 
respectively. The mode of action was the distinct substitutions on the imidazole ring 
that have a significant influence on the cytotoxicity of these alkaloids [29]. Some 
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marine fungi Ampelomyces sp. that possesses potent antimicrobial and antifouling 
compounds. The antilarvicidal effect was due to the presence of compound 3-chloro-
2,5-dihydroxybenzyl alcohol that effectively inhibited larval settlement of the 
tubeworm Hydroides elegans and of cyprids of the barnacle Balanus amphitrite. The 
compound is non-toxic and is also a potent antifoulant and/or antibiotic agent [30]. 
Another example of marine-derived fungus Cladosporium sp. also exhibited antibi-
otic and antifouling activity. It was later named as strain F14. The fungus produced 
the bioactive compounds in nutrient enriched cultivation media, in the presence of 
glucose or xylose [31]. Another study reported the marine-derived fungus Fusarium 
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ethanol extracts. This compound was later identified and named as Fusarielin E [32].
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aureus, whereas Gliotoxin showed a significant radical scavenging activity against 
1,1-diphenyl-2-picrylhydrazyl (DPPH) [33].
A marine isolate of the fungus Exophiala was also reported to exhibit a mild 
antibacterial activity against Staphylococcus aureus due to the presence of two novel 
antibacterial aspyrone derivatives, viz., Chlorohydroaspyrones A and B, and the 
previously described aspyrone, asperlactone, and penicillic acid from its broth [34].
Marine fungi also exhibited nematicidal effect along with antimicrobial activity. 
The same activity has also been reported from marine ascomycete Lachnum papyra-
ceum (Karst.) [35].
Another marine-derived Phoma herbarum strain was reported with significant 
radical scavenging activity against DPPH due to the presence of halogenated benzo-
quinones (bromochlorogentisylquinones A and B) [36].
2.3 Marine-derived actinomycetes
Actinomycetes are well-known to be the producers of secondary metabolites. 
Many well-known antibiotics, such as streptomycin, erythromycin, and tetracycline, 
with potent biological activities are produced by them [37]. Many marine-derived 
actinomycetes were found to be the producers of novel antitumor [38], antimalarial 
[39], and antimicrobial compounds [40, 41]. Another marine-derived actinomycete 
namely Nocardiopsis lucentensis produced four novel 3-methyl-4-ethylideneproline-
containing peptides called as Lucentamycins A-D from their fermentation broth [42]. 
Only compound Lucentamycins A and B exhibited strong in vitro cytotoxicity against 
HCT-116 human colon carcinoma [42]. In a similar study, marine-derived isolate of 
Streptomyces sp. were found to produce four new derivatives, Mansouramycin A-D, 
and the known 3-methyl-7-(methylamino)-5,8-isoquinolinedione from their ethyl 
acetate extract. These bioactive compounds, exhibited strong cytotoxicity with great 
degree of selectivity for non-small cell lung cancer, breast cancer, melanoma, and 
prostate cancer cells [43] suggesting their potential as anticancer drugs. Similarly, 
Perez and coworkers [44] isolated a macrodiolide Tartrolon D from the fermenta-
tion broths of Streptomyces sp. MDG-04-17-069. The isolated tartrolon was found 
to exhibit strong cytotoxic activity against three human tumor cell lines, viz., lung 
(A549), colon (HT29), and breast (MDA-MB-231) [44]. In yet another study, the 
secondary metabolites of a marine Saccharomonospora sp. yielded a novel alkaloid 
Lodopyridone, was found to be cytotoxic to HCT-116 human colon cancer cells [45].
Besides their antitumor and anticancerous potential, marine actinomycetes 
are also known for their antimicrobial activities also. A marine actinomycete, 
Marinispora was used to isolate a series of chlorinated bisindole pyrroles, 
Lynamicins A–E that exhibited a broad-spectrum antimicrobial activity against 
both the groups of Gram-positive and Gram-negative bacteria. These compounds 
were also effective against important drug-resistant pathogens, such as methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus 
faecium [41]. In a similar study, Carlson et al. [46] isolated the two novel bioactive 
compounds namely dienoyl tetramic acids tirandamycin C and D from the marine 
environmental isolate Streptomyces sp. These compounds were effective against 
vancomycin-resistant Enterococcus faecalis and are structurally similar to the previ-
ously identified compounds Tirandamycins A and B with a slight variation in the 
pattern of pendant oxygenation on the bicyclic ketal system.
Similarly, ethyl acetate extract of Streptomyces sp. isolate B8652 was used to isolate 
Trioxacarcins A, B, and C along with three new derivatives designated as Trioxacarcins 
D, E, and F [47]. These types of trioxacarcins exhibited good antimicrobial, antitumor, 
and antimalarial activity. Similarly, the crude extract of a marine Streptomyces strain 
that was isolated from deep sea sediments, exhibited potent antifouling activity [48].
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In yet another study, a marine-derived Actinomyces strain (NPS554) that was iso-
lated from Japan yielded two trialkyl-substituted aromatic acids, Lorneic acid A and 
B. It was observed that Lorneic acid-A had significant inhibition activity against 
phosphodiesterase (PDE)5 [49]. PDE5 inhibitors are of great pharmacological 
importance as they are used in erectile dysfunctions and pulmonary hypertension.
2.4 Marine-derived microalgae
Cyanobacteria are a diverse group of Gram-Negative bacteria, also known as 
blue-green algae that produce an array of secondary metabolites with antifungal, 
antiviral, antibiotic, and other properties. They also exhibit selective bioactivity 
against vertebrates, invertebrates, plants, microalgae, fungi, bacteria, viruses, and 
cell lines [50]. Thus, they are of great pharmaceutical value. Besides, there are other 
anticancer compounds, which were initially thought to be obtained from marine 
sources, are now known to be produced by cyanobacteria [51]. Ulithiacyclamide 
and Patellamide A belong to Cyanobactins, produced by cyanobacteria; possess 
potent antimalarial, antitumor, and multidrug reversing activities [52].
Some other examples of marine cyanobacterial bioactive natural products are 
viridamides A and B. It was observed that Viridamide A produced by a blackish-
green, mat-forming, filamentous cyanobacterium Oscillatoria nigroviridis showed 
antitrypanosomal, and antileishmanial activity [53]. In yet another study, the 
crude extracts of four green marine algae (Cladophora rupestris, Codium fragile sp. 
tomentosoides, Ulva intestinalis, and Ulva lactuca) were found to exhibit antiproto-
zoal activity [54]. All the algal extracts were active against T. brucei rhodesiense, and 
exhibited potent leishmanicidal activity [54]. This study was reportedly the first 
study to show antiprotozoal activity of British marine algae. Further, Desbois et al. 
[55] isolated an antibacterial polyunsaturated fatty acid, eicosapentaenoic acid 
(EPA) from the marine diatom, Phaeodactylum tricornutum Bohlin, which showed 
activity against a range of both Gram-positive and Gram-negative bacteria, includ-
ing methicillin-resistant Staphylococcus aureus (MRSA) [55].
Both micro- and macroalgae are used as nutraceuticals. Studies have shown that 
microalgae are rich sources of all the vital nutrients such as beta-carotene, vitamins 
C, A, E, H, B1, B2, B6, and B12, astaxanthin, polysaccharides, and polyunsaturated 
fatty acids [9]. Thus, their bioactive molecules are produced commercially for use as 
food additives, infant milk formulations, and dietary supplements [10].
Macroalgae, are also commonly known as seaweeds. They are the most popular 
type of algae in the nutraceutical industry and are used in a great variety of food 
and food ingredients, especially in Asian countries like Korea, Japan, and China. 
Macroalgae are also well-known for the production of agarose. They are also an 
important source of many bioactive metabolites and natural products that possess 
many nutritional and therapeutic functions. Some of the examples of bioactive 
constituents are proteins, furanone, polyunsaturated fatty acids (PUFA), L-α kainic 
acid, phenotics, pigments, phlorotannins, phyco-colloids (carrageenan and agar), 
and minerals. Likewise, red and brown seaweeds are also good sources of many 
vitamins, minerals, proteins, and essential fatty acids [56, 57]. They are also used 
to prepare bioactive peptides and to improve protein digestibility. Further, antihy-
pertensive bioactive peptides have also been isolated that can act as angiotensin-
converting enzyme (ACE) inhibitors [58].
2.5 Symbiotic interaction between marine microbes
Symbiosis is the mutual association between any two organisms for their mutual 
benefit that can be in terms of their nutritional needs or protection from prey. 
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Research studies have shown that a variety of secondary metabolites are produced 
as a result of this association especially obtained from algae and invertebrates. Their 
associated microbes perform various biological activities [59]. Some of the various 
marine fungi isolated are Haliclona simulans, Agaricomycotina, Mucoromycotina, 
Saccharomycotina, and Pezizomycotina [60]. A variety of media were used for their 
isolation and identification and their antimicrobial activities were also determined. 
Some of these isolates exhibited antimicrobial activity against Escherichia coli, 
Bacillus sp., Staphylococcus aureus, and Candida glabrata [60]. It has been found 
that sponge-microbial association is a potential chemical and ecological phenom-
enon that can serve as a sustainable resource for generating novel pharmaceutical 
leads. Thus, sponge microsymbionts are an important focus nowadays [61, 62]. In 
yet another study, a marine-derived fungal strain named M-3 was isolated from 
marine red alga Porphyra yezoensis. It was assessed for its antifungal activity against 
Pyricularia oryzae [63]. As a result, a novel compound diketopiperazine was isolated 
from the culture extracts and its structure was also elucidated by spectroscopic 
methods.
In another study, the butanol extracts of algal associated species 
Pseudoalteromonas issachenkonii were reported to show hemolysis and inhibition of 
Candida albicans. Their ethyl acetate extracts were also subjected to spectroscopic 
studies and revealed the presence of indole-2,3-dione, a type of isatin that was 
responsible for its antifungal activity [63]. In another study, a red-brown hemolytic 
pigment was also discovered [64]. Coral reefs widely prevalent in oceans are also 
unexplored source of novel bioactive compounds [65].
In another study, a marine gorgonian associated bacterium Bacillus amyloliq-
uefaciens was isolated from the South China Sea gorgonian, Junceella juncea. The 
studies showed their antibacterial against Escherichia coli, Bacillus subtilis, and 
Staphyloccocus aureus and antilarval properties against the larvae of bryozoan Bugula 
neritina. In yet another study, an antimicrobial activity of about 42 marine bacterial 
strains belonging to genera Alteromonas, Pseudomonas, Bacillus, and Flavobacterium 
was reported [66]. Besides this, certain mycoparasitic and fungicolous fungi were 
also shown to colonize other fungal physiological structures and were known 
to produce various bioactive agents [67]. In a study, five new natural products, 
Phomadecalins A, B, C, D, and Phomapentenone A, were reported from cultures of 
Phoma sp., a mitosporic fungal colonist isolated from the stromata of Hypoxylon sp. 
These bioactive compounds were found to be active against Gram-positive bacteria, 
Bacillus subtilis (ATCC 6051) and Staphylococcus aureus (ATCC 29213) [68].
3. Classification of marine nutraceuticals on the basis of chemical nature
Marine nutraceuticals can be broadly classified into Marine lipids (microalgal 
origin), polysaccharides derived from macro algae, marine probiotics, marine 
natural pigments, chitin and other related products, bioactive marine peptides/
enzymes, and vitamins.
3.1 Lipids
Lipids derived from marine microalgae are used in larval nutrition of aquacul-
ture, especially for enrichment of live feeds. Their other biological properties are 
anti-inflammatory, antiallergic, antiviral, and therapeutic. The wide spectrum of the 
properties is due to the presence of various components like polyunsaturated fatty 
acids (PUFA), highly unsaturated fatty acids (HUFA), and other substances. Various 
microalgal originated lipid/fatty acids and their activities [69] are given in Table 1.
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In yet another study, a marine-derived Actinomyces strain (NPS554) that was iso-
lated from Japan yielded two trialkyl-substituted aromatic acids, Lorneic acid A and 
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blue-green algae that produce an array of secondary metabolites with antifungal, 
antiviral, antibiotic, and other properties. They also exhibit selective bioactivity 
against vertebrates, invertebrates, plants, microalgae, fungi, bacteria, viruses, and 
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pertensive bioactive peptides have also been isolated that can act as angiotensin-
converting enzyme (ACE) inhibitors [58].
2.5 Symbiotic interaction between marine microbes
Symbiosis is the mutual association between any two organisms for their mutual 
benefit that can be in terms of their nutritional needs or protection from prey. 
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Research studies have shown that a variety of secondary metabolites are produced 
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3.2 Polysaccharides
Generally, bacterial capsules contain polysaccharides. They form one of the 
important classes of secondary metabolites that are also important from pharmaceu-
tical point of view. Research studies have shown that these exopolysaccharides (EPS) 
particularly from marine bacteria can be used in various pharmaceutical and food 
processing agents. They can also be used in industries as thickeners, coagulating 
agents, adhesive agents, stabilizers, and as gelling agents. The exopolysaccharides 
possess good viscosity and pseudo-plastic properties that impart them ability to 
resist extremes of temperature, pH, and salinity. This increases their potential to be 
used as an industry friendly resource [70]. In a study, exopolysaccharides have been 
shown to possess immunomodulatory and antiviral properties on immunocompe-
tent cells in a marine bacteria Geobacillus thermodenitrificans that was isolated from a 
shallow marine vent of Volcano Island (Italy). This bacterium not only produced sec-
ondary metabolites against other organisms, but also produced certain compounds 
which help in bioremediation [71]. Certain other marine bacterial species are known 
as prolific producers of biosurfactants, bioemulsifiers, and exopolysaccharides.
Some polysaccharides are also derived from macroalgae. Seaweeds contain 
higher amounts of the polysaccharides like agar, alginates, and carrageenan. These 
act as food fiber and are collectively called phyco-colloids or hydrocolloids. Being 
rich in fiber, seaweeds exhibit health benefits like reducing the absorption of 
toxins, anticarcinogenic, and antioxidant properties. Example of the few important 
bioactive polysaccharides isolated from macroalgae (seaweeds) that possess the 
potential to be used as nutraceuticals are Fucoidan, Sphinganine amide, and caul-
erpicin (green algae), Carrageenan, Alginic acid and xylofucans, Hyperoxaluria, 
Sulfated polysaccharides, and Alginates. All these compounds possess wide range 
of biological properties such as antioxidant, antiangiogenic, antibacterial, antiviral 
and antitumor activities anticoagulant, immuno-modulating, hypolipidemic, and 
anti-inflammatory [72]. In addition to the phyco-colloids, seaweeds are sources 
of biologically active phytochemicals like carotenoids, phycobilins, fatty acids, 
vitamins, sterols, tocopherol, phycocyanins, and others.
Macroalgae are also rich sources of insoluble and soluble dietary fiber. They con-
tain chiefly indigestible sulfated polysaccharides. Some of the notable examples of 
structural and storage polysaccharides are fucan, agar, laminaran, carrageenan, and 
alginates that are found both in red and brown seaweeds. The alginates obtained 
from brown seaweeds are used as hydrocolloids and fucans from brown seaweeds 
are used in both food and cosmetics industries [73].
Microalgal lipid/fatty acid Biological action/function
Eicosapentaenoic acid (EPA) Nutraceutical; antimicrobial and anti-inflammatory
Gamma-linolenic acid (GLA) Integrity of tissue and delay of aging
Arachidonic acid (ARA) Aggregative and vasoconstrictive of platelets
Docosahexaenoic acid (DHA) Nutraceutical and brain development
Brassicasterol and stingmasterol Hypercholesterolemic
Gamma-amino-butyric acid 
(GABA)
Neuro-transmitter, antioxidant and anti-inflammatory




Microalgal lipid/fatty acids and their activity.
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A research highlighted the role of marine bacteria Bacillus circulans in the 
biodegradation of anthracene (a polyaromatic hydrocarbon) [74]. The said bacteria 
also produced a novel type of biosurfactant that exhibited excellent emulsification 
properties. It was shown that Bacillus circulans utilized anthracene as a sole carbon 
source for the production of biosurfactant. The researchers also reported the pro-
duction of another biosurfactant by an unnamed marine bacteria that has the ability 
to remove metal from solutions [75].
3.3 Bryostatins: bryozoan origin
The marine bryozoan, Bugula neritina, is the sole source of the bryostatins, a 
family of macrocyclic lactones with anticancer activity. Bryostatins are actually the 
bacterial products as B. neritina harbors the uncultivated gamma proteobacterial 
symbiont Candidatus Endobugula sertula. The clinical studies of bryostatins are also 
under going to study their potential for the treatment of leukemias, lymphomas, 
melanomas, and solid tumors [76]. Their mode of action is that they act through 
protein kinase C signal transduction to alter cellular activity.
3.4 Probiotics: marine lactic acid bacteria (LAB) origin
Microbial diversity of marine environments is very rich and can be helpful to 
develop safe and effective probiotics. Novel marine probiotics can be an effective 
alternative for fighting the antibiotic resistance. Lactobacillus and Bifidobacterium 
are found to possess antimutagenic [77] and immunomodulatory [78] activity 
in host animal. Different strains of marine probiotic bacteria are Lactobacillus 
(L. casei, L. acidophilus, L. rhamnosus GG (ATCC 53013), L. johnsonii La-1), 
Bifidobacterium (B. bifidum, B. longum, B. infantis, B. breve, B. adolescentis), 
Leuconostoc spp. (Ln. lactis, Ln. mesenteroides subsp. cremoris, Ln. mesenteroides subsp. 
dextranicum), and Streptococcus spp. (S. salivarius subsp. thermophiles).
The problem posed during the development of new marine probiotics is the 
isolation and identification of potential strain. Application of biotechnological and 
molecular biological tactics is necessary for the development of marine probiotic 
strains for use of aquatic industry [72].
3.5 Pigments: marine algae
Besides polysaccharides and lipids, marine macro- and microalgae also provide 
various types of the bioactive natural pigments. The natural pigments of the marine 
algae provide food by photosynthesis and also provide the pigmentation. In addition 
to these, the natural pigments are also found to exhibit health benefits which make 
them one of the important marine nutraceuticals. Chlorophyll-a, Lutein, zeaxan-
thin, and canthaxanthin possess antimutagenic properties; pheophytin-a exhibits 
neuroprotective, and anti-inflammatory action; Chlorophyll-a, Pheophorbide-a, 
Pyropheophytin-a, Phycoerythrobilin, Lutein, Fucoxanthin, Phycocyanin, 
Astaxanthin, Zeaxanthin, and Canthaxanthin are all good antioxidants. Alpha-
Carotene is also used as a food additive [72].
3.6 Chitosan: chitin
Chitosan is a natural polymer derived from chitin and it is the second most 
abundant polysaccharide after cellulose. Chitin is recovered from processing dis-
cards of shrimp, crab, lobster, and crayfish following de-proteinization and demin-
eralization. The chitin so obtained may then be deacetylated to afford chitosan. 
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Fungal cell walls are also rich in chitin. Chitin and chitosan are used as biomaterials 
in a variety of application in edible film industry, additives, for improving nutri-
tional quality, recovery of solid materials from food processing waste, in purifica-
tion of water, etc. The other biological properties of chitosan are antioxidant, 
hypocholesterolemic, antimicrobial, and anti-inflammatory activities [79].
Chitosan disrupts the barrier properties of the outer membrane of Gram-
negative bacteria due to ionic interaction between the cationic groups of the 
chitosan molecules and the anionic groups of the microbial cell membrane, which 
can rupture the cell membrane. Chitosan can also function as an antifungal agent 
by forming gas-permeable coats, interference with fungal growth and stimulation 
of various defense processes like, build-up of chitinases, production of proteinase 
inhibitors, and stimulators of callous synthesis.
The antioxidant property could be attributed to the ability of chitosan to 
chelate metals and combine with lipids. Derivatives of chitosan, namely, N,O-
carboxymethyl chitosan, N,O-carboxymethyl chitosan lactate, N,O-carboxymethyl 
chitosan acetate, and N,O-carboxymethyl chitosan pyrrolidine carboxylate had 
also exhibited the antioxidant activity. Chitosan possesses special properties for 
use in pharmaceutical, biomedical, food industry, health, and agriculture due to its 
biocompatibility, biodegradability, and non-toxic nature. Through encapsulation, 
it is being used as a vehicle for nutraceutical compounds and pharmacological com-
pounds. Chitosan derivatives may also be produced in order to obtain more effective 
products for certain applications [72].
3.7 Bioactive peptides/enzymes: marine origin
Peptides refer to the specific protein fragments that exhibit a specific biologi-
cal activity. Some of the peptides may exhibit multifunctional properties like 
opioid, immunomodulatory, antibacterial, antithrombotic, and antihypertensive 
activity. Biofunctional peptides have a size range of 2–20 amino acid residues and 
are encrypted within the sequence of the parent protein and are released during 
processing. They can be formed either by acid or alkaline hydrolysis. The major 
bioactivities of peptides are antihypertensive (ACE inhibitory), antioxidant, 
antimicrobial, antihypoallergenic activity, and cell immunity [80].
Proteins isolated from bacteria such as Dunaliella, Phaeodactylum tricornutum, 
and Arthrospira platensis possess potent antioxidant and anti-inflammatory activ-
ity which can be effectively used in aquaculture practices. Similarly, enzymes 
such as superoxide dismutase and carbonic anhydrase derived from Porphyridium, 
Anabaena, Isochrysis galbana, and Amphidinium carterae play an important role in 
regulating the metabolite waste (CO2).
3.8 Vitamins: marine microalgal origin
Marine microalgae are also known to have good amount of alpha-carotene. 
Microalgae like, Arthrospira, Isochrysis galbana, Porphyridium cruentum, and 
Tetraselmis are rich in vitamin C, K, A, E, and alpha-carotene which possess strong 
antioxidant activity. Vitamins A specially provitamin-A or alpha-carotene and vita-
min E or alpha-tocopherol function as source of strong antioxidant compounds and 
protect the cells from free radical damage by quenching these free radicals. Vitamin 
E, together with vitamin C and alpha-carotene, helps in improving antioxidant 
defenses in the body. Fat soluble vitamin K isolated from Pavlova helps in blood clot-
ting or coagulation. The role of antioxidant vitamins in health and disease control 
has been well documented [73]. Some of the important marine microorganisms, 
their bioactive metabolites and biological activity are highlighted in Table 2 [20].
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4.  Classical examples of some marine microflora and their nutraceutical 
potential
The oceans harbor one of the most diverse flora and fauna on our earth surface. Its 
biodiversity serves as an inexhaustible source of variety of biologically active com-
pounds such as antibiotic, antimicrobial, anti-inflammatory, anticancer, antioxidant, 
antimicrotubule, cytotoxic, photo-protective, and antifouling properties. A variety 
of novel range of microorganisms, such as bacteria (both free living and symbiotic), 
fungi, actinomycetes, microalgae-cyanobacteria, and diatoms, are found in the marine 
environment that are potent producers of important therapeutic compounds. They 
have also been found effective against many deadly infectious diseases such as AIDS, 
drug-resistant bacteria, including conditions of multiple bacterial infections. Only little 
research has been done on the biophysical and biochemical properties, their chemical 
structures and biotechnological applications of these marine bioactive substances, 
and their potential utilization in both cosmeceuticals and nutraceuticals. Some of the 
research studies on bioactive molecules from marine sources are discussed below.
Seaweeds provide a rich source of bioactive molecules. In this study, the anti-
microbial potential of Red sea weed, Gracilaria opuntia was investigated against 
Microorganism Marine microbial 
metabolites
Biological activity
Cyanobacteria Dolastatin-10 Antimicrotubule; and the synthetic analog, TZT-1027, 
as antitumor




Actinomycetes Resistoflavine Anticancerous and antibacterial
Marinomycin A Antitumor and antibiotic
Daryamide C Antitumor
Violacein Antiprotozoal
Bacteria Macrolactin S Antibacterial





Algae Norharman Enzyme inhibitor
Calothrixin-A Antimalarial and anticancerous
Eicosapentanoic acid 
(EPA)
Treats heart disease, anti-inflammatory agent 
(rheumatoid arthritis and immunodeficiency 
diseases)
Symbiotic microbes Macrolactin V Antibacterial and antilarval
DAPG Antibacterial (anti-MRSA, anti-VRSA and anti-VRE)
BE-43472B Antibacterial (anti-MRSA and anti-VRE)
Table 2. 
Name and biological activity of some of the marine microbial metabolites.
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Anabaena, Isochrysis galbana, and Amphidinium carterae play an important role in 
regulating the metabolite waste (CO2).
3.8 Vitamins: marine microalgal origin
Marine microalgae are also known to have good amount of alpha-carotene. 
Microalgae like, Arthrospira, Isochrysis galbana, Porphyridium cruentum, and 
Tetraselmis are rich in vitamin C, K, A, E, and alpha-carotene which possess strong 
antioxidant activity. Vitamins A specially provitamin-A or alpha-carotene and vita-
min E or alpha-tocopherol function as source of strong antioxidant compounds and 
protect the cells from free radical damage by quenching these free radicals. Vitamin 
E, together with vitamin C and alpha-carotene, helps in improving antioxidant 
defenses in the body. Fat soluble vitamin K isolated from Pavlova helps in blood clot-
ting or coagulation. The role of antioxidant vitamins in health and disease control 
has been well documented [73]. Some of the important marine microorganisms, 
their bioactive metabolites and biological activity are highlighted in Table 2 [20].
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4.  Classical examples of some marine microflora and their nutraceutical 
potential
The oceans harbor one of the most diverse flora and fauna on our earth surface. Its 
biodiversity serves as an inexhaustible source of variety of biologically active com-
pounds such as antibiotic, antimicrobial, anti-inflammatory, anticancer, antioxidant, 
antimicrotubule, cytotoxic, photo-protective, and antifouling properties. A variety 
of novel range of microorganisms, such as bacteria (both free living and symbiotic), 
fungi, actinomycetes, microalgae-cyanobacteria, and diatoms, are found in the marine 
environment that are potent producers of important therapeutic compounds. They 
have also been found effective against many deadly infectious diseases such as AIDS, 
drug-resistant bacteria, including conditions of multiple bacterial infections. Only little 
research has been done on the biophysical and biochemical properties, their chemical 
structures and biotechnological applications of these marine bioactive substances, 
and their potential utilization in both cosmeceuticals and nutraceuticals. Some of the 
research studies on bioactive molecules from marine sources are discussed below.
Seaweeds provide a rich source of bioactive molecules. In this study, the anti-
microbial potential of Red sea weed, Gracilaria opuntia was investigated against 
Microorganism Marine microbial 
metabolites
Biological activity
Cyanobacteria Dolastatin-10 Antimicrotubule; and the synthetic analog, TZT-1027, 
as antitumor




Actinomycetes Resistoflavine Anticancerous and antibacterial
Marinomycin A Antitumor and antibiotic
Daryamide C Antitumor
Violacein Antiprotozoal
Bacteria Macrolactin S Antibacterial





Algae Norharman Enzyme inhibitor
Calothrixin-A Antimalarial and anticancerous
Eicosapentanoic acid 
(EPA)
Treats heart disease, anti-inflammatory agent 
(rheumatoid arthritis and immunodeficiency 
diseases)
Symbiotic microbes Macrolactin V Antibacterial and antilarval
DAPG Antibacterial (anti-MRSA, anti-VRSA and anti-VRE)
BE-43472B Antibacterial (anti-MRSA and anti-VRE)
Table 2. 
Name and biological activity of some of the marine microbial metabolites.
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clinically important microorganism such as Escherichia coli, Staphylococcus aureus, 
Klebsiella pneumonia, and Pseudomonas putida that cause diseases in diabetic 
patients. Crude extracts prepared from aqueous, ethanol, and methanol extraction 
procedures revealed that aqueous extraction procedure have a wide range of anti-
microbial activity against all the test pathogens. The overall antibacterial activity 
assessed from the above results indicates the presence of active constituents in the 
extractions of seaweeds, which can be explored for the production of significant 
molecules that could be used in pharmaceutical industry [81].
In a similar another study on Gracilaria edulis, their phytochemical, antibacte-
rial, and antifungal activities of crude extracts were investigated. The methanol 
and aqueous extracts of Gracilaria edulis showed the presence of a number of 
metabolites such as alkaloids, saponin, phenols, terpenoids, proteins, flavonoids, 
glycosides, coumarins, and tannins. The red algae showed the significant antibacte-
rial activity against the clinical pathogens of Pseudomonas aeroginosa, Staphylococcus 
aureus, Bacillus cereus, Bacillus subtilis, Streptococcus pyogenes, Salmonella typhi as 
well as the fungus Aspergillus niger, Aspergillus flavus, Rhizopus indicus, and Candida 
albicans. The methanol extract showed the broader spectrum of antibacterial and 
antifungal activity when compared with aqueous extract [82].
In yet another study, the phytochemical and biological evaluation of some 
Sargassum species from Persian Gulf was also studied. These plants contain impor-
tant phytochemical constituents and have various potential biological activities. 
The study investigated the presence of phytochemical constituents and total 
phenolic quantity of the seaweeds Sargassum angustifolium, Sargassum oligocystum, 
and Sargassum boveanum. Cytotoxicity and antioxidant potential of these three 
Sargassum species was also analyzed. Sargassum angustifolium had the highest con-
tent of total phenolics and showed the highest antioxidant activity. Cytotoxic results 
showed that all species could inhibit cell growth effectively, for S. oligocystum, S. 
angustifolium, and S. boveanum, respectively. Thus considerable phytochemicals 
and moderate cytotoxic activity of S. angustifolium, S. oligocystum, and S. boveanum 
make them appropriate candidate for further studies and identification of their 
bioactive principles [83].
Further study on screening the algae for their phytochemicals from their 
extracts and testing on their antibacterial, antifungal and antioxidant potential 
was carried out. The algal strains were Tetraselmis sp., Dunaliella sp., Chlorella sp., 
Synechocystis sp., and Oscillatoria sp. Their extracts were prepared in an organic 
solvent and were used to screen for the presence of any phytochemicals. Later, their 
antimicrobial activity was also assessed against some selected bacterial and fungal 
species. Their antioxidant activity was also determined by DPPH scavenging assay 
and confirmed the presence of flavonoids in majority of the solvent extracts. In 
addition, the microalgal strains exhibited better antifungal activity as compared to 
bacterial. The solvent acetone from Dunaliella sp. showed highest antioxidant activ-
ity. The results showed the presence of Octadecanoic acid-4-hydroxy-methyl ester, 
benzoic acid, hexadecanoic acid, and Tetradecanoic acid, confirming the bioactive 
compounds in the algal extracts [84].
5. Other marine sources of nutraceuticals
Besides the microbes (which contributes around 19%), there are other 
marine flora and fauna, such as sponges (38%), coelenterates (23%), algae (10%), 
echinoderms (7%), tunicates (7%), mollusks (3%), and bryozoans (2%), have 
also shown to exhibit their potential to produce various therapeutic compounds 
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including some novel anticancer substances. These compounds can also work 
against infectious diseases and inflammation [85].
6. Current market of nutraceuticals
Nutraceuticals, including functional foods and dietary supplements, have 
tremendous market potential. It has been estimated that the consumer demand of 
these health foods were around $250 billion only in 2014 alone and this figure is 
continue to rise and is expected to reach around $385 billion by 2020 [86].
Nutraceutical products are in demand throughout the world especially in 
developed countries, including United States of America (USA), Europe, Japan, 
Asia Pacific, Middle East, and Latin America. In particular, the global market is 
dominated by the United States of America, Europe, and Japan, which account 
for more than 85% of the market [87]. As per the Mintel survey carried out in the 
United Kingdom on vitamins and minerals supplements, it was observed that 25% 
of all adult populations were satisfied with the results of the nutraceutical products. 
The percentage of the usage varied according to the age of the consumers like the 
consumption of nutraceutical products was more common in elderly population as 
compared with the younger generation. There is a strong belief that in the com-
ing years, nutraceutical industry would remain at the forefront market including 
the Asian countries such as India and China. This is because of greater consumer 
awareness toward their health, increasing income levels and greater confidence in 
traditional and complimentary medicines [73].
The consumption of nutraceutical products in the USA is comparatively higher 
and accounts for approx. 40% of adults; in Spain, the nutraceuticals are consumed 
by the population aged between 35 and 80 years, and only around 9% consume 
dietary supplements as the source of vitamins and minerals. Besides, about 72% 
educated women that are of age between 35 and 49 years are more likely to choose 
nutraceuticals and dietary supplements [88].
In addition, the geriatric populations are also the most common consumers of 
these health supplements as they are more prone to micronutrient deficiencies. Due 
to the steady rise of geriatric population in developed countries, there is an urgent 
need to encourage and maintain a healthy lifespan and prevent chronic illnesses 
associated with aging [89].
Thus individuals with healthy lifestyles are more commonly the users of nutra-
ceutical products.
7. Conclusion
From the above discussion, it is quite pertinent to conclude that the marine 
environment harbors variety of microbial flora that have capability to produce a 
wide array of bioactive metabolites that can be used both in nutrition and pharma-
ceuticals to formulate new drugs that are effective against various drug-resistant 
pathogens. Though the saga of marine microbial bioactive metabolites is continuing 
with new compounds being added day by day, our knowledge is still a miniscule of 
what exists deep in the oceans. Interdisciplinary research and collaborative endeav-
ors are required amongst scientists, medical practitioners, marine microbiologists, 
and biotechnologists, to provide innovative approaches to marine based biomedical 
research. Thus, it is imperative to utilize our marine biodiversity and their bioac-
tive metabolites for discovering new therapeutic compounds of nutraceutical 
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addition, the microalgal strains exhibited better antifungal activity as compared to 
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compared with the younger generation. There is a strong belief that in the com-
ing years, nutraceutical industry would remain at the forefront market including 
the Asian countries such as India and China. This is because of greater consumer 
awareness toward their health, increasing income levels and greater confidence in 
traditional and complimentary medicines [73].
The consumption of nutraceutical products in the USA is comparatively higher 
and accounts for approx. 40% of adults; in Spain, the nutraceuticals are consumed 
by the population aged between 35 and 80 years, and only around 9% consume 
dietary supplements as the source of vitamins and minerals. Besides, about 72% 
educated women that are of age between 35 and 49 years are more likely to choose 
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In addition, the geriatric populations are also the most common consumers of 
these health supplements as they are more prone to micronutrient deficiencies. Due 
to the steady rise of geriatric population in developed countries, there is an urgent 
need to encourage and maintain a healthy lifespan and prevent chronic illnesses 
associated with aging [89].
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importance. Recent biomedical tools, such as metabolomics and genetic engineer-
ing, can also be applied to increase their yield.
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